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 The ability of music to produce calming effects on us is well documented, and its use is 
becoming an increasingly accepted intervention with populations displaying agitated and 
disruptive behaviors, such as people with Alzheimer’s disease (AD) or other dementias. One 
reason for its widespread use is because research has demonstrated music’s efficacy in reducing 
agitation, and consequently disruptive behaviors, in those with AD. Prior studies on music’s 
effects on agitation in older people with AD have utilized either recorded music used passively, 
or active sessions with a music therapist or musicians, but none have compared the effects of 
each type of intervention. The purpose of the current study is to examine music’s effects on 
levels of agitation in people with AD or other dementias. The research design is quasi-
experimental, utilizing a convenience sample of people with AD who live at home and are cared 
for by an informal caregiver. The current study is unique in several ways. First, past studies of 
music interventions with people with AD and related dementias have used either passive or 
active interventions, but have not compared the effects of both as the current study attempts to 
do. Next, past studies of music therapy with people with dementia have not examined how 
participation during the music sessions affects agitated behaviors. Past studies have demonstrated 
variations in participants’ responses to music therapy and activities, and this may be due to 
whether or not the participant is actually engaged with the intervention. This study assesses 
engagement by including participation as a variable. Lastly, the current study utilizes a unique 
sample of people with AD and related dementias who will continue to live at home during the 
course of the study.
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CHAPTER 1: INTRODUCTION 
 A famous proverb states that “music has charms to soothe a savage breast” (note: often 
misquoted as “beast”; Congreve, 1697). Music’s use as a tool for physical relaxation and 
emotional regulation dates back to ancient times, and is even mentioned in the bible when David 
plays the lyre (i.e., a small harp) for King Saul and he is “relieved and feels better” (online bible, 
www.bible.com). Mounting evidence in social science research of how music has a calming 
effect on us has demonstrated music’s poignant effects (Ledger & Baker, 2007; Sung & Chang, 
2005; Witzke, Rhone, Backhaus, & Shaver, 2008), and actual neuro-physiological changes have 
been confirmed in neuroscience research as well (Andrade & Bhattacharya, 2003; Sacks, 2008). 
The ability of music to produce calming effects on us is well documented, and its use is 
becoming an increasingly accepted intervention with populations displaying agitated and 
disruptive behaviors, such as people with Alzheimer’s disease (AD) or other similar dementias 
(Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & Chang, 2005; Witzke, et al., 2008), 
and children with autism spectrum disorders (Gold & Wigram, 2007; Whipple, 2004). Beyond 
having a soothing effect, the use of music has also been implicated in pain control (Kneafsy, 
1997), improving verbal communication (Gotell, Brown, & Ekman, 2009), and enhancing 
cognitive abilities, such as short-term memory (Baker, 2001; Carruth, 1997), in a variety of 
populations, including people with AD. 
Music therapy, music activities, and the use of recorded music are becoming 
progressively acknowledged methods for intervening with the agitation and disruptive behaviors 
associated with AD, and are also considered a good source of cognitive stimulation for those 
suffering (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sacks, 2008; Sung & Chang, 2005; 
Witzke, et al., 2008). Music’s utility as an emotional regulator and a source of cognitive 
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stimulation has been demonstrated in many prior studies, and reducing negative emotions such as 
anxiety and stimulating cognition such as memory, can increase the quality of life of people 
suffering from AD (for a thorough review of literature, see Chapter 4). One reason for its 
widespread use is because research has demonstrated music’s efficacy in reducing agitation, and 
consequently disruptive behaviors, in those with AD, and because the use of music as an 
intervention can be relatively easy to implement (Gardiner & Furois, 2000; Ledger & Baker, 
2007; Sung & Chang, 2005; Witzke, et al., 2008).  
Music interventions can be as simple and straightforward as playing recorded music to 
AD sufferers (i.e., a passive music intervention) (e.g., Sung & Chang, 2005; Witzke, et al., 
2008), although singing and/or playing simple instruments in a group and/or individual setting 
with a music therapist (i.e., an active music intervention) has also been shown to be effective in 
treating the agitated symptoms of AD (e.g., Gardiner & Furois, 2000; Ledger & Baker, 2007). 
Prior studies on music’s effects on agitation in people with AD have utilized either recorded 
music used passively (Sung & Chang, 2005; Gerdner, 1997, 2001), or active sessions with a 
music therapist or musicians (Gardiner & Furois, 2000; Ledger & Baker, 2007), but none have 
compared the effects of each type of music intervention. Reducing agitation in people with AD 
may not reduce instances or slow the progression of the disease- which is far beyond the scope of 
this research- but it may improve the quality of life of both AD sufferers and those around them. 
Prevalence and Scope of Alzheimer’s Disease 
There are an estimated 36 million adults worldwide who are currently living with AD or 
other similar types of dementia (Alzheimer’s Association, 2011), with 5.4 million of those 
instances occurring within America (Alzheimer’s Association, 2012). The number of AD 
diagnoses is continually increasing, as much as one new diagnosis every 68 seconds, making AD 
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the most prevalent type of dementia found in older adults worldwide (Alzheimer’s Association, 
2011; Hayslip, Han, & Anderson, 2008; Parks & Novelli, 2005; Richter & Richter, 2004). The 
2000 U.S. Census data estimated that there are 73,000 people in Louisiana alone living with 
Alzheimer’s disease, and this is projected to increase by 14% to 83,000 in the 2010 census 
(Alzheimer’s Association, 2012; Herbert & Scherr, 2003). This is projected to continue to 
increase up to 100,000 by 2025 (Alzheimer’s Association, 2012). This projected increase is 
largely due to the rising average age of the population. Once older adults reach the age of 65 and 
beyond, both normal and abnormal age-related cognitive decline, and also the risk of developing 
senile dementia including AD, continue to  increase (Richter & Richter, 2004; U.S. Department 
of Health and Human Services, 2011). Alzheimer’s Association (2012) estimates that 11% of 
men and 16% of women aged 71 and over have some form of dementia, and almost half (45%) 
of people over the age of 85 have AD (Alzheimer’s Association, 2012). While advancing age has 
the biggest influence on developing AD, it can also occur in people under the age of 65.   
Younger-Onset Alzheimer’s Disease 
AD is commonly thought of as a disease affecting those older than 65 years of age, 
although younger-onset Alzheimer’s disease (YOAD), which occurs in people younger than the 
age of 65, also affects a significant number of people (Alzheimer’s Association, 2012). A large, 
national survey of people age 50 and older in the U.S. estimated that 480,000 people age 55-64 
had some form of cognitive impairment severe enough to be considered disabling (Ofstedal, 
McAuely & Herzog, 2002). Disabling cognitive impairment in this study was at a level 
equivalent to a dementia diagnosis; that is, it was severe enough to significantly interfere with 
daily activities. Using this and other survey data, the Alzheimer’s Association (2011) estimated 
that there are approximately 500,000 people in the U.S. under age 65 with some form of 
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dementia, with approximately 200,000 people specifically having YOAD. YOAD and other 
younger-onset dementias usually progress much more rapidly than dementias found in people 
over age 65, making them an even greater concern. In addition, 6-10% of people over age 65 
diagnosed with dementia were reported to have had symptoms that appeared before age 65, with 
onset sometimes as young as age 40 (Alzheimer’s Association, 2006). The pervasive effects of 
AD, particularly in instances of YOAD, continue to increase AD’s cost to society.  
Societal and Individual Effects of Alzheimer’s Disease 
The high frequency of AD in the population has devastating costs to not only those 
afflicted and their close relatives and caregivers, but also to society as a whole. Numerous 
economic studies have shown that AD costs American businesses and Medicare and Medicaid 
billions of dollars annually, with the current, national annual cost estimated at $172 billion and 
worldwide cost at $604 billion USD (Alzheimer’s Association, 2011). This current cost is nearly 
triple what it was only 10 years ago, and this cost to society is projected to continue rising 
steadily (Alzheimer’s Association, 2011). Several factors add to the expenditure of AD in 
America. Some of these are increasing direct healthcare and nursing home costs, increases in 
Medicare and Medicaid reimbursements for services, and impacts on caregivers’ and care 
recipients’ employment, such as missed work and lost productivity (Alzheimer’s Association, 
2012; Scott, Roberto, Hutton,  & Slack, 1985).  
 AD and other dementia caregivers also struggle with the enormous burden associated 
with meeting the daily needs of those with the disease, and particularly with watching the 
progressive, functional decline of a loved one (Alzheimer’s Association, 2012; Vitaliano, Zhang, 
& Scanlan, 2003). Some services offered by both national and local dementia-focused programs 
are specifically designed to decrease caregiver burden, including respite care, psychoeducation 
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and training, and support groups for caregivers (Alzheimer’s Association and National Alliance 
for Caregiving, 2004; Vitaliano, et al., 2003). Respite programs provide temporary relief from 
caregivers’ duties while also providing direct care to the clients with AD and other dementias. 
Respite programs often include cognitively-stimulating activities and social interventions that are 
offered to the clients who attend. Among these may be arts and crafts, gardening, light physical 
exercise, storytelling, cooking classes, game playing, and music and pet therapy that may help 
assuage agitation and other symptoms in clients with dementias.  
Agitation in Alzheimer’s Disease 
One hallmark of AD as it progresses is increasing levels of agitation (Gardiner & Furois, 
2000; Ledger & Baker, 2007; Richter & Richter, 2004; Sung & Chang, 2005; Witzke et al., 
2008). Agitation often results from feelings of frustration commonly experienced by the AD 
sufferer of not being able to function, either cognitively or physically, or be able to express 
oneself, as well as one once has before acquiring the disease (Gardiner & Furois, 2000; Ledger & 
Baker, 2007; Sung & Chang, 2005; Witzke, et al., 2008). These feelings of frustration can often 
lead to agitated and aggressive, sometimes disruptive behaviors if nothing is done by caregivers 
or others to intervene (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & Chang, 2005; 
Witzke, et al., 2008).   
Additionally, agitation and the resultant behaviors in AD sufferers are frequently reported 
by caregivers to be the most challenging aspect of their duties (Sung & Chang, 2005; Witzke, et 
al., 2008). The presence of agitation in people with AD and related dementias adds burden onto 
their caregivers and can also negatively influence the caregivers’ perceptions toward the care 
recipients (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & Chang, 2005; Witzke, et al., 
2008). Reducing the agitation associated with AD and the related behaviors in people with AD 
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can improve the quality of life of both AD sufferers and those around them, including their close 
family and other relatives, who are often also their caregivers. Many psychosocial interventions 
are known to have calming effects, including the use of music, and can be utilized by both 
professional and informal caregivers, social workers, and others who work with people with AD 
and other forms of dementia, along with medical treatment, for this application.  
Treatment of Alzheimer’s Disease 
Treatment of AD with the use of medications is becoming increasingly common; 
however, because of the limited focus of only mildly enhancing cognitive and sometimes also 
physical functioning, it is important to consider all possible interventions that are available. 
Because of the well-known limited efficacy in treating AD using the currently available 
medications, many psychosocial interventions that provide cognitive stimulation or social 
engagement are usually also a part of treatment regimens. While there is no treatment that can 
completely ameliorate the disease, it is becoming increasingly clear that there are many methods, 
including psychosocial interventions such as music therapy and other interventions involving 
music, which when used together, may help to temporarily prevent or at least slow the worsening 
of some of its symptoms once AD has appeared.  Individualized, multidisciplinary treatment 
regimens, including psychosocial interventions that provide cognitive stimulation and social 
support such as group music interventions provide, and also medications when necessary, appear 
to be the best treatments available for AD at this time.    
Purpose and Conceptual Framework 
The purpose of the current research study is to examine music’s effects on levels of 
agitation in people with AD. The research design utilized is a quasi-experimental design using a 
convenience sample of people with AD who live at home and are cared for by an informal 
7 
 
caregiver (e.g., family member or friend). There were two levels of music intervention (the 
primary independent variable) used while assessing agitation levels (the dependent variable). The 
levels of intervention were active, in which a musician performed live and encouraged singing 
along, and passive, in which recorded music consisting of popular songs from the 1940’s through 
the 1960’s or other music were played for participants. The design of this study is based on 
testing the following hypotheses:  
Hypothesis 1: The level of music intervention (e.g., passive and active) will influence 
agitation differently in people with AD;  
Hypothesis 2: Agitation is expected to be reduced during the intervention when compared 
to baseline measurements;  
Hypothesis 3: Greater participation (e.g., if participants sing or clap rather than simply 
listen) will result in greater reductions of agitation whether the intervention is active or 
passive;  
Hypothesis 4: The active form of music intervention in which participation is encouraged 
will result in greater reductions in agitation than the passive form.  
That is, it is expected that the active intervention will lead to greater participation in music 
therapy, and thus greater reduction in agitation in people with AD and related dementias. During 
the passive intervention prerecorded music will simply be played for participants without 
encouraging singing; however, participation will still be measured since participants may also 
sing along or participate by moving in rhythm to the recorded music (e.g., tapping foot, 
clapping).   
Few prior studies of music’s effects on agitation in people with AD and related dementias 
have been conducted using a true experimental design, where a large random sample was 
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randomly assigned to treatment or matched conditions, to this author’s knowledge. This is likely 
due to feasibility issues of such a study. Therefore, like research in almost any field using human 
participants, the research on music’s effects in people with AD suffers from the various threats to 
both internal and external validity, including many confounding variables that also influence 
agitation in people with AD. The current study, while not adhering to the “gold standard” of a 
true experimental design, utilized strong research methodology which helped control for some of 
these various confounds, and will therefore contribute original knowledge to the field.  
Planned Contributions of the Current Study 
 The current study of music’s effects on agitation in people with AD is unique in several 
ways. First, past studies of music interventions with people with AD and related dementias have 
used either passive or active interventions, but have not compared the effects of both. Since this 
study compares both types, it may provide evidence of what type of intervention is most 
efficacious and allow for those implementing music interventions for people with AD to utilize 
best practices. Next, past studies of music therapy with people with AD have not examined 
participation during the music sessions. Past studies have demonstrated variations in participants’ 
responses to music therapy and activities, and this may be due to whether or not the participant is 
actually engaged with the intervention. Participants with AD and related dementias may be less 
responsive during music sessions for a variety of reasons, such as tiredness, hunger, not enjoying 
music, or numerous other factors, all of which could not be assessed in any feasible study. While 
the countless factors influencing participation in music sessions could not be realistically 
assessed, actual participation can be assessed relatively easily. No prior studies have examined 
participation as a variable affecting the outcome of music sessions in people with AD to this 
author’s knowledge. Examining participant engagement could provide insight into the best 
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methods of engaging clients in music interventions, and therefore help them get the most out of 
the sessions.  
 Lastly, most prior studies on music’s effects on agitation in people with AD have been 
done with residents in assisted-living facilities, such as nursing homes (e.g., Ledger & Baker, 
2007). While residents of these facilities are provided with a more structured environment, they 
are usually exposed to multiple treatment interventions and activities throughout the day, which 
may make it difficult to separate the effects of music from other treatments included in 
participants’ regimens. Only one small, pilot study has been done on music therapy’s effects on 
people with AD who live at home and are cared for by a family member; however, this study 
required that participants all stay together with their caregivers in a residential facility during the 
course of the study, which may have affected the outcome (Gerdner, 2005).  People with AD and 
related dementias who do not live in assisted-living facilities encompass a large proportion of the 
population of people with AD. Studying music’s effects in this population will help further the 
generalizability of music interventions and may provide informal caregivers a potential method 
of reducing agitation in their care recipients that they could implement at home. The current 
study utilized a sample of people with AD and related dementias who continued to live at home 
during the course of the study, and had already been receiving weekly music sessions at a respite 
center. Therefore, this study did not manipulate participants’ daily routines, allowing for 
naturalistic observations of the effects of participation in music activities in a unique sample of 
people with AD living at home.    
This research utilized a quasi-experimental design that was intended to study music’s 
effect of decreasing agitation in people with AD. Agitation in participants with AD in this design 
was measured by the Cohen-Mansfield Agitation Inventory (CMAI; Cohen-Mansfield, 1997) 
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and the Richmond Agitation-Sedation Scale (RASS, Sessler, et al., 2002). Music therapy 
interventions that were used include both active participation in live music sessions through 
singing, clapping, and other movements to popular songs, and passive listening to prerecorded 
music. These were compared to baseline measures during times when music was not played, but 
participants were assessed for agitation levels. Agitation levels were assessed on a weekly basis 
both before and after the music interventions were implemented in order to demonstrate the 
changes resulting from them. Although the study lasted for 10 weeks, no long-term effects were 
expected due to a lack of long-term effects in prior research (Ledger & Baker, 2007). The length 
of the study adds weight to the findings through replication of assessments each week. Reduced 
agitation during music interventions as compared to assessment times without music was 
anticipated.   
Conclusion 
 The use of music interventions to reduce agitation and improve wellbeing among 
individuals with AD and related dementias has been demonstrated in many prior studies (e.g., 
Baker, 2001; Brotons & Marti, 2003; Gerdner, 2001, 2005; Gotell, Brown, & Ekman, 2009; 
Hicks-Moore, 2005; Janata, 2012; Ledger & Baker, 2007; Sung & Chang, 2005). However, the 
majority of these studies had methodological limitations that possibly affected both the internal 
and external validity of the findings. The current study focused on music therapy and musical 
activities and their utility in treating agitation associated with Alzheimer’s disease (AD) and 
related dementias. Both active and passive forms of music therapy were utilized and compared, 
and participation and engagement with the intervention were also measured. The study also 
included a unique population of people with dementia who remained living at home during the 
course of the study. Music’s beneficial effects on cognition and behavior are examined in people 
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with Alzheimer’s disease and related dementias and also other populations through a thorough 
review of literature in this area. The efficacy of music to reduce agitation and disruptive 
behaviors associated with AD and related dementias are given extra emphasis since this is the 
primary area of interest for the current study.  
Chapter 2 thoroughly explores and discusses many aspects of AD, including the use of 
psychosocial interventions such as music therapy in treatment. AD is known to affect not only 
cognitive functioning, but physical and social functioning as well. Psychosocial interventions 
such as music therapy are often used in conjunction with other treatment methods to help 
ameliorate agitation and other symptoms associated with the disease. This chapter will discuss 
the history, prevalence, risk and protective factors, symptoms of cognitive and physical 
dysfunction, criteria and stages for diagnosis, and available treatments associated with the most 
common type of dementia —AD— found in older adults.  
Next, chapter 3 examines possible underlying theoretical mechanisms for music’s 
soothing effects in both normal and diseased populations, including people with AD. The effects 
of music discussed include both biological and neurological changes in listeners along with the 
subjective experiences of lowering stress and anxiety based on self-report in listeners. Music as a 
means of communicating emotions and its evolution as a primary method of communication are 
discussed with a focus on communication and regulation of emotions, particularly for stress and 
anxiety release.  Music’s link to and effects on autobiographical memory are also examined since 
specific pieces of music are often associated with significant life events. While the exact 
underlying mechanism for music’s ameliorating effect on agitation in people with AD may not 




This chapter concludes with a discussion of relevant theories to the use of music for treating the 
symptoms of AD. 
Chapter 4 conceptualizes music therapy by exploring various definitions, including the 
methods and techniques that are commonly used in treatment. Next, this chapter explores 
different types of music therapy, and discusses the potential benefits and any possible negative 
effects associated with it, in a variety of populations. Consequently, applications of music 
therapy to other disorders besides AD are briefly discussed in order to demonstrate music 
therapy’s broad utility. A thorough review of the literature regarding the treatment of agitation 
with music in people with AD, and the limitations of this research, including internal and 
external validity issues concludes Chapter 4. Reducing agitation can improve the quality of life 
of both dementia sufferers and those around them, including their caregivers and their close 
family and other relatives and loved ones. Agitation levels were mostly reduced after receiving 
either active or passive types of music interventions in the research examined in this chapter, 
demonstrating the efficacy of music therapy and other music interventions for people with 
dementia.   
 Prior studies on music’s effects on agitation in people with AD, however, have utilized 
either recorded music used passively (Sung & Chang, 2005; Witzke, et al., 2008), or active 
sessions with live music (Gardiner & Furois, 2000; Ledger & Baker, 2007), but have not 
compared both. The current study outlined in Chapter 5 focuses on comparing the effects of both 
active and passive music interventions in order to determine which has greater effects on 
agitation levels in people with AD. Further research in this area may not only help reveal the 
beneficial influences of music therapy on individuals with AD, but could also improve 
multidisciplinary treatment regimens for AD sufferers, AD treatment efficacy, and the overall 
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wellbeing of individuals with AD and their caregivers. The current study utilized a quasi-
experimental design based on Gerdner’s (1997) theoretical model for music’s effect of reducing 























CHAPTER 2: CONCEPTUALIZATION OF ALZHEIMER’S DISEASE 
Alzheimer’s disease (AD) has not only captured the attention of older adults who are 
concerned about developing it, but also that of gerontology researchers worldwide. This is partly 
because of the increasing life expectancy of persons living today and the consequential diseases 
related to aging such as AD (Alzheimer’s Association, 2012). Medical advances are now 
allowing life spans that reach beyond a hundred years, something that was virtually unheard of 
just a short time ago. Because of the increasing number of older adults in the world, there is a 
growing concern of preserving their functioning late in life. Older adults want to have the 
physical and mental capacity to fully participate in the expanding number of years left in their 
lives and also preserve their wisdom and memories of experiences they have already had. 
Consequently, there has been a dramatic increase in published research on AD within the last 
two decades. Advances in science have demonstrated that it is not inevitable to completely lose 
your cognitive functional capacity, including memory, concentration, and problem solving 
ability, with advancing age. However, once older adults reach their mid-seventies, the magnitude 
of age-related cognitive decline and the risk of developing senile dementia significantly increase 
(Richter & Richter, 2004; U.S. Department of Health and Human Services, 2011). AD is known 
to affect not only cognitive functioning, but physical and social functioning as well. This chapter 
will discuss the history, prevalence, risk factors, diagnosis and cognitive dysfunction associated 
with AD, the most common type of dementia found in older adults. 
History of Alzheimer’s Disease 
 Alzheimer’s disease (AD) is named after Alois Alzheimer, who is frequently credited for 
discovering the disease early in the 20th century (Berrios, 1990; Maurer, Yolk, & Gerbaldo, 
1997). However, age-related cognitive decline, which has many potential causes, has been 
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recognized throughout history (Berrios, 1990). Furthermore, the association between brain 
pathology and mental functioning in the elderly was clearly identified decades before Alzheimer 
put a specific name to the disease (Mandell & Green, 2011). However, senile dementia was the 
general clinical term used for age-related cognitive decline and no distinctions of different causes 
for dementia were typically made at that time (Berrios, 1990). Alzheimer, however, was the first 
to keep a detailed account of an instance of AD with the case of Auguste D. (Maurer, Yolk, & 
Gerbaldo, 1997).  
 Alzheimer was confronted with Auguste D.’s case in 1901, with symptomology of “a 
sudden change in her behavior, dominated by panic, terror, and suspicions of [the husband] 
having an affair with the neighbor” and “weakening of memory, persecution mania, 
sleeplessness, restlessness… rarely free of fear and agitation” (p. 3, Mandell & Green, 2011). 
Auguste D. was hospitalized and never released because of the severity of her symptoms. This 
allowed Alzheimer to work with Auguste D. closely, and after her death Alzheimer was allowed 
to examine her brain and note the physical changes that he found (Maurer, Yolk, & Gerbaldo, 
1997). While dementia was already a term in clinical use at this time, Alzheimer distinguished 
AD with the physical changes in the brain he had found in Auguste D. (Maurer, Yolk, & 
Gerbaldo, 1997). Alzheimer presented his case in a 1907 article describing what he had found as 
possible underlying causes for the disease. These changes included the recognition of plaques 
and tangles within the brain that are still considered primary aspects of AD today (Mandell & 
Green, 2011; Maurer, Yolk, & Gerbaldo, 1997).    
 The earliest instance of use of the diagnosis of AD, besides by Alzheimer himself, was in 
1908 (Maurer, Yolk, & Gerbaldo, 1997). AD became regularly used as a diagnosis at this time, 
and for the next 50 years, for instances of “presenile dementia” in order to distinguish it from 
16 
 
what was considered normal “senile dementia” (p. 4, Mandell & Green, 2011). Senile dementia 
was considered a normal, inevitable part of aging at the time (Berrios, 1990). Alzheimer, 
however, noted that AD was not a precursor to senile dementia by pointing out that there were 
not significant differences in AD cases based on age (Maurer, Yolk, & Gerbaldo, 1997). 
Nonetheless, senile dementia remained thought of as a normal aspect of the aging process late 
into the 1940’s, with AD thought of as a precursor (Maurer, Yolk, & Gerbaldo, 1997; National 
Institute on Aging & National Institutes of Health, 2011).   
 It wasn’t until the 1950’s that scientists began to examine the structures of the plaques 
and tangles associated with AD (National Institute on Aging & National Institutes of Health, 
2011). In the 1960’s when a strong association could be made between the plaques and tangles 
within the brain and having dementia, AD became accepted as a separate entity from senile 
dementia, and not a normal part of aging (Mandell & Green, 2011; Maurer, Yolk, & Gerbaldo, 
1997). Plaques and tangles have continued to be researched, and are discussed further under the 
“Characteristics of Alzheimer’s Disease” section in this chapter.  
The 1970’s led to discoveries of other biomarkers of AD, including low levels of the 
neurotransmitter acetylcholine (Ach; National Institute on Aging & National Institutes of Health, 
2011). Ach is the primary neurotransmitter associated with learning and memory within the 
brain, and most of the drugs available today for treating AD are Ach agonists (i.e., boost Ach; 
Alzheimer’s Association, 2012). It has been demonstrated consistently in prior research that 
persons with AD show severe deficits of Ach, and drugs that boost Ach have proven useful for 
slowing the progression of some symptoms of the disease (Alzheimer’s Association, 2012; 
Richter & Richter, 2004). These drugs, however, have proven to have limited utility in treating 
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AD, so other underlying mechanisms for AD were still suspected, including a genetic 
connection.  
Genetic links for acquiring younger-onset AD were beginning to surface in the 1980’s 
(National Institute on Aging & National Institutes of Health, 2011). However, genetic coding 
was in its infancy at this time, therefore no robust associations could be made for genetic causes 
for most instances of AD (Alzheimer’s Association, 2012). Even today when one can be more 
easily tested for carrying the suspected genes, in most cases genetics only play a small role in the 
risk of acquiring AD (Alzheimer’s Association, 2012). Research has shown that even for people 
with a strong family history of younger-onset AD, only roughly 50 percent of cases are related to 
a known genetic defect, and that about 75 percent of all types of AD are classified as sporadic, 
occurring in individuals from families with no history of the disease (Alzheimer’s Association, 
2012). This means that only about 25% of all instances of AD are estimated to be due to 
hereditary influences.  
 More importantly, biological pathways for the build-up of beta-amyloid plaques between 
neurons in the brain and the abnormal tau protein within the neurons causing tangles were 
beginning to be understood in the 1980’s (see Characteristics of Alzheimer’s Disease in this 
chapter for further explanation; National Institute on Aging & National Institutes of Health, 
2011). Diagnostic criteria for AD were also created in the 1980’s and are still in use today 
(Alzheimer’s Association, 2012; McKhann et al., 2011). Although recent changes to diagnostic 
guidelines have been proposed, they are not yet in widespread use, and most clinical settings still 





In the 1990’s additional genetic mutations thought to be partially responsible for 
acquiring AD were discovered (National Institute on Aging & National Institutes of Health, 
2011). Although separate genes for both early-onset and late-onset forms of AD were identified, 
the genetic link still remained largely unclear due to the majority of sporadic instances 
(Alzheimer’s Association, 2012). Additionally, virtually all sporadic cases are late-onset 
(Alzheimer’s Association, 2012), and while the exact cause of these cases is not known, it is 
believed that genetics may still play a part. One major genetic factor that was identified as a 
likely contributor to developing AD is the presence of the APOE-e4 allele, the primary gene 
which is suspected as playing a role in developing AD late in life (Alzheimer’s Association, 
2012; Richter & Richter, 2004). Although having the APOE-e4 allele is a well-known risk factor 
for developing late-onset AD, people with two APOE-e4 alleles (i.e., one from each parent) 
exhibit an earlier age of onset, and also show higher beta-amyloid plaque counts and marked 
reductions in Ach as compared to non- APOE-e4 allele carriers (Alzheimer’s Association, 2012; 
Richter & Richter, 2004). The APOE-e4 allele provides one potential biomarker for AD that is 
often used to facilitate diagnosis, especially in recently proposed diagnostic criteria for AD (see 
Diagnosis of Alzheimer’s Disease below for further explanation; McKhann et al., 2011).  
 The 1990’s also brought the distinction of Mild Cognitive Impairment (MCI) from AD 
(National Institute on Aging & National Institutes of Health, 2011). While MCI can be a 
precursor to AD, it is now distinguished as a separate diagnosis, sometimes caused by AD and 
sometimes by other causes (see section on MCI in this chapter; Alzheimer’s Association, 2012; 
National Institute on Aging & National Institutes of Health, 2011). Also important in this decade 
is the appearance of the first drugs used to treat AD. While the drugs helped with slowing the 
progression of some symptoms of AD, they were still quite limited, not unlike the current drugs 
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available today (Alzheimer’s Association, 2012; U.S. Department of Health and Human 
Services, 2011).  
 The 2000’s brought about other drugs for the treatment of AD, although, they were still 
limited to affecting only certain symptoms of the disease (Alzheimer’s Association, 2012; 
National Institute on Aging & National Institutes of Health, 2011). Additionally, these drugs 
merely slow the progression of worsening of symptoms, and do almost nothing for the actual 
physical deterioration of the brain associated with AD (U.S. Department of Health and Human 
Services, 2011). A vaccine acting on eliminating the beta-amyloid plaque build-up in the brain 
was also being researched in this decade, although it was found not to have a significant effect on 
AD (U.S. Department of Health and Human Services, 2011). Research on the prevention of AD, 
including other vaccination methods, is still underway (U.S. Department of Health and Human 
Services, 2011; Williams, Plassman, Burke, Holsinger & Benjamin, 2010).  
Several other genes have also been discovered during this time that have some influence 
on developing AD, although the link between these genes and the risk of developing the disease 
is not as strong as for APOE-e4 (U.S. Department of Health and Human Services, 2011; 
Williams et al., 2010). These more recently discovered genes, however, along with APOE-e4, all 
seem to be involved in similar biological pathways, which may partially explain their influence 
and also possibly elucidate some of the underlying biological processes involved in AD. The 
presence of the APOE-e4 allele or the other abovementioned genes in persons with AD 
demonstrate their possible genetic influence on the risk of developing the disease, however, it 
does not make acquiring AD inevitable for the most part. It merely raises the odds of developing 
the disease, and current researchers consider the overall genetic influence on risk of AD to be 
only modest (U.S. Department of Health and Human Services, 2011; Williams et al., 2010).  
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The one exception to the inevitability of acquiring AD is genetic mutations discovered 
during this time, which are responsible for less than 1% of instances of the disease (Alzheimer’s 
Association, 2012). There are three known genetic mutations that can be considered underlying 
causes of AD. In all three mutations the genes are involved in abnormal protein synthesis, with 
one specifically affecting a beta-amyloid precursor (National Institute on Aging & National 
Institutes of Health, 2011). However, the other two mutations, while not direct precursors, are 
also involved in the production of beta-amyloid. These genetic defects almost guarantee 
developing AD, and usually with a younger onset. People with these genetic defects normally 
will develop symptoms before the age of 65, with symptoms sometimes starting as young as age 
30 (Alzheimer’s Association, 2012). Because these genetic defects are involved in either 
dysfunctional production or clearance of beta-amyloid, this demonstrates a robust link in the 
accumulation of beta-amyloid in the brain and having AD (Alzheimer’s Association, 2012; U.S. 
Department of Health and Human Services, 2011). Because of the strength of association 
between these genetic mutations and beta-amyloid and acquiring AD, these biomarkers that are 
now able to be detected early on can be a reliable source for diagnosis.   
 The most recent developments in AD research include the advancements in biomarkers, 
including neuro-imaging technology that allows the plaques in the brain to be revealed without 
the previously required posthumous examination of the brain (Alzheimer’s Association, 2012). 
Neuro-imaging, however, is far from perfect. Images of the brain with the technology available 
today may reveal possible plaque build-up between neurons, although the imaging resolution is 
not high enough to reveal individual neurons or the presence of tau protein within the neuron 
(U.S. Department of Health and Human Services, 2011). While tau proteins cannot be positively 
identified with brain imaging, the loss of functioning or shrinkage within specific areas of the 
21 
 
brain can be revealed and often indicate the accumulation of tau protein (Alzheimer’s 
Association, 2012; U.S. Department of Health and Human Services, 2011). The biomarkers of 
this brain dysfunction and shrinkage that results from the presence of plaques and tangles, while 
not perfect, can make definitive diagnoses of AD more probable.   
 Other biomarkers include the abnormal presence of beta-amyloid and tau protein in 
cerebrospinal fluid or blood, which also does not require physical examination of the brain after 
death (Alzheimer’s Association, 2012; National Institute on Aging & National Institutes of 
Health, 2011). The amount of beta-amyloid and tau protein in cerebrospinal fluid and blood is 
thought to be an indicator of their levels within the brain. This, along with neuro-imaging, can 
reveal a greater possibility of a positive AD diagnosis than ever before.  Biomarker technology is 
mostly what led to proposed changes in the diagnostic criteria for AD in 2011 (McKhann et al., 
2011), but, because of the relative inaccuracy of biomarkers due to the current state of the 
technology available, biomarkers cannot be relied on as the sole method of diagnosis for AD (see 
section on Diagnosis of Alzheimer’s disease; Alzheimer’s Association, 2012; McKhann et al., 
2011). However, these recent advancements in AD research do help increase the understanding 
of the biological pathways and possible underlying causes of the disease. Although the etiology 
of AD remains largely unknown (Alzheimer’s Association, 2012; National Institute on Aging & 
National Institutes of Health, 2011), research continues to uncover additional, potential 
biological pathways, as physiological mechanisms underlying the symptomology of the disease. 
Recent research has discovered myriad potential biophysiological factors which may 
influence a person’s risk of developing AD; however, evidence for the influence of most is 
sparse or weak at the present time (Alzheimer’s Association, 2012; U.S. Department of Health 
and Human Services, 2011).  Research is currently in progress on discovering the exact functions 
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of some newly-discovered genes and other biophysiological mechanisms associated with AD, 
and continuing advancements in technology are making this research more promising. However, 
this means that currently, the actual cause and risk of developing AD may be too complex to be 
fully understood (Alzheimer’s Association, 2012). For many years it was assumed that 
developing AD or related dementias with advancing age was unavoidable and could not be 
prevented or postponed in one’s senior years (e.g., senile dementia), but, because the genetic 
influence is not the definitive cause in the majority of cases, and because many other factors are 
involved including some lifestyle factors that are modifiable, almost no one is absolutely 
destined to get AD (Alzheimer’s Association, 2012; Richter & Richter, 2004; Williams et al., 
2010). Although the advancements in the research of genetic factors and biological pathways 
involved in AD do not point to definitive etiology of the disease, they have revealed greater 
knowledge of potential physiological mechanisms involved in AD that underlie its psychological 
symptomology. This deeper understanding of AD has allowed for earlier and more accurate 
diagnoses largely due to the better assessment of both biomarkers and symptoms of the disease.  
Even with early detection, AD will always have pervasive biopsychosocial effects, but it does 
not affect all individuals the same, putting some more at risk than others.  
Risk Factors for Alzheimer’s Disease 
              Age. The greatest known risk factor in developing AD is increasing age, with the 
majority of individuals with the disease aged 65 years and older (Alzheimer’s Association, 2012; 
Richter & Richter, 2004). Research shows that the likelihood of developing AD approximately 
doubles every five years after 65 years of age (Williams, Plassman, Burke, Holsinger & 
Benjamin, 2010). Lifetime risk of developing AD in people aged 65-74 is estimated at only 9.1% 
for men and 17.2% for women, while the risk of developing AD for people over 85 is 
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astoundingly 45% (Alzheimer’s Association, 2012). At the current time, little is known about 
why this risk increases so drastically with advancing age.  One theory, based on animal models, 
posits that as the brain ages, it becomes less resilient to stress, which may accelerate cognitive 
decline since stress is known to cause degenerative changes within the brain (U.S. Department of 
Health and Human Services, 2011). The increased effects of stress due to age-associated 
cognitive decline has been specifically applied to AD by Hall and Buckwalter (1987), who 
created the Progressively Lowered Stress Threshold (PLST; see chapter 3 for further 
explanation). These theories point out that the escalating effects of stress may partially explain 
the increasing risk of developing AD as people age. Although advancing age is known to 
increase the likelihood of developing AD, it is important to note that aging and other risk factors 
are not the cause of the disease. The underlying reasons for the risk of developing AD with 
advancing age are still largely unknown (Alzheimer’s Association, 2012; Richter & Richter, 
2004). 
             Gender. Another possible risk factor for developing AD is one’s gender. Development 
of AD is far more widespread amongst women than amid men, with estimates at 2/3 of all AD 
cases being women (Alzheimer’s Association, 2012). This could be simply because of the 
significantly greater number of older women as compared to men, and does not necessarily 
represent a true gender difference (Alzheimer’s Association, 2012; Richter & Richter, 2004).  
Because of women’s relative longevity compared to men, the incidence rate of AD is naturally 
going to be higher among them since advanced age is a primary risk factor. For Americans over 
70, it is estimated that 16% of women (3.4 million), and only 11% of men (1.8 million) have AD 
(Alzheimer’s Association, 2012). Some researchers assume women may be slightly more at risk 
than men in developing AD, even when accounting for the fact that they live longer (Richter & 
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Richter, 2004). However, this evidence for a gender effect has been shown to interact with age. 
Some studies have shown that women may become more at risk above the age of 80, while other 
research suggests that being female is not a risk factor until over 90 years of age (Richter & 
Richter, 2004). Results from a large cohort study of the Dutch suggest that at a very old age, 
women may be more likely to have AD, while the risk of developing vascular dementia is larger 
for men (Richter & Richter, 2004). Nonetheless, Alzheimer’s Association (2012) reports that 
once age is completely controlled for, gender has only a small effect and is not a significant risk 
factor for developing AD. Overall, it appears that gender and age may have an interactive 
influence in the risk of developing AD or other dementias, with gender playing a much smaller 
role than age.   
 Ethnicity. Distinct ethnic differences in the risk of acquiring AD and other dementias 
have also been found in survey data (Alzheimer’s Association, 2012). Specifically, older 
African-Americans and other non-white minorities (e.g., Hispanic, Latino) have been found to be 
at a significantly greater risk of developing AD or other dementias, with estimates for African-
Americans being two to three times as likely to have AD as Caucasians (Alzheimer’s 
Association, 2012; Dilworth-Anderson et al., 2008). The greater frequency of AD found in 
minorities, especially African-Americans, is posited to be due to an earlier age of onset of the 
disease than in non-minorities (Alzheimer’s Association, 2012). Studies also suggest differences 
in symptomology, with minorities experiencing more severe symptoms such as hallucinations 
and delusions more often than Caucasians (Alzheimer’s Association, 2012). This disparity is 
thought to be due to differences in health status among minorities and Caucasians. Adverse 
health conditions such as high blood pressure and diabetes are more prevalent in minorities than 
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in Caucasians, which puts them at greater risk for developing AD (Alzheimer’s Association, 
2012).   
Hormonal Factors. Researchers of AD propose that stress, which triggers a flood of 
hormones that can damage brain cells, can play a part in developing AD (Richter & Richter, 
2004; U.S. Department of Health and Human Services, 2011). The aforementioned PLST theory 
(Hall & Buckwalter, 1987) suggests that people with AD are more prone to the effects of stress, 
and studies on persons with AD have found high levels of some hormones, especially stress 
hormones (e.g., cortisol) in participants (U.S. Department of Health and Human Services, 2011). 
Aging itself seems to reduce the brain’s ability to stop the production of stress hormones since 
levels typically increase with age, with or without the presence of AD (Richter & Richter, 2004). 
Stress hormones are known to increase inflammation in the body and brain, and high levels of 
inflammation are also associated with having AD (Alzheimer’s Association, 2012; U.S. 
Department of Health and Human Services, 2011). AD is likely the result of numerous factors, 
and there is the possibility that the brain’s increasing reaction to stress hormones as we age plays 
a role. 
Another hormone that affects the risk for developing AD is estrogen, which possibly has 
neuro-protective effects (Richter & Richter, 2004; U.S. Department of Health and Human 
Services, 2011). The female hormone appears to improve the diminishing cognitive functioning 
due to age. Post-menopausal women who have low estrogen levels appear to have an increased 
risk of developing cognitive impairment and AD than women of similar age with higher levels of 
estrogen (U.S. Department of Health and Human Services, 2011). Prior studies have 
demonstrated estrogen’s effectiveness for protecting the brain, and older women on hormone 
replacement therapy were found to be nearly 40% less likely to develop AD in one study, and the 
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longer the women were on the therapy, the less the risk (Williams et al., 2010). Estrogen’s 
effects on risk of AD are posited to be due to the protection of neurons and enhancing brain cell 
health (Richter & Richter, 2004). Estrogen is also is believed to stimulate the growth of synapses 
and help the brain maintain its output of acetylcholine (Ach), a neurotransmitter essential to 
learning and memory. It has been demonstrated consistently in prior research that persons with 
AD show severe deficits of Ach and that people with higher estrogen levels also have higher 
levels of Ach (Alzheimer’s Association, 2012; Richter & Richter, 2004). This means that 
estrogen may have neuroprotective effects against AD. 
Dietary Factors. A study comparing prevalence rates of AD in Japanese- and African-
Americans with very different diets found that caloric and fat intake highly correlated with AD 
prevalence (Grant, 1997). Highly caloric and fatty foods can oxidize into neurotoxins, by 
creating free radicals in the blood which then enter the brain and cause inflammation of the 
neurons and eventual cell death. Not all fats seem to be the culprit, however. Only saturated and 
hydrogenated fats have been linked to an increase in the risk of developing AD (Grant, 1997; 
U.S. Department of Health and Human Services, 2011). Figures about eating patterns in 
England, Sweden, Spain, Japan, and Singapore all point to a link between less saturated fat in the 
diet and less incidence of AD (Grant, 1997; U.S. Department of Health and Human Services, 
2011). High consumption of saturated fats has a well-known negative association with 
cardiovascular health, which is also associated with a higher risk of AD (Alzheimer’s 
Association, 2012). However, other researchers consider the link between saturated fat in the diet 
and increased risk of AD to be insufficient to demonstrate a significant effect at this time 




Another dietary factor that may be involved in lowering the risk of developing AD is the 
consumption of antioxidants, which are mostly found in fruits and vegetables (Grant, 1997; U.S. 
Department of Health and Human Services, 2011; Williams et al., 2010).  Because oxidation in 
the body can cause tissue damage and cell death, including within the brain, antioxidants may 
help prevent signs of AD from appearing by neutralizing free radicals in the blood before they 
can do any damage. Research that adds some weight to the theory that AD may in part be caused 
by damage from free radicals has discovered that beta-amyloid, a plaque made of proteins that 
build up in the brain between neurons, and a suspected underlying factor in developing AD, 
stimulates the release of toxic free radicals in the blood (Grant, 1997). High levels of free 
radicals in the bloodstream create the condition of oxidative stress in the body, which is also 
typically found in those with AD (U.S. Department of Health and Human Services, 2011). The 
effectiveness of antioxidants against AD was shown in one study utilizing vitamin E, which 
found that it significantly reduced the normal worsening of symptoms as the disease progresses 
(Grant, 1997). Antioxidants include vitamins A (including beta-carotene, a precursor to vitamin 
A), C, and E, and trace minerals such as selenium, and low levels of these antioxidants have been 
found in those with AD (Grant, 1997; Williams et al., 2010). However, recent research has 
focused mostly on vitamin E and selenium, since they have shown the most promise (U.S. 
Department of Health and Human Services, 2011; Williams et al., 2010). Although research 
studies have revealed some effectiveness of antioxidants in the prevention of AD, the current 
research suggests that the benefits of antioxidants are still quite limited. Additionally, the 
evidence for antioxidants providing some protection against AD is stronger when they are 
consumed from fresh fruits and vegetables, and not from vitamin supplements (Williams et al., 
2010). Research is underway to further elucidate the specific role of some antioxidants in the 
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prevention of dementia, with trials currently studying the effects of vitamin E and selenium (U.S. 
Department of Health and Human Services, 2011).  
Genetic Factors. There is a large body of evidence that demonstrates a strong 
relationship between AD and related dementias and the influence of genetic factors (Alzheimer’s 
Association, 2012; Richter & Richter, 2004; Williams et al., 2010). One such association lies 
within AD’s hereditary nature in some instances. Younger-onset AD, while relatively rare 
compared to late-onset AD, has been shown to have a strong familial link (Alzheimer’s 
Association, 2006, 2012). The risk of developing late-onset AD has also been shown to 
significantly rise when first-degree relatives (i.e., parents or siblings) also have the disease 
(Alzheimer’s Association, 2012; U.S. Department of Health and Human Services, 2011). If one 
immediate, first-degree relative has the disease, the risk of developing late-onset AD is estimated 
to quadruple, and if two immediate relatives have the disease, the estimated risk is drastically 
increased, with some estimates as high as a forty-fold increase (Alzheimer’s Association, 2012; 
Richter & Richter, 2004).  Consequently, the risk of having both parents with the disease comes 
as a close second to the risk of advancing age, the primary risk factor for developing late-onset 
AD (Alzheimer’s Association, 2012; U.S. Department of Health and Human Services, 2011).  
The familial link of AD is so robust that it is what led researchers to examine and 
discover some of the underlying genetic mechanisms. However, research has shown that even for 
people with a strong family history of younger-onset AD, only roughly 50 percent of cases are 
related to a known genetic defect, and that about 75 percent of all AD cases are classified as 
sporadic, occurring in people with no history of the disorder in their family (Alzheimer’s 
Association, 2012; Richter & Richter, 2004). This means that only about 25% of all instances of 
AD are estimated to be due to hereditary influences. However, it is important to note that the 
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familial link of AD may also partially be due to shared environments and lifestyle factors, which 
tend to be similar within families (Alzheimer’s Association, 2012). Additionally, virtually all 
sporadic cases are late-onset, and while the exact cause of these cases is not known, it is believed 
that genetics may still play a part.  
One major genetic factor that was identified as a likely contributor to developing AD is 
the presence of the aforementioned APOE-e4 allele. This allele is the primary gene which is 
suspected as playing a role in developing AD late in life (Alzheimer’s Association, 2012; Richter 
& Richter, 2004; Williams et al., 2010). Although having the APOE-e4 allele is a well-known 
risk factor for developing late-onset AD, patients with two APOE-e4 alleles (i.e., one from each 
parent) exhibit an earlier age of onset, and also show higher beta-amyloid plaque counts and 
marked reductions in Ach as compared to non- APOE-e4 allele carriers (Alzheimer’s 
Association, 2012; Richter & Richter, 2004). Carrying even two APOE-e4 alleles, however, does 
not guarantee developing AD with advancing age. Williams et al. (2010), after reviewing over 
250 prior studies on AD, considers the risk of developing AD specifically from carrying the 
APOE-e4 genotype to be no more than moderate.  
Several other genes have also been discovered as having some influence on developing 
AD, although the link between these genes and the risk of developing the disease is not as strong 
as for APOE-e4 (U.S. Department of Health and Human Services, 2011; Williams et al., 2010). 
These recently discovered genes, however, along with APOE-e4, all seem to be involved in 
similar biological pathways, which may partially explain their influence and also possibly 
elucidate some of the underlying biological process involved in AD. The presence of the APOE-
e4 allele or the other abovementioned genes in persons with AD demonstrate their possible 
genetic influence on the risk of developing the disease, however, it does not make acquiring AD 
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inevitable for the most part. It merely raises the odds of developing the disease, and current 
researchers consider the overall genetic influence on risk of AD to be only modest (U.S. 
Department of Health and Human Services, 2011; Williams et al., 2010).  
The one exception to the inevitability of acquiring AD is genetic mutations that are 
responsible for less than 1% of instances of the disease (Alzheimer’s Association, 2012). There 
are three known genetic mutations that can be considered as causing AD. In all three mutations 
the genes are involved in abnormal protein synthesis, with one specifically affecting a beta-
amyloid precursor (National Institute on Aging & National Institutes of Health, 2011). However, 
the other two mutations, while not direct precursors, are also involved in the production of beta-
amyloid. These genetic defects almost guarantee developing AD, and usually with a younger 
onset. People with these genetic defects normally will develop symptoms before the age of 65, 
with symptoms sometimes starting as young as age 30 (Alzheimer’s Association, 2012).  
 Recent research has discovered myriad potential biological factors, including a number of 
other genes, which may also influence a person’s risk of developing AD; however, evidence for 
the influence of each alone is sparse at the present time (Alzheimer’s Association, 2012; U.S. 
Department of Health and Human Services, 2011).  Research is currently in progress on 
discovering the exact functions of some newly-discovered genes and biological mechanisms 
associated with AD, and continuing advancements in technology are making this research more 
promising. However, this means that currently, the actual cause and risk of developing AD may 
be too complex to be fully understood (Alzheimer’s Association, 2012). For many years it was 
assumed that developing AD with advancing age was unavoidable and could not be prevented or 
postponed in one’s senior years, but, because the genetic influence is not the definitive cause in 
the majority of cases, and many other factors are involved- including some lifestyle factors that 
31 
 
are modifiable- almost no one is absolutely destined to get AD (Grant, 1997; Richter & Richter, 
2004; Williams et al., 2010). 
 Education and Cognitive Stimulation. Some research has suggested that the number of 
years of education one has may contribute to the risk of developing AD, with those with fewer 
years of education having higher incidences of the disease (Alzheimer’s Association, 2012; 
Richter & Richter, 2004; Williams et al., 2010). Having more years of formal education has been 
suggested as a factor for reduced risk, possibly because of increased synaptic and/or dendritic 
complexity and density in one’s brain resulting from greater cognitive stimulation (Chapman, 
Weiner, Rackley, Hynan, & Zientz, 2004; Williams et al., 2010). Those with more education 
presumably have exercised their brains more, which is thought to reinforce and build up the 
synaptic networks in the brain. Studies have shown that those with university-level education and 
those whose occupation or daily activities have high mental demands are less likely to show 
signs of AD or other cognitive impairments than people with lower levels of education or less 
cognitively-demanding daily involvement (Richter & Richter, 2004; Williams et al., 2010). Thus, 
one potential protective mechanism against developing AD appears to be the choice to expand 
and continually use your mind by engaging in mentally challenging activities, including problem 
solving, completing logic puzzles, reading, and playing and listening to music. However, 
because reduced risk of AD is based on prior educational involvement and continuing and 
current participation in cognitively-stimulating activities, the addition of cognitive stimulation to 
treatment regimens for people who already have the disease is likely to have a much smaller 
effect. Though the effects of AD can be devastating, the influence of education and cognitive 
stimulation known from the aforementioned research demonstrates that people do have some 
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control over slowing age-related cognitive decline and the risk of developing AD by altering 
these and other lifestyle factors.  
Lifestyle Factors. A person’s lifestyle choices regarding diet, exercise, and other aspects 
of wellbeing are known to significantly influence one’s health, and mounting evidence suggests 
that one’s overall health is also linked to brain health (Alzheimer’s Association, 2012; U.S. 
Department of Health and Human Services, 2011). There is some evidence that the accumulation 
of cholesterol and other fats in blood vessels may contribute to AD (U.S. Department of Health 
and Human Services, 2011; Williams et al., 2010). This means that maintaining a healthy 
cardiovascular system through regular exercise, a healthy diet, and avoidance of smoking may 
decrease the risk of developing AD and possibly slow the cognitive decline associated with it 
(Alzheimer’s Association, 2012; Williams et al., 2010). Future research is necessary to 
separately assess the individual effects of more specific dietary factors and different forms of 
exercise on AD, and longer-term studies are still needed to further strengthen the association 
between cardiovascular health and rate of cognitive decline in people with AD (U.S. Department 
of Health and Human Services, 2011).  
In addition to cardiovascular disease, having diabetes has also been linked to cognitive 
decline and greater incidence of AD (U.S. Department of Health and Human Services, 2011; 
Williams et al., 2010). This is likely due to insulin’s role in many biological processes involved 
in cognitive functioning, since people with diabetes are either deficient or resistant to this 
endogenous hormone (U.S. Department of Health and Human Services, 2011). It is important to 
note that adult-onset diabetes, like cardiovascular disease, is largely preventable through 
modification of lifestyle factors such as diet and exercise as previously mentioned, further 
demonstrating some control over the risk of developing AD (Alzheimer’s Association, 2012; 
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U.S. Department of Health and Human Services, 2011). However, more research is still needed 
to strengthen the association between diabetes and cognitive decline and risk of developing AD, 
especially with regard to glycemic control in people with adult-onset diabetes, since prior 
research did not take this into account (U.S. Department of Health and Human Services, 2011). 
For example, a person diagnosed with adult-onset diabetes may alter diet and exercise habits to 
help control blood glucose, and by doing so, may reduce their risk of developing AD, although 
the correlational studies mentioned have not assessed this. At present, it is merely known that 
having diabetes, regardless of how well it is controlled, increases your risk for developing AD 
(U.S. Department of Health and Human Services, 2011; Williams et al., 2010).  
Another potential lifestyle risk factor for cognitive decline and possibly developing AD is 
low levels of social engagement (Alzheimer’s Association, 2012; Williams et al., 2010). Prior 
research has shown that remaining socially active supports brain health, and that a lack of social 
engagement and self-reported chronic loneliness are associated with poorer mental health in 
general (Williams et al., 2010). Studies have also revealed that people who do not cohabitate 
with a partner late in life are not only more depressed, but also potentially at greater risk for 
developing AD than people who do not remain single or live alone (Williams et al., 2010). 
Additionally, decreased social networks and dissatisfaction with social contacts have been 
associated with higher risk of AD (Williams et al., 2010). However, Alzheimer’s Association 
(2012) considers the evidence for the influence of social engagement on AD to be less 
convincing than for other lifestyle risk-factors such as having cardiovascular disease, due to 
fewer studies having been done in this area and using smaller sample sizes. It is also possible that 
the decreases in social engagement found in these studies could have been due to early 
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symptoms of AD, since social withdrawal can be characteristic of early stages of the disease 
(Alzheimer’s Association, 2012).  
 Work Environment. The occurrence of cognitive impairment and dementia, including 
AD, in the workplace can be affected by the demand of one’s job duties and the conditions of 
one’s working environment (Ansiau, 2005; Feychting et al., 1998; Finkel et al., 2009). For 
instance, one study revealed a significant positive relationship between work-related cognitive 
stimulation and cognitive performance (Ansiau, 2005). Even though workers’ age was associated 
with normal age-related decline in cognitive performance, results specified that older workers 
were less likely to benefit from cognitive stimulation at work than their younger counterparts. 
Ansiau (2005) concluded that, in general, older workers are not exposed to as cognitively 
stimulating work environments as younger workers, but that the older workers who were 
exposed to more cognitively stimulating work environments had higher levels of cognitive 
functioning than other older workers. Similarly, another study found that occupational 
complexity positively correlated with cognitive performance on verbal, spatial, and speed factors 
(Finkel et al., 2009). However, this study found that while occupational complexity was 
associated with slower declines in verbal cognitive performance before retirement, after 
retirement older adults declined faster in spatial cognitive abilities.  Consequently, Finkel et al. 
(2009) argue that one’s occupational complexity may help slow down specific types of age-
related cognitive decline in performance.  
 Harsher environmental working conditions have also been associated with quicker 
cognitive decline and dementia in older workers (Feychting et al., 1998; Mortimer et al., 1991). 
Blue collar workers have been found to have more instances and earlier onset of dementia 
symptoms than those in higher status jobs due to differences in working environments (Mortimer 
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et al., 1991). One reason for this is the greater number of workplace accidents, such as head 
injuries, in blue collar workers (Mortimer et al., 1991). One study also revealed that exposure to 
extremely low-frequency magnetic fields at work (e.g., at a power plant) can possibly influence 
the development of dementia (Feychting et al., 1998). However, another study found that 
exposure to organic solvents and lead in workers at a chemical plant did not correlate with an 
increased risk of dementia (Shalat, Seltzer, & Baker, 1988). Taken together, these studies 
indicate that only specific types of working environments may contribute to the occurrence of 
dementia in the workplace; nonetheless, there is growing concern among employers and others 
regarding the problems of harsh work environments, due to the present aging of the population 
that remains in the workforce. In addition, occupational complexity and the availability of 
cognitive stimulation at work is also a concern of employees wishing to retain their mental 
functioning and perhaps stave off symptoms of AD. 
Characteristics of Alzheimer’s Disease 
Symptomology of Alzheimer’s Disease 
Alzheimer’s disease (AD) is a progressive, degenerative disease which has devastating 
effects that can ultimately rob a person of their personality, cognitive and physical functioning, 
and in the end, be the cause of death (Alzheimer’s Association, 2012; Richter & Richter, 2004). 
The primary biological characteristic of AD is the increasing dysfunction or death of neurons 
within the brain (Alzheimer’s Association, 2012). This was found to be due to the build-up of 
beta-amyloid plaques between neurons, which hinders their connections, and neuro-fibular 
tangles associated with increases in cross-linking of tau protein (i.e., tau proteins abnormally 
bind and block biochemical pathways) within the neurons, also blocking communication 
between them (Alzheimer’s Association, 2012; U.S. Department of Health and Human Services, 
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2011). Psychosocial symptoms that result from this brain degeneration are problems with 
memory, thinking, and behavior, all which worsen as the disease progresses (see Diagnostic 
Criteria for Alzheimer’s Disease in this chapter for additional information; Alzheimer’s 
Association, 2012; Richter & Richter, 2004). Eventually, persons with AD will need total care, 
since they will not be able to perform even basic daily activities such as bathing or eating on 
their own (Alzheimer’s Association, 2012). Once diagnosed with AD, however, the length of 
time it will take for the advancement of the disease to this severe stage varies between people, 
and therefore the course of AD is not entirely predictable. The traditional stages of AD will be 
discussed below, along with a possible precursor to the earliest stage.  
Mild Cognitive Impairment. Mild Cognitive Impairment (MCI) is a title used for the 
diagnosis of a level of cognitive impairment that does not significantly interfere with daily 
activities, such as a noticeable decline in memory retention and recall which may be bothersome, 
but is not severe enough to cause any significant difference in daily functioning in one’s life 
(Alzheimer’s Association, 2012; Jack et al., 2011).  Abstract thought and planning may also be 
mildly affected. Symptomology of MCI is similar to the early warning signs of AD, but MCI can 
sometimes, but not always, be a precursor to developing AD (U.S. Department of Health and 
Human Services, 2011). However, people diagnosed with MCI or other cognitive impairment not 
due to dementia were found to be at a much higher risk for developing AD (e.g., 12-15%) than 
cognitively-healthy older adults (e.g., 1-2%, Williams et al., 2010). Additionally, Alzheimer’s 
Association (2012) estimates that nearly half of all people who visit a doctor for symptoms of 
MCI will develop AD within 3-4 years. Therefore, it is recommended that frequent assessments 
be made if diagnosed with MCI, in order to track its possible progression to AD. Recently 
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proposed guidelines that classify AD as a possible cause for MCI will be discussed further in the 
section on the NIH proposed changes to criteria for AD.  
Agitation. One prominent symptom of AD is increasing levels of agitation as the disease 
progresses; however, since late-stage AD affects physical and verbal functioning (see Stages of 
Alzheimer’s Disease in this chapter), people who have late-stage AD may not be able to express 
these feelings well, therefore agitation may seem to decrease along with functionality (Gardiner 
& Furois, 2000; Ledger & Baker, 2007; Richter & Richter, 2004; Sung & Chang, 2005; Witzke 
et al., 2008). Agitation in people with AD can be defined as any inappropriate behavior that is 
unrelated to needs, and can be separated into either verbal or physical behaviors that can either 
be classified as aggressive or not aggressive (Gardiner & Furois, 2000; Ledger & Baker, 2007; 
Sung & Chang, 2005; Witzke, et al., 2008). An example of a verbal non-aggressive agitated 
behavior would be “repeated unwarranted requests for attention,” while verbal aggressive 
behaviors include “threatening or insulting language” (Ledger & Baker, 2007, p. 333). Physical 
non-aggressive behaviors can be any repetitive inappropriate behaviors, which are commonly 
such things as “tapping, wandering, or undressing at inappropriate times” (Ledger & Baker, 
2007, p. 333). Physical aggressive behavior involves acting out towards either objects or others, 
and includes “throwing or destroying objects” and “pushing” or “grabbing” other people (Ledger 
& Baker, 2007, p. 333). Agitation often results from frustration experienced by the AD sufferer 
of not being able to function optimally, either cognitively or physically, as they have prior to 
having the disease (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & Chang, 2005; 
Witzke, et al., 2008). If left uncontrolled, agitation can sometimes lead to further disruptive or 
aggressive behaviors if not dealt with by caregivers or others, and may put AD sufferers at risk 
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of harm to themselves or others (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & 
Chang, 2005; Witzke, et al., 2008).   
Stages of Alzheimer’s Disease. Since the progression of AD can last for as long as 20 
years (Richter & Richter, 2004), it is identified by distinct stages of its advancement. Currently, 
the stages of AD commonly used for clinical diagnosis are identified as mild/early-stage, 
moderate/mid-stage, and advanced/severe/late-stage (Alzheimer’s Association, 2012). In the 
early stage of AD, people may have trouble remembering recent events, activities, or the names 
of familiar people or things, and show decrements in other cognitive functions such as abstract 
reasoning and judgment (Alzheimer’s Association, 2012; Richter & Richter, 2004). They also 
may not be able to solve simple problems, show reduced spontaneity, apathy, withdrawal, and 
disorientation in familiar environments (Richter & Richter, 2004). People with AD in the early 
stage will probably notice and be bothered by these symptoms, but usually will not need a 
caregiver since physical functionality normally remains intact and mental functioning is not yet 
impacted severely (Alzheimer’s Association and the National Alliance for Caregiving, 2004). 
Since caregivers are most often family members, however, they may aid in the care of the person 
with AD at this time even though it is not essential at this early stage of the disease. 
Other symptoms of the early stage of AD include the aforementioned accumulation of 
beta-amyloid plaques and neuronal tangles due to tau protein within the brain (Alzheimer’s 
Association, 2012; Richter & Richter, 2004). The abnormal build-up of these proteins is thought 
to be one underlying cause for the death of neurons and resulting dysfunction in the brain 
associated with AD. These physical characteristics of AD can be present and detected even 
before the psychological symptoms of the disease appear (Alzheimer’s Association, 2012; Jack 
et al., 2011; McKhann et al., 2011). AD will normally affect some areas of the brain more than 
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others, with areas associated with the formation of new memories (e.g., the hippocampus) 
typically greatly affected (National Institute on Aging & National Institutes of Health, 2011). 
The accumulation of beta-amyloid and tau protein throughout the brain continues as AD 
progresses, which consequently leads to the increasing deterioration of neurons and results in 
greater shrinkage and dysfunction within the brain (National Institute on Aging & National 
Institutes of Health, 2011). However, there is great variability in the progression of AD into its 
sequential stages, making the predictability of remaining functionality once diagnosed with AD 
difficult.  
The early symptoms will normally progress to a greater level of severity and additional 
symptoms will present themselves in the middle stage of AD. Once the disease progresses to its 
middle stage, people with AD may experience language impairments such as problems with 
word finding and naming familiar objects (Alzheimer’s Association, 2012; Richter & Richter, 
2004). This is due to the further spreading of the death of neurons, usually into the cerebral 
cortex, which is involved with language abilities, sensory processing, and conscious thought 
(National Institute on Aging & National Institutes of Health, 2011). People in this stage of AD 
may also lose the ability to perform tasks that they have formerly known well, even basic 
grooming such as brushing their teeth and combing their hair, despite intact motor ability 
(Richter & Richter, 2004; U.S. Department of Health and Human Services, 2011).  
The symptoms from the early stage also worsen and are more easily noticed. They 
usually become serious enough to cause people with AD and their family members to seek 
medical help (Alzheimer’s Association, 2012; Alzheimer’s Association and the National 
Alliance for Caregiving, 2004; Richter & Richter, 2004). AD-associated symptoms begin to 
persistently interfere with daily activities in the middle stage, and AD sufferers may now require 
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a caregiver (Alzheimer’s Association and the National Alliance for Caregiving, 2004; Richter & 
Richter, 2004). AD sufferers may no longer think clearly and they can consistently fail to 
recognize familiar people and places. They may also begin to have problems speaking, 
understanding, reading, and writing in the middle stage of the disease. All of these symptoms can 
result in feelings of agitation or possibly result in aggressive behavior in people with AD, which 
also typically appear in the middle stage and usually increase as the disease continues to progress 
(Richter & Richter, 2004; U.S. Department of Health and Human Services, 2011). 
Behavioral problems also appear in the middle stage, such as wandering, outbursts of 
anger, agitation and aggression, and repetitive or sudden movements (e.g., muscle twitches, tics), 
and inappropriate undressing and vulgar language or behavior (Alzheimer’s Association, 2012). 
This severe impact to functionality is the hallmark of the middle stage of AD (Alzheimer’s 
Association, 2012; Richter & Richter, 2004). Without a caregiver at this stage, people with AD 
may not be able to care for themselves, and as a result, may put themselves at risk of harm to 
themselves and others (Alzheimer’s Association, 2012; U.S. Department of Health and Human 
Services, 2011). People at this stage will typically require help with the most basic daily 
activities, including bathing, dressing, eating, and using the bathroom, and cognitive functioning 
becomes severely impacted due to continued shrinkage of affected areas within the brain. The 
greater shrinkage within the brain also results in increased ventricles within the brain (i.e., space 
between areas of the brain containing cerebrospinal fluid), another biomarker for AD. The death 
and dysfunction of neurons causes this shrinkage and disrupts the communication between 
neurons within the brain, causing the slowing or malfunction of the signals normally required to 
carry out physical activities (U.S. Department of Health and Human Services, 2011). This 
physical deterioration of the brain continues as AD progresses into its final stage.   
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In its late, most severe stage, people with AD start to show a loss of motor function with 
increased muscle rigidity as a frequent indicator, and the symptoms from the earlier two stages 
also progressively worsen (Alzheimer’s Association, 2012; Richter & Richter, 2004; U.S. 
Department of Health and Human Services, 2011). Language ability becomes even more 
impaired, sometimes making coherent speech impossible, with complete mutism also potentially 
occurring (Alzheimer’s Association, 2012; Richter & Richter, 2004). This can make a person 
with late-stage AD have great difficulty expressing their needs to caregivers and can often result 
in frustration, agitation, or aggression (Alzheimer’s Association, 2012). These characteristics of 
late-stage AD are thought to be due to the continuing accumulation of plaques and tangles, and 
thus deterioration, which at this stage have spread throughout the brain, including areas involved 
in motor and speech control (Richter & Richter, 2004; U.S. Department of Health and Human 
Services, 2011). Individuals in this stage may also have disturbed sleep and wake cycles, 
experience regular muscle jerks and possible seizures, and may become severely anxious, 
agitated, or aggressive, possibly putting themselves at harm to themselves or others, making 
caregiving a necessity (Alzheimer’s Association, 2012; Alzheimer’s Association and the 
National Alliance for Caregiving, 2004).  
Eventually, patients in the late stage of AD will become bedridden and need total care 
(Alzheimer’s Association, 2012; Alzheimer’s Association and the National Alliance for 
Caregiving, 2004). The lack of movement in bedridden people with late-stage AD can often 
result in greater instances of infections, including pneumonia (Alzheimer’s Association, 2012). 
While being bedridden increases the risk for pneumonia, difficulty in swallowing due to motor 
dysfunction in late-stage AD also often results in liquids entering the lungs and can be a primary 
cause of pneumonia (Alzheimer’s Association, 2012; U.S. Department of Health and Human 
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Services, 2011). Because of this, AD-related pneumonia is thought to contribute to AD-related 
death in many co-occurrences of these two diseases (Alzheimer’s Association, 2012). While 
many of the symptoms of AD may be present and simply increase in severity throughout the 
progression of AD through its stages (e.g., cognitive and behavioral problems), death is 
ultimately the end result of the disease itself, with or without secondary infections (Alzheimer’s 
Association, 2012). The unrelenting deterioration of one’s brain makes death from AD 
inevitable.   
The three stages of AD currently in clinical use for diagnostic purposes that were 
discussed above provide a clear framework for the progression of the disease. The stages help 
define both the biophysiological and psychological symptomology of AD as it progresses. 
However, these stages of symptomology and diagnoses were defined over 25 years ago, and the 
current AD researchers at NIH and Alzheimer’s Association feel that they are outdated since 
much advancement in AD research has occurred during this time period (McKhann et al., 2011). 
The NIH workgroups, working with Alzheimer’s Association, have therefore recently proposed 
changes to the diagnostic criteria, including the stages of AD.   
Proposed Changes to Criteria for Alzheimer’s Disease 
AD is commonly separated into three main stages while symptoms of the disease are 
present: mild or early stage, moderate or middle stage, and advanced, severe or late stage 
(Alzheimer’s Association, 2012; Richter & Richter, 2004). However, recent technological 
advancements have allowed earlier diagnoses and better detection of changes in the progression 
of AD.  Currently, the three abovementioned stages of AD are still identified and are in use; 
however, it has been proposed that the stages be redefined as preclinical AD, Mild Cognitive 
Impairment (MCI) due to AD, and dementia due to AD (see Diagnostic Criteria for Alzheimer’s 
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Disease below for further explication; Alzheimer’s Association, 2012; McKhann et al., 2011). 
The proposed changes are largely due to the refinement of assessment instruments, which has 
improved the detection of more subtle changes in the worsening of symptoms, and the detection 
of biomarkers (i.e., biological changes in the brain and body) with advanced technology such as 
neuro-imaging and genetic coding, before psychological symptomology is even present 
(Alzheimer’s Association, 2012; McKhann et al., 2011).  These technological advancements in 
the assessment of AD have allowed much earlier and more accurate diagnoses of the disease to 
be made, especially when utilizing the new NIH diagnostic criteria.   
Diagnostic Criteria for Alzheimer’s Disease 
Recent diagnostic guidelines have been proposed by the National Institutes of Health 
(NIH) and the subsidiary National Institute on Aging (NIA)  to separate AD into three distinct 
stages, including the diagnosis of a preclinical stage, before psychological symptoms of the 
disease are identifiable (Alzheimer’s Association, 2012; McKhann et al., 2011). However, 
physicians are still generally using the older guidelines for AD diagnoses, in which 
psychological symptomology must be present (Alzheimer’s Association, 2012). The NIH 
workgroups that proposed the newly refined guidelines suggest that more research needs to be 
done, especially with regard to biomarkers, before implementing them in clinical settings (Jack 
et al., 2011; McKhann et al., 2011). One reason for this is because the NIH guidelines propose a 
preclinical stage of AD which, since symptoms of the disease have not yet appeared, relies solely 
on biomarkers in order for a diagnosis to be made, and, as previously mentioned, the technology 
to accurately determine diagnoses by biomarkers alone is still inadequate (Alzheimer’s 
Association, 2012; McKhann et al., 2011).  
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A clinical diagnosis of AD would only be made with the currently used diagnostic criteria 
in the final stage of the new guidelines, dementia due to AD (McKhann et al., 2011). This means 
that, according to the diagnostic criteria for AD that is currently in widespread use, the 
psychological symptoms of the disease would have to be severe enough to significantly affect 
one’s daily activities in order for a diagnosis of AD to be made (Alzheimer’s Association, 2012). 
The two earlier stages in the recent guidelines, preclinical AD and MCI due to AD, are not 
currently diagnosed as AD by the older guidelines currently in use. For example, the middle 
stage in the new NIH guidelines, MCI due to AD, would not typically be diagnosed as AD by the 
currently-used diagnostic criteria, but simply as MCI. Biomarkers would need to be used in order 
to identify the potential cause of MCI as AD. Additionally, Preclinical AD is only recognizable 
by biomarkers, so it would also not currently be acknowledged as AD (Jack et al., 2011; 
McKhann et al., 2011).  
The diagnostic criteria for AD in the DSM-5 also reflect much of the newly proposed 
NIH guidelines. That is, the DSM-5 contains diagnostic criteria for Mild Neurocognitive 
Disorder and Major Neurocognitive Disorder or dementia, both of which can be attributed to 
AD as a possible etiology (Blazer, 2013). If either category of neurocognitive disorder (NCD) is 
suspected, the underlying cause is attempted to be found, with possibilities being Alzheimer’s, 
vascular, or frontotemporal NCD. Additionally, similar to the NIH guidelines, memory and 
learning problems, while still the most common symptoms of AD, do not have to be present for a 
diagnosis to be made. Other symptoms such as attention, executive functioning, language, 
perceptual motor problems, or social cognition may also be severe enough for a diagnosis of 
Alzheimer’s NCD to be made even in the absence of memory or learning problems, according to 
the DSM-5 criteria (Blazer, 2013).  
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In the clinical stages where symptoms are present, however, AD primarily affects 
cognition, and especially memory. At first, the only symptom may be mild forgetfulness, which 
can be confused with normal age-related changes in cognitive functioning (Alzheimer’s 
Association, 2012; Richter & Richter, 2004). However, people with only mild forgetfulness do 
not have AD, since they would not meet all the current diagnostic criteria, which includes the 
development of multiple cognitive or physical deficits (Alzheimer’s Association, 2012; Cairns, 
Evans, & Prince, 2005; McKhann et al., 2011). The recently proposed guidelines from NIH on 
AD diagnoses require physical or cognitive impairment in at least two domains, including 
learning, reasoning or judgment, visuospatial abilities, language, and personality or behavior 
(Jack et al., 2011; McKhann et al., 2011). It is important to note that according to the revised 
guidelines, impaired memory does not have to be one of the two domains affected. This is 
because AD may initially manifest in other ways such as negatively affecting abstract reasoning 
or judgment instead of memory (Alzheimer’s Association, 2012). The impairment in two 
domains must also be severe enough to negatively interfere with one’s usual daily activities and 
not be explained by another disorder in order for a diagnosis of AD to be made. Additionally, the 
concurrent presence of biomarkers along with AD-related symptoms may also help distinguish 
the probability of early AD or MCI due to AD from normal age-related cognitive decline or 
another disorder (McKhann et al., 2011). 
Although biomarkers may provide some evidence of the presence and progression of AD, 
there is no standardization for using them in diagnosis at this time (Jack et al., 2011; McKhann et 
al., 2011). Biomarkers for AD can include brain imaging, displaying plaque build-up (e.g., beta-
amyloid) between neurons and areas of dysfunction possibly due to the accumulation of tau 
protein within neurons which can lead to the tangled neuro-fibers typically found in AD; 
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elevated levels of beta-amyloid or tau protein in cerebrospinal fluid or blood; and the presence of 
one or two APOE-e4 alleles or other possible AD-related genes, marking a genetic predisposition 
and raising the odds of AD (Alzheimer’s Association, 2012).  However, the NIH workgroups 
that defined the new diagnostic guidelines consider it premature to rely on biomarkers to 
specifically define cutoff points for stages of AD. Nonetheless, the proposed diagnostic 
guidelines do allow more precise classification of the occurrence of AD by relying on both the 
presence of symptomology and biomarkers concomitantly (Jack et al., 2011; McKhann et al., 
2011).   
In addition to redefining the stages of AD, the NIH-proposed guidelines describe three 
potential diagnoses: 1) probable AD, 2) possible AD, and 3) probable or possible AD with patho-
physiological evidence (p. 265, McKhann et al., 2011). Probable AD meets the aforementioned 
diagnostic criteria for AD, and exhibits an insidious onset while being able to rule out other 
explanations for symptoms. Possible AD is distinguished from probable AD by possible AD 
having an atypical course (e.g., sudden onset of symptoms), history of cerebrovascular disease 
(e.g., stroke), or evidence of other neurological diseases. Probable or possible AD with patho-
physiological evidence indicates the presence of biomarkers in either of the other two diagnoses. 
However, the presence of biomarkers is not always clearly positive or negative with the current 
methods of detection (Alzheimer’s Association, 2012; McKhann et al., 2011). While AD usually 
has a subtle onset and progresses slowly, these new diagnostic guidelines and refined detection 
techniques have allowed earlier exposure of the disease, and have also allowed improved 
distinction from other age-related causes of cognitive impairment such as MCI not due to AD 
(Alzheimer’s Association, 2012; McKhann et al., 2011).  
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The guidelines proposed by NIH classify MCI as the second stage of AD if the cognitive 
impairment is thought to be due to AD, since the first, preclinical stage is asymptomatic 
(Alzheimer’s Association, 2012; McKhann et al., 2011). However, since there may be other 
causes of MCI, some people with it may not develop AD or experience worsening of symptoms, 
and, depending on the cause, may even recover from it (U.S. Department of Health and Human 
Services, 2011). Additionally, recent refinements in assessment and diagnosis of AD, such as 
advancements in brain imaging technology and genetic coding, have made the distinction of AD 
as a possible cause of MCI more apparent. Currently being better able to rule out AD, many 
potential AD diagnoses are being diagnosed as MCI since other causes are now more likely to be 
found (McKhann et al., 2011).  Early differential diagnosis of the underlying cause of MCI is 
essential since it may reveal other potential health problems besides AD (e.g., stroke, severe 
depression) that may be treatable. Furthermore, if the underlying cause of MCI is discovered to 
be AD, early diagnosis would still allow for better planning of treatment before the disease 
progresses to its later stage and severely affects one’s life.  
The proposed refinement of the criteria for the diagnosis and stages of AD by NIH and in 
the DSM-5 would allow for much earlier and more precise diagnoses of AD to be made 
(Alzheimer’s Association, 2012; Blazer, 2013; McKhann et al., 2011). This would allow 
individuals and their family members to be better prepared in advance for the physiological and 
psychological effects of the disease to come. NIH, working with Alzheimer’s Association, 
proposed these changes mainly because of the outdated, currently used diagnostic criteria for AD 
are over 25 years old and early detection from biomarkers was not possible then (Alzheimer’s 
Association, 2012). Much advancement in the detection and understanding of AD has been made 
during this time, and the new guidelines, and consequently the DSM-5 criteria, reflect this 
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(Blazer, 2013). However, since the guidelines largely rely on biomarkers and the technology to 
detect these are not yet sufficiently precise, more research, including the further refinement of 
biomarker detection instruments, is still necessary in order to properly implement the recently 
proposed guidelines from NIH for diagnosing AD (Jack et al., 2011; McKhann et al., 2011).    
Treatment of Alzheimer’s Disease 
Treatment of AD in older adults focuses on the management of cognitive as well as 
physical symptoms in order to maintain the highest possible level of psychological, physical, and 
social functioning, in the face of the disabling effects of the illness. Treatment of AD usually 
includes medications, which can help slow the worsening of some symptoms of the disease; 
however, medications are not thought to slow down the progression of the disease itself 
(Alzheimer’s Association, 2012).  Because of the currently available medication’s well-known 
limited efficacy in treating AD, many psychosocial interventions that provide cognitive 
stimulation or social engagement are usually also a part of treatment regimens. Furthermore, 
since people with AD will certainly experience the worsening of symptoms of the disease as it 
progresses no matter what treatments are utilized, caregiving is eventually an important and 
necessary part of treatment.  
Caregiving 
Caregiving is an essential component in the treatment process of persons with AD 
(Alzheimer’s Association and National Alliance for Caregiving, 2004; Louderback, 2000). This 
can include, but is not limited to, helping the person with AD in his/her activities of daily living, 
such as eating and bathing, and managing behavioral symptoms of the disease (Louderback, 
2000). While caregivers can be paid individuals unrelated to the person with AD, there is a 
growing population of almost 11 million family and friends providing an average of 863 hours of 
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home-based care each year to a loved one coping with the disease (Alzheimer’s Association, 
2011). About 60% of these caregivers are women, usually family members, and 30% of 
caregivers are also simultaneously caring for children at home (Alzheimer’s Association, 2011; 
Alzheimer’s Association and National Alliance for Caregiving, 2004). Although caregivers may 
report some positive aspects of caregiving, they also struggle with the immense burden 
associated with meeting the daily physical, psycho-social, emotional, and safety needs of their 
care recipients (Louderback, 2000; Schultz, et al., 2003; Vitaliano, Zhang, & Scanlan, 2003). In 
particular, caregivers of family members with AD often report struggling with the emotional 
strain and grief associated with watching the functional and expressive decline of a loved one, 
the stress of pending institutionalization for the care recipient, financial hardships, time 
constraints, and strained relationships (Alzheimer’s Association, 2012; Louderback, 2000; 
Schultz, et al., 2003; Vitaliano, Zhang, & Scanlan, 2003). While the currently available 
treatments for AD, such as medications and psychosocial interventions, can help ease some of 
the burden on caregivers, their effect is limited.  
Caregiver Burden. Research on caregiver burden has flourished in the last decade (e.g., 
Gitlin, Winter, Dennis, & Hauck, 2007; Hagerty, Martire, & Schulz, 2005; Herbert, Weinstein, 
Martire, & Schulz, 2006; Hilgeman et al., 2007; Rodriguez et al., 2003; Schultz et al., 2003; 
Spurlock, 2005; Vitaliano, Zhang, & Scanlan, 2003).   In the context of AD, caregiver burden is 
conceptualized as the physical, emotional, social and financial hardships experienced by family 
or friends who provide care to an individual with the disease (Alzheimer’s Association, 2011; 
Bedard, et al., 2001; Gupta, 1999). Specific types of burden include heightened emotional stress, 
social isolation, financial burden, and a decline in the caregiver’s physical and mental health 
(Alzheimer’s Association, 2011; Bedard, et al., 2001; Gupta, 1999). AD caregivers are much 
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more likely to report having less time for family, hobbies, vacations, and other leisure activities 
compared to non-caregivers of a similar age (Alzheimer’s Association, 2011). In addition, almost 
fifteen percent of caregivers report experiencing a physical or mental health problem as a result 
of the stress of caregiving (Alzheimer’s Association, 2011). 
Because of the copious research done on caregiver burden recently, a good amount is 
known about what predicts high levels of it. Much of this research focuses on the functionality of 
the persons with the disease. One study on caregivers of people with dementia found significant 
correlations between caregiver burden and the dementia patients’ ability to perform activities of 
daily living (ADLs; Razani, et al., 2007). That is, the less the persons with dementia were able to 
carry out their ADLs (e.g., grooming, eating, shopping, transportation needs, financial skills), the 
greater the reported burden levels in the caregivers. Consequently, caregivers who felt their time 
was most restricted reported the highest levels of burden. Another study that confirms the 
influence of ADL and time restraints on caregiver burden also found that the neuropsychiatric 
symptoms of AD (e.g., cognitive impairment, behavioral disturbance) were a strong predictor 
(Germain, et al., 2009).  
While some studies of caregiver burden focus on the functionality of the care recipients, 
other studies have focused on aspects of the caregivers themselves, especially their mental health 
and well-being. For instance, one study on predicting AD caregiver burden found that a lack of 
social support among the caregivers and anxiety about their own aging predicted both perceived 
burden and depression (Hayslip, Han, & Anderson, 2008). While the lack of social support has 
been found as a predictor in other studies of caregiver burden (Donaldson & Burns, 1999; 
Germain, et al., 2009), other features of the caregivers are also known to influence burden as 
well. For example, caregivers’ attitudes towards the recipients, along with the caregivers’ 
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perception of their behavior (i.e., as deliberate rather than disease-related) were found to predict 
burden in one study (Donaldson & Burns, 1999). This same study also found that caregivers’ 
gender and relationship to the care recipients were also influential in predicting caregiver burden.  
Some prior studies have unexpectedly found that while perceived caregiver burden is 
reportedly high, caregivers also report high resilience and a positive impression of caregiving 
(Herbert et al., 2006; Hilgeman et al., 2003; Louderback, 2000; Wilks & Vonk, 2008). This 
positive impression of caregiving can include reminiscence of happy times, pleasurable activities 
done together, and having a deeper appreciation of the caregiver’s and recipient’s time together. 
Although positive and meaningful experiences are reported by some caregivers, other studies 
find that the negative effects of stress from caregiving can be overwhelming and can affect one’s 
physical and mental well-being (Alzheimer’s Association, 2009; Bar-David, 1999; Gupta, 1999; 
Rodriguez et al., 2003; Vitaliano, Zhang, & Scanlan, 2003). One study found that caregivers who 
employed more problem-focused coping strategies (i.e., feeling in-control of situations and 
therefore using strategies that focus on solving problems) had less depression than caregivers 
relying on emotion-focused coping (i.e., feeling a lack of, or little control over situations and 
therefore not attempting to solve problems, but rather focusing on emotions; Li, Seltzer, & 
Greenberg, 1999). Additionally, the caregivers utilizing problem-focused coping had reductions 
in depression over an 18-month period, while the caregivers using emotion-focused coping had 
increases in depression over the same period (Li et al., 1999). Utilizing supportive services 
designed to reduce caregiver burden can be an important method for caregivers to learn methods 
of coping and possibly avoiding the negative effects of caregiving. 
 Supportive Services for Caregivers. Most AD researchers would agree that services are 
necessary not only for the person with the disease, but for the caregiver as well. While some 
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recent AD caregiver research has focused on caregivers’ well-being and mental health (Germain, 
et al., 2009; Hayslip, Han, & Anderson, 2008), public education on maintaining mental health 
and overall well-being for caregivers may also be of assistance. Many studies on caregiver 
burden have demonstrated its negative effects on health and well-being (Bar-David, 1999; Gupta, 
1999; Hayslip, Han, & Anderson, 2008; Rodriguez et al., 2003; Vitaliano, Zhang, & Scanlan, 
2003). While the need to care for the caregiver is becoming more well-known in the general 
public, psychoeducational classes for caregivers could adopt coping techniques and other 
methods of maintaining well-being in caregivers, and not merely focus on caring for persons 
with AD.   
 While many caregivers for individuals with AD are family members, paid caregivers can 
help assist with the treatment and are often utilized to provide much needed respite to the family 
members caring for the AD patient around the clock. Respite care was created to allow 
caregivers time away from taking care of family members and others with disabling illnesses 
such as AD, with the goal of helping the caregiver lower stress while still filling the needs of the 
individual receiving care (Alzheimer’s Association, 2011; Alzheimer’s Association and National 
Alliance for Caregiving, 2004). This can include ‘day’ programs that will care for the individual 
during the daytime hours, so as to allow the unpaid family caregivers to continue working 
throughout the day. This can be an important factor in the treatment of elderly persons with AD, 
while not completely disrupting the lives of their family members.  
Another supportive service designed to reduce burden in AD caregivers is educational 
seminars and/or classes in which the caregivers can learn more about the disease and what 
changes to expect in the care recipient’s cognition and behavior (Alzheimer’s Association and  
National Alliance for Caregiving, 2004; Giltin et al., 2007; Hagerty, Martire, & Schulz, 2005). 
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These psychoeducational classes can also include caregiver training to teach potential caregivers 
how to know what needs to be done for their recipients.  This can include going over the 
physical, psycho-social, emotional, and safety needs of care recipients and how caregivers can 
facilitate meeting them. Caregivers may be educated on helping the person with AD in his/her 
activities of daily living, such as eating, grooming, and cleaning, and also helping manage the 
behavioral symptoms of the disease (Bar-David, 1999; Giltin et al., 2007; Hagerty, Martire, & 
Schulz, 2005; Louderback, 2000; Parks & Novelli, 2005). These types of educational services for 
caregivers are usually offered free-of-charge by non-profit agencies such as regional branches 
(e.g., Alzheimer’s Services of the Capital Area) overseen by national organizations such as 
Alzheimer’s Association (Alzheimer’s Association, 2012; Alzheimer’s Association and National 
Alliance for Caregiving, 2004). 
Lastly, AD caregiver burden can also be addressed through the utilization of support 
groups designed specifically for AD caregivers (Alzheimer’s Association, 2011; National 
Alliance for Caregiving and the AARP, 2004; Louderback, 2000; Parks & Novelli, 2005). These 
are groups of unpaid, informal AD caregivers that will meet on a regular basis to discuss aspects 
of caregiving, and are usually facilitated by organizations such as Alzheimer’s Association 
(Alzheimer’s Association, 2011; Alzheimer’s Association and National Alliance for Caregiving, 
2004). Discussing the trials and tribulations associated with caregiving for someone with AD 
with others in similar situations can purportedly help buffer the stress and perceived burden in 
caregivers (Alzheimer’s Association, 2009; National Alliance for Caregiving and the AARP, 
2004; Louderback, 2000; Parks & Novelli, 2005). Like all support groups, members not only 
provide social support for one another, but they can also learn from each other such things as 
what to expect as the disease progresses, when to utilize other services, such as respite care, and 
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other comparable expertise to what can be learned in psychoeducational classes and seminars for 
caregivers.  
Medications 
Some existing medications for treating the symptoms of AD and other related dementias 
can slow down the worsening of some symptoms, especially declining cognitive functioning, 
although they are known to be restricted in their efficacy (Alzheimer’s Association, 2012; 
Richter & Richter, 2004). Since these medications have demonstrated limited effectiveness, 
potential rehabilitation and treatment of the disease normally requires a multidisciplinary 
approach that uses non-drug interventions along with medications, if required (Richter & 
Richter, 2004; U.S. Department of Health and Human Services, 2010).  Although there are 
specific medications known to somewhat improve both cognitive and behavioral functioning in 
some people with dementia, it is important to recognize the limited effectiveness and potential 
side effects of these drugs. Older people with dementia are far more likely to suffer from side 
effects from a drug because of normal neurochemical deficits that occur with advancing age 
(Richter & Richter, 2004; U.S. Department of Health and Human Services, 2010). Also, because 
of old age, those with AD usually suffer from other illnesses that may require additional 
medications that may interact with the drugs used to treat AD symptoms, or can even be the 
cause of dementia-like symptoms themselves (Richter & Richter, 2004). Since people with AD 
tend to respond variably to the different drugs currently used to treat dementia, it is important for 
physicians to find the right medication or combination of medications that minimize the side 
effects while maximizing the potential functioning in the patient and concurrently utilizing other 
forms of treatment besides medications.  
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Being the most popular treatment for AD, one would assume that drug therapies are the 
most efficacious for treating the disease; however, the aforementioned research (Alzheimer’s 
Association, 2012; Chapman, et al., 2004; Richter & Richter, 2004) points out the limitations of 
the currently available drug therapies for AD and further advocate a multidisciplinary approach 
to its treatment. Although psychotropic medication is commonly used to treat agitation and 
aggressive behavior in this population, side effects of these medicines can often interfere with 
other symptoms of AD, and therefore are not desirable (Gardiner & Furois, 2000; Ledger & 
Baker, 2007; Sung & Chang, 2005; Witzke, et al., 2008). For example, the use of psychotropic 
medications to treat agitation or aggressive behavior in those with AD can further impair 
cognitive functioning; therefore, one or more other interventions are preferable if they are as 
effective (Chapman, et al., 2004). Physical restraints are also sometimes used in cases of 
physically aggressive behaviors, although these too can have negative consequences, and most 
would agree they should only be used in extreme cases (Gardiner & Furois, 2000; Ledger & 
Baker, 2007; Sung & Chang, 2005; Witzke, et al., 2008). While drug treatments or physical 
restraints may sometimes be necessary, a multi-disciplinary approach including cognitive 
stimulation and social engagement is considered best to maximize AD treatment regimen 
efficacy (Alzheimer’s Association, 2012; Chapman, et al., 2004).  
Psychosocial Interventions  
 Although medications are often considered the first line of treatment for AD and other 
related dementias, non-pharmacological approaches to treatment are also commonly utilized, 
even when medications are needed and used (Alzheimer’s Association, 2012; Kasl-Godley & 
Gatz, 2000). This multidisciplinary approach is necessary because of the limited efficacy of each 
line of treatment that is currently available for AD. That is, each treatment usually targets only a 
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limited range of symptoms, such as music therapy used to decrease agitation (see Chapter 4 for 
further explanation; Sung & Chang, 2005; Witzke, et al., 2008). Non-pharmacological 
approaches to treatment usually employ some form of psychosocial intervention that may 
provide cognitive stimulation, social engagement, or simply something for a person with AD to 
focus on at the time, such as listening to prerecorded music. For example, listening to music is 
thought to provide a focal point which blocks out other distracting stimuli in the immediate 
environment, and consequently lowers the stress of having to process too much simultaneously 
(see Chapter 3 for further explanation; Gerdner, 1997, 2001; Spiro, 2010).  
Many psychosocial interventions are done in group settings within day care centers for 
older adults or assisted-living facilities and nursing homes, and therefore may simultaneously 
provide cognitive stimulation while also enhancing social engagement. Some examples of this 
would be art and music therapy groups, community gardening, arts and crafts groups, memory 
training groups, and reminiscence therapy groups (Chapman, et al., 2004; Kasl-Godley & Gatz, 
2000; Sung & Chang, 2005; Witzke, et al., 2008). While these group activities have 
demonstrated some efficacy in the treatment of AD, the underlying mechanisms for why these 
psychosocial interventions would work remains largely speculative (see Chapter 3 for possible 
explanations for why music therapy is effective for AD). One theory is that interventions and 
activities that are done in group settings provide social support, making the actual activity that is 
done less important than the meeting and socialization within the group (Kasl-Godley & Gatz, 
2000).  
Other interventions that may provide opportunities for socialization, such as support 
groups for people with AD, may also have positive effects on the distressing symptoms of AD 
(Kasl-Godley & Gatz, 2000).  Support groups allow for the sharing of personal coping strategies 
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between its members, and therefore members may learn new methods that help them effectively 
deal with their symptoms. Additionally, therapies such as cognitive-behavioral training can also 
have a positive influence on behavioral symptoms of AD (Kasl-Godley & Gatz, 2000). Other 
therapies that are typical non-pharmacological approaches to AD treatment are interpersonal 
therapy, validation therapy, reminiscence therapy, and reality orientation (Douglas, James, & 
Ballard, 2004; Kasl-Godley & Gatz, 2000). Besides these common psychosocial approaches to 
the treatment of AD, myriad alternative therapies that have some evidence for their efficacy, 
including art and music therapy, have been applied to the treatment of AD symptoms (Douglas, 
James, & Ballard, 2004; Sung & Chang, 2005; Witzke, et al., 2008). It is important to explore the 
many available psychosocial intervention alternatives when planning an effective treatment 
regimen for AD since each individual is unique, and their response to different therapies will 
conceivably vary. Therefore individualized, multidisciplinary treatment regimens, including 
psychosocial interventions that provide cognitive stimulation and social support such as group 
music interventions, along with medications if necessary, would currently be the optimum 
treatment available for AD.    
Policy Responses to Alzheimer’s Disease Treatment 
With the current treatment of AD focused on medical interventions along with caregiving 
and psychosocial interventions, some of the cost of treatment can be covered by Medicare and 
Medicaid policies. Medicare and Medicaid are programs designed for eligible elderly adults (i.e., 
65 years of age and above), and low-income individuals and families to receive a variety of 
healthcare services from providers at little to no cost to them (LA DHH, 2009). Both Medicare 
and Medicaid are combined U.S. federal and state means-tested programs. Because they are joint 
programs between the federal government and each individual state, the way the programs are 
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run varies by state. Congress and the federal center for Medicaid and Medicare services set the 
main rules of the programs, but each individual state can decide exactly what services are 
funded. Although everyone age of 65 and over is eligible to receive Medicare health insurance 
supplements, the amount one receives is based on one’s income, and this amount was reduced in 
2007 with the implementation of rate cuts to Medicare Part B (LA DHH, 2008).  Medicare Part 
B covers medical services vital to aging Americans - doctors' visits, tests, durable equipment and 
outpatient hospital care. Other parts of Medicare partly cover hospital stays and prescription drug 
costs and other services such as hospice care that are important to treatment of the older adult 
population in the U.S., including those with AD.  
Hospice care cost is also covered by Medicare (i.e., except co-pay and other out-of-
pocket expenses) when a person is diagnosed with a terminal illness and has 6 months or less left 
to live (U.S. DHH, 2010). Hospice care would provide management of pain and other symptoms 
of the terminal illness, and could also include counseling and other ‘comfort care’ to the 
individual and family members. This can include people in the final stage of AD. Guidelines 
based on the progression of dementias, including AD, are available to help determine when a 
dementia patient may only have 6 months left to live in order to qualify for Medicare coverage of 
hospice care. Like other services available to treat AD, such as caregiving, hospice care can be 
received in the individual’s home, at an independent facility, in a hospital, or in a nursing home.  
Caregiving is also an important aspect in the treatment of persons with AD, and is also 
covered in part by Medicare and Medicaid. While many caregivers for individuals with AD are 
family members, paid caregivers can help assist with the treatment and are often utilized to 
provide much needed respite to the family members caring for the AD patient around the clock. 
Respite care was created to allow caregivers time away from taking care of family members and 
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others with disabling illnesses such as AD, with the goal of helping the caregiver lower stress 
while still filling the needs of the individual receiving care (Alzheimer’s Association, 2012). Part 
A of Medicare’s policy covers respite care when a person requires 24 hour, continuous live-in 
care (U.S. DHH, 2010). Respite care can be provided in-home or out-of-home, where family 
members can leave their loved-one with AD in the care of a paid caregiver for short periods. This 
treatment coverage by Medicare can be an important factor in the treatment of older adults with 
AD.  
 It is important to note, however, that there are a large number of people with AD that are 
below the age of 65, and therefore are not eligible to receive Medicare coverage for treatment. It 
is estimated that this number is 500,000 people under age 65 who currently have AD and other 
dementias (Alzheimer’s Association, 2011). This population of AD sufferers under age 65 may 
receive Medicaid coverage, although they must meet multiple criteria for eligibility. Being poor- 
even being very poor- does not automatically make someone eligible to receive Medicaid 
funding for healthcare services. Research done by DHH (2008) in Louisiana estimates that 
approximately 60% of Louisiana’s poor do not have medical health insurance and are not 
covered by Medicaid because they are not eligible. It is a means-tested program, though other 
requirements besides being poor are needed to be eligible for Medicaid. Some of these 
requirements are being over 64 years old (i.e., qualifies one for Medicare), pregnant women, 
families having children under 19 years old, being physically or mentally disabled in some way, 
and having little or no medical health insurance.  The requirement of ‘mental disability’ is not a 
feature at the beginning stages of AD, and therefore someone with the disease under the age of 
65 would not be eligible for Medicaid coverage of treatment, even though treating the disease 
early on can slow down the progression of symptoms (Livingston & Katona, 2004; Richter & 
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Richter, 2004). In addition, Medicare will sometimes not cover the costs of treatments if they are 
misinterpreted as not being beneficial to the person (National Association of Social Workers 
[NASW], 2000). This means that access to rehabilitative and psychotherapeutic services may be 
denied because of an AD diagnosis. This policy is based on the misguided idea that no one with 
AD or other dementias could benefit from these services. According to the NASW (2000), a 
superior policy would be one based on individualized determination of treatment, such as the 
premise that while some people with AD indeed would not benefit from these services, others 
can. These limitations of the Medicare and Medicaid programs, along with their limited 
coverage, may prevent many with AD from receiving proper treatment if they have no health 
insurance of their own.  
 A comprehensive examination of AD-related policy would need to address myriad issues 
regarding the delivery and financing of care for those who now have AD, and for the hundreds of 
thousands of people who will become AD patients as the population ages. Such an undertaking is 
beyond the scope of this research and the resources available to this author. However, because 
Medicare and Medicaid laws vary by state, each state’s laws can have a dramatic effect, for 
example, on whether a patient with AD can get needed services in the community instead of in a 
nursing home, a younger person with early-onset mild AD can get treatment at all, or someone 
whose genes put the person at a higher risk of future AD can buy private long-term care 
insurance. While Medicare coverage does include many aspects of AD treatment, it is not all-
inclusive and usually does not cover services in full. Furthermore, recent cuts to Medicare and 
Medicaid mean greater out-of-pocket expenses for doctor visits and medications even when one 
is covered. The implementation of Medicare and Medicaid policy changes and other policy 
matters could make a real difference in the lives of AD patients and their families, especially 
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through service accessibility. For example, whether respite services are covered by Medicare and 
Medicaid policy influences the availability of psychosocial interventions such as music therapy 
for people with AD, which also possibly reduces the burden on their caregivers. Because the 
burden associated with caring for someone with AD can have a harmful impact on one’s health, 
the implementation of policies relating to early detection and appropriate interventions for 
caregivers and AD sufferers could improve their well-being and potentially stave off both mental 
and physical illness.  
Summary 
The increasing life expectancy of persons living today has resulted in remarkable growth 
in research of the consequential diseases related to aging such as AD (Alzheimer’s Association, 
2012). AD is among the most common and costly conditions associated with aging. It afflicts 
more women with a family history of the disease more often than those without immediate 
relatives with AD, although it can strike anyone since the main risk factor associated with 
developing the disease is advancing age. However, the risk-factor research discussed here 
demonstrates that most individuals do have some control over the risk of developing the disease 
and its symptomology. Protective mechanisms include lifestyle and dietary factors, which are 
easily modifiable; however, they have shown only minor influence on the risk of developing AD. 
Preventing older adults from developing AD, or at least keeping its symptoms at bay, extends 
their independent functioning, which, in turn, reduces the caregiver’s load in assisting them.  
 Current research on AD, while still ongoing, has revealed a greater depth of 
understanding, largely due to advancements in technology. One main area of advancement is in 
brain imaging which allows the displaying of the accumulation of plaques and areas of 
dysfunction within the brain (National Institute on Aging & National Institutes of Health, 2011). 
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Additionally, a number of genetic influences have been identified as playing a role in acquiring 
AD, although acquiring the disease is not inevitable when carrying these genes in the majority of 
instances (Alzheimer’s Association, 2012). Progression of AD has been defined by three stages 
that are currently in widespread use for diagnosis (Alzheimer’s Association, 2012). These stages 
help define the progressive worsening of symptoms of the disease. However, NIH proposed 
changes to the stages and diagnostic criteria for AD, due to advancements in the detection of 
biomarkers (Jack et al., 2011; McKhann et al., 2011). The current diagnostic criteria allow for 
earlier diagnoses to be made, and therefore may allow people with AD and their families to be 
better prepared for the devastating effects of AD. The multidisciplinary approach to AD 
treatment necessitates complexity and individuality in treatment regimens. Although this chapter 
is not comprehensive, it does discuss a number of AD-related issues that help determine the 
diagnostic criteria and symptomology of the disease, the environment in which treatment is 













CHAPTER 3: THEORIES OF MUSIC’S EFFECTS ON EMOTION AND BEHAVIOR 
 Every culture on earth includes some form of music (Cross & Morley, 2008; Levitin & 
Tirovolas, 2009). Even some animals engage in song (e.g., birds) or other rhythmic activities 
(e.g., primates hitting rocks together), or vocalizations at specific pitches (e.g., dogs howling). 
Musicologists that study its evolution believe that music may exist today because it has selective 
beneficial effects in humans, including the ability to convey and modulate emotion (Cross & 
Morley, 2008; Levitin & Tirovolas, 2009). This chapter will discuss the evolution of music, 
theories of music as a means of communicating emotions, theoretical explanations for music’s 
effects on emotion, music’s role in memory, and various models of therapeutic uses for music, 
including explanations for why it is being used in the treatment of AD.  
Evolution of Music 
 One prominent focus in recent musicology research has been on studying the origins of 
music (Cross & Morley, 2008; Levitin & Tirovolas, 2009). This area of research questions why 
music might have evolved, why it continues to play a role in modern society, and what roles it 
may play. Examining music from an evolutionary perspective, some musicology researchers 
believe that music developed and remains a part of every culture because it has selective benefits 
(Cross & Morley, 2008). Others, however, consider music to be nothing more than a byproduct 
of the evolution of human language and that any pleasure obtained from listening to or playing 
music is incidental (i.e., the “auditory cheesecake” theory; Pinker, 1997, cited in Levitin & 
Tirovolas, 2009). The hypothesized benefits of our ancestors playing music include increasing 
cognitive and emotional flexibility, and physical fitness and motor coordination, since dance or 
movement usually accompanied music making (Levitin & Tirovolas, 2009).  
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 Because music is thought to be capable of transmitting emotional information to many 
people simultaneously, it is hypothesized to have increased group cohesion by modulating the 
emotions of the group members (Blacking, 1969, cited in Cross & Morley, 2008).  This is 
believed to have been advantageous to our ancient ancestors since group cohesiveness likely 
increased cooperation with other group behaviors, something that is beneficial to the survival of 
the group. Another theory states that music may have evolved from mother-infant 
communication, and that its primary function was to convey speech and other communicative 
information from mother to infant and consequently act to strengthen the bond between them 
(Roederer, 1984, cited in Cross & Morley, 2008). This possibility and other views of music 
serving as mechanisms of communication are widely popular among musicologists.  
Music as Communication 
 It has been proposed over a hundred years ago that music may have its origins in a 
musical proto-language (i.e., a primitive form of language consisting of distinct rhythmic, tonal 
calls; Darwin, 1871/1998). That is, music as a form of communication is believed to have 
evolved either before, or simultaneously with, spoken language in humans. Many great thinkers 
of the past, from Descartes to Darwin to Nietzsche, have considered the origins of music and 
language to have some association. One musicologist has even proposed that music and language 
may have evolved concurrently as a single communication system that he coined ‘musilanguage’ 
(Brown, 2000, cited in Cross & Morley, 2008).  The musilanguage theory is well-accepted by 
many musicologists, although some believe that music preceded language, and others that 
language preceded music (Cross & Morley, 2008; Levitin & Tirovolas, 2009). While a full 
review of the connection between music and language is beyond the scope of this work, it is 
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important to note that this link exists and that it specifically plays a role in the communication of 
emotion. 
 The proto-language, or musilanguage, of our ancient ancestors is theorized to have 
consisted of pitch and timbral-varying, rhythmic calls that were used to express various emotions 
(Cross & Morley, 2008). It is believed that the different primal calls were distinct enough to 
convey specific emotional content.  This transmission of affective information is thought to be a 
key element of musilanguage since the expression of emotions was essential to survival. For 
example, when a predator may have been approaching, fear needed to be expressed to warn 
others and prevent them from being harmed. However, musicologists that study language and  
music consider music and musilanguage communication to be more ambiguous in their meanings 
than spoken words (Cross & Morley, 2008). Although these primitive calls were a language in 
itself, they eventually developed into the more complex communication system of speech 
because of the need for greater stability in the meanings of messages.  
 Musicologists that study the evolution of music point out the evidence for the 
musilanguage theory in that the characteristics of speech, such as rhythm, pitch, and phrasing, 
are very similar to those of music (Cross & Morley, 2008; Levitin & Tirovolas, 2009). However, 
two differences between music and spoken language are notable. One is the aforementioned 
ambiguity in the meanings of music, and the other is that music usually allows and encourages 
participants to act simultaneously, whereas speech communication is normally done 
consecutively, alternating between those involved (Cross & Morley, 2008). Regardless of these 
differences, the aforementioned acoustic qualities of speech have been found to change with the 
emotional state of a person, demonstrating that the nonverbal part of speech remains an 
important component of expressing emotion and relaying affective information beyond the 
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words spoken (Juslin & Vastfjall, 2008; Levitin & Tirovolas, 2009). This is posited to indicate 
that musicality may have evolved primarily as a means to express and induce emotion. Using 
music for communicating emotion is a common use of music therapy when utilized with people 
with autism spectrum disorders (Gold & Wigram, 2007; Whipple, 2004). Persons with dementia 
in later stages of the disease normally will lose the ability to communicate using coherent speech 
(Alzheimer’s Association, 2012); therefore music may also provide a potential means of 
communicating emotions in this population.  
 Music and Emotion 
 The conveyance of emotions and other affective information is considered a primary 
function of music by many musicology researchers that specialize in perception of music (Juslin 
& Vastfjall, 2008; Levitin & Tirovolas, 2009). This area of research has also demonstrated that 
people today mainly value music for the emotions it is capable of evoking in listeners, and 
emotional regulation has been commonly reported as the main reason for listening to music in 
prior studies (Juslin & Vastfjall, 2008). People have reported listening to music specifically to 
change, release, or match their current emotional states in order to enjoy or comfort themselves, 
or in order to relieve stress. Listening to classical music has also been found to produce strong 
emotional responses along with biophysical changes (e.g., chills, shivers, changes in heart rate) 
in listeners (Levitin & Tirovolas, 2009). Music listeners’ responses, including the biophysical 
responses related to emotion, have been an area of intense focus for much of musicology 
research in the area of perception and cognition. However, Juslin and Vastfjall (2008) state that 
there is yet to be a satisfactory explanation of the underlying mechanisms for music’s effects on 
emotion. While biophysiological responses to music have been studied extensively, they are only 
considered characteristics or indicators of emotions, and not the emotions themselves. 
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Cognitive Processing of Emotions 
 Many prior neuro-imaging studies have revealed that the limbic system is primarily 
involved in the generation, detection, maintenance, regulation, and termination of all emotions in 
humans (Koelsch, 2010). While music-related emotion is accepted as being processed primarily 
within the limbic system of the human brain, this area is not well-defined in mammals (Juslin & 
Vastfjall, 2008; Levitin & Tirovolas, 2009). The mammalian limbic system is believed to have 
evolved differently in different species (Reep, Finlay, & Darlington, 2007). For example, while 
some lower species’ limbic systems may be dominated by olfaction (e.g., dogs), higher species, 
such as the primate and human limbic systems have evolved to be more dependent on visual and 
auditory systems (Reep et al., 2007). This means that the interconnections and potential parts of 
the limbic system are different among different mammalian species. Additionally, not all 
neurologists agree on what parts of the brain make up the limbic system even within a species 
(Juslin & Vastfjall, 2008; Levitin & Tirovolas, 2009). That is, even in humans, the limbic system 
is defined differently, containing dissimilar parts of the brain, some not agreed on among 
neurological researchers. 
 However, one featured part of the limbic system of all mammals is the amygdala, which 
is known for its role in the processing and generation of emotions, especially those considered 
essential to survival, such as fear (Brattico et al., 2011; Koelsch, 2010). The amygdala has been 
implicated in research on intensely pleasurable responses to music, such as chills and shivers 
down the spine, which prior neuro-imaging studies having demonstrated a deactivation within 
this region during these events (Koelsch, 2010; Levitin & Tirovolas, 2009). One possible reason 
for this is that the amygdala is strongly associated with negative emotions such as fear and 
anxiety, and therefore deactivation of this region may decrease the autonomic, fight-or-flight 
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arousal associated with it and allowed the pleasurable responses to music to occur. Besides 
pleasurable experiences, the deactivation of the amygdala, along with other biophysiological 
responses, are postulated to play a role in the therapeutic effects of music, including reducing 
stress and anxiety (Koelsch, 2009).  
Biophysiological Effects of Music 
 Research on the biophysical effects of music has focused on changes in both physical 
characteristics (e.g., heart rate, respiration, skin conductance) and the neural processing of music 
within a variety of regions in the brain. Neuro-imaging technology has demonstrated activation 
in several distinct brain regions when either listening to or playing music. It has been well-
established that the processing of music-related emotions is done in sub-cortical regions of the 
limbic system in the brains of music listeners (Brattico et al., 2011; Levitin & Tirovolas, 2009). 
Because music affects the limbic system, it is considered an appropriate tool for studying the 
changes in the brain associated with emotions. However, only a few studies have examined 
correlations of emotions induced by music and brain region activation thus far (Brattico et al., 
2011).  Advances in neural-imaging technology (e.g., fMRI) have made this research possible, 
although their use is not widely available to researchers. Additionally, it is important to note that 
while the limbic system does play an important role related to music and emotions, other exterior 
brain regions have also been found to interact with the limbic system during emotional responses 
(Levitin & Tirovolas, 2009).  
 Past researchers have hypothesized that music was processed primarily in the right brain 
because of its emotional content, while speech was processed in the left side (Levitin & 
Tirovolas, 2009). Advances in neuro-imaging technology have more recently shown that areas of 
both sides are activated when processing music and emotion, since emotion-related circuits are 
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located throughout the brain and music can induce such a wide range of both simple and 
complex emotions. However, other aspects of music have been shown to be processed within 
different, specific regions localized to specific areas of the brain (Brattico et al., 2011; Levitin & 
Tirovolas, 2009). For example, the perception of pitch and melody (i.e., patterns of pitch) 
primarily activate the right hemisphere while rhythm and semantic information (i.e., recognition 
of intervals, identification of familiar melodies) activate the left.  Although the identification of 
familiar melodies was found to activate the left hemisphere in the brain, reproduction of those 
melodies (i.e., asking someone to play or sing the melody) was shown to primarily be done using 
the right side (Andrade & Bhattacharya, 2003). Fine distinctions such as these make it difficult to 
precisely conceptualize the functions of different characteristics of music within the brain.  
 Many aspects of music are closely-related, as in the previous example of melody, and 
therefore cannot easily be isolated. For this reason, and because multiple areas of the brain are 
usually involved in processing any feature of music, modern musicologists consider the 
hemisphere explanation an oversimplification (Brattico et al., 2011; Levitin & Tirovolas, 2009; 
Koelsch, 2010). For instance, the processing of a familiar melody may not be able to be isolated 
from the emotional response of the listener, and since emotional processing takes place 
throughout the limbic system of the brain, it may be impossible to pinpoint exact regions of 
processing for such a specific aspect of music. However, most musicologists that study cognition 
agree that music processing is done in a modular manner, utilizing different areas for processing 
different characteristics of music. Some evidence for this comes from prior studies showing 
greater brain activation while listening to music in people with musical training than those 
without musical backgrounds (Lowis, 2010). It is believed that people with musical ability tend 
to listen to music more analytically and thus activate more regions within the brain when doing 
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so than people without any musical training. This deeper, analytical listening was also found to 
increase the intensity of emotional responses to music, which may be due to the greater 
activation within the brain (Lowis, 2010).   
 One study of music’s effects on people with dementia demonstrated that the type of 
dementia influenced the emotional recognition of various pieces of music (Omar, Hailstone, 
Warren, Crutch & Warren, 2010). This study included two participants who had backgrounds 
with musical training and also had a clinical diagnosis of dementia. Their results were compared 
with a normal population of cognitively-healthy musicians as a control. One participant had been 
diagnosed with semantic dementia, and showed severely restricted emotional recognition of 
music, while the other participant had AD and demonstrated a normal recognition of the 
emotional content of music (Omar et al., 2010). The participants differed on recognizing other 
aspects of music as well, with the participant with semantic dementia showing preserved 
recognition for musical objects (e.g., compositions), and symbols (e.g., music notation), while 
music sources (e.g., different instruments, timbre) and emotions were impaired (Omar et al., 
2010). Interestingly, the participant with AD demonstrated preserved emotional recognition of 
pieces of music and recognition of music sources, while recognition of musical objects and 
symbols were found to be impaired. This suggests that different areas of the brain are activated 
during the recognition of each of these dissimilar aspects of music. Furthermore, the finding that 
emotional recognition of music is preserved in AD strengthens the case for its utility to modulate 
emotion in people with the disease. While biophysiological responses to music add credence to 
the evidence for the efficacy of music therapy in reducing stress and anxiety, other psychosocial 
explanations for music’s effects that go beyond physiology have also been posited (Koelsch, 
2009; Lowis, 2010).    
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Psychosocial Theories for Music’s Effects on Emotion 
 Personal feelings and subjective experiences have been considered an essential 
component of emotion since the time of Aristotle (cited in Lundqvist, Carlsson, Hilmersson, & 
Juslin, 2009). Regardless of years of continuing biophysiological research on music’s effects on 
emotions, musicologists believe that the changes within the brain and body found when listening 
to music do not truly or totally represent the emotional effects of music or what emotions 
actually are (Juslin & Vastfjall, 2008; Koelsch, 2009; Lowis, 2010). Some musicologists believe 
that the application of the scientific method to such personal, subjective experiences as emotional 
responses to music will never provide sufficient information as to how they work (Lowis, 2010). 
There is not even absolute agreement among musicologists and other researchers of emotions 
regarding the conceptualization of emotion itself (Lundqvist et al., 2009). Thus, musicologists 
have often relied on self-report in addition to biophysical changes in an attempt to more 
accurately understand the subjective, emotional experiences of music listeners. 
 Many musicologists believe that biophysiological responses, such as autonomic arousal, 
are not necessary in order for music listeners to feel emotion (Johnsen, Tranel, Lutgendorf, & 
Adolphs, 2009). That is, listeners can feel and describe an emotional response to music without 
any biophysical indication that a reaction has occurred. There is also evidence for a dissociation 
between the cognitive processing of music and emotional responses. Prior studies of people with 
brain lesions in areas within the limbic system that are associated with emotion have 
demonstrated the preservation of the cognitive processing of music, but have not displayed 
emotional responses to music (Matthews, May, Chang, Engstrom, & Miller, 2009). The converse 
has also been found to be true, where severe deficits were found in the cognitive processing of 
music, but strong emotional responses were still reported. This dissociation has been found in 
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case studies of people with generalized auditory agnosia (i.e., impaired interpretation of sounds; 
Matthews et al., 2009), and AD (Omar et al., 2010). This preservation of emotional recognition 
and reactions found along with deficits in cognitive processing or autonomic arousal from music 
highlight that other pathways are probably involved in emotions related to music. Additionally, 
this emphasizes that music remains a viable method for the communication of emotion in people 
with cognitive impairment, such as those with AD, who may not show normal biophysiological 
responses to music.  
  There is no one mechanism that is likely to fully explain the effects of music on 
emotions. Therefore, several theories, including some not involving biophysical responses, have 
been posited as to how music may induce and modulate emotions in its listeners. Some of these 
theories involve: brain stem reflexes, evaluative conditioning, emotional contagion, mental 
imagery, episodic memory, and musical expectancy (Juslin & Vastfjall, 2008). Juslin and 
Vastfjall (2008) attempted to combine these disparate theories into a complete, theoretical 
framework for music’s effects on emotion. However, few of these theories or the framework in 
its entirety have been empirically tested.  Some of the individual theories will be briefly 
discussed for their relevance to music therapy.  
 Evaluative conditioning refers to the pairing of a piece of music to other concurrent 
stimuli, either positive or negative (Juslin & Vastfjall, 2008). Pairing of the music with a positive 
stimulus, such as repeatedly hearing a piece of music during each occurrence of a happy event 
(e.g., hearing someone’s favorite song that you enjoy being with), may condition the listener to 
later produce a positive response to the music alone. This can transpire without awareness of its 
occurrence, and is posited to be a powerful regulator of emotion that may be responsible for 
many of the emotional reactions to music in everyday life (Juslin & Vastfjall, 2008). Evaluative 
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conditioning is relevant to music therapy because it suggests that familiar music associated with 
positive emotions in the past could be utilized in sessions in order to stimulate current positive 
responses. It is important to note that this mechanism is different from that of episodic memory 
(discussed in Music and Memory below), since pieces of music are paired with emotions and not 
past memories in this instance.  
 Emotional contagion refers to listeners emulating the emotional content conveyed in the 
musical work itself (Juslin & Vastfjall, 2008). It is generally acknowledged that music in a major 
key portrays happy emotions, while music in a minor key portrays sad emotions. Lyrics can also 
contribute to the emotional content of non-instrumental musical works. For example, hearing a 
song with sad content, whether lyrical or instrumental, may be recognized and consequently 
induce a feeling of sadness in a listener. This mimicking of emotion is the basic, most direct 
mechanism of how music may affect emotion, and has been demonstrated in many prior studies 
(Juslin & Vastfjall, 2008; Koelsch, 2009). Implications for music therapy suggest including 
relevant songs with the emotional content wished to be conveyed and evoked in participants 
during sessions.  
 Mental imagery theory postulates that emotions are induced in music listeners through 
the invoking of visual imagery from the music (Juslin & Vastfjall, 2008). For example, a slow, 
peaceful song may evoke pleasant, peaceful imagery in listeners, which is partially responsible 
for the resultant peaceful feelings from the music. This suggests utilizing only pleasant and calm 
songs for therapeutic use if the goal is to reduce agitation, stress, or anxiety, while up-tempo, 
happy musical numbers may be utilized for depression to induce arousal levels by evoking lively 
mental imagery. Music therapists that work with individuals may ask their clients what they 
imagine with certain pieces and how it makes them feel, and then continue to utilize the most 
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effective pieces since music therapy’s effectiveness is likely due to many different underlying 
mechanisms (Koelsch, 2009). While emotional regulation plays a primary role in music therapy, 
memories of past events may partially explain this phenomenon.  
Music and Memory 
 Music and memory are thought to interrelate in numerous ways. However, memory for 
music, including the ability to play instruments, recognition of familiar pieces, and perception of 
various aspects of music, are sometimes found to be preserved in people who otherwise 
demonstrate severe deficits in other areas of memory (Cuddy & Duffin, 2005; Omar et al., 2010; 
Swartz, Hantz, Crummer, Walton, & Frisina, 1989). One specific example is with people with 
AD. Several studies indicate that people with AD, even when in the late stage, can recognize and 
respond to familiar pieces of music, and a few studies have even demonstrated that some musical 
abilities, including the ability to play previously memorized pieces, is also spared in AD (Cuddy 
& Duffin, 2005; Gerdner, 1997; Omar et al., 2010; Swartz et al., 1989).  One reason for this may 
be because playing previously memorized pieces of music does not rely on declarative memory 
(i.e., memory of explicit, articulatable knowledge), but on implicit, procedural memory (Omar et 
al., 2010; Swartz et al., 1989). Procedural memory is memorized knowledge of how to carry out 
procedures, usually involving motor movement, and is usually relatively spared in AD. This 
means that someone with AD who may be able to play previously learned musical works may 
not be able to articulate the knowledge about the piece (Cuddy & Duffin, 2005; Swartz et al., 
1989). This suggests that the implicit, procedural memory responsible for making music and the 
emotional and other responses to music are separate from explicit, declarative memory.  
 AD primarily affects declarative memory in all of its stages; however, memories of 
distant past events (e.g., episodic or autobiographical memories) are usually spared during the 
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initial stages (Alzheimer’s Association, 2012). Since the music people favor in their teens and 
early 20’s is usually the music they prefer for life (Bruhn, 2002; Schafer & Sedlmeier, 2009), 
any autobiographical memories associated with familiar music in people with AD should 
normally be intact in the early stages of the disease. Music therapy with people with AD 
(discussed in depth later), takes this into consideration and normally utilizes familiar music from 
the time when the person was an adolescent to young adult (Gerdner, 1997, 2001). However, 
even people with late-stage AD who show severe deficits in autobiographical and episodic 
memories can continue to respond normally to music, including with the regulation of emotion 
(Cuddy & Duffin, 2005; Gerdner, 1997; Omar et al., 2010). Additionally, even when other 
declarative knowledge is not able to be articulated well, people with AD demonstrate an 
uncharacteristic ability to recall and recite lyrics along with a melody normally (Carruth, 1997; 
Gerdner, 1997, 2001). This preservation of musical memory and responses to music in people 
with AD has led to its widespread use in therapeutic situations, not only to regulate emotion, but 
also to facilitate communication and autobiographical memory.  
          Autobiographical memories are sometimes strongly associated with specific pieces of 
music (Bruhn, 2002; Juslin & Vastfjall, 2008; Omar et al., 2010). Autobiographical memories 
that are most commonly reported as being associated with music are social events, including 
with romantic partners (e.g., “They’re playing our song”), events with friends (e.g., music 
concerts), or other events such as vacations, movies, sporting events, or the birth or death of a 
loved one. Any event in which music may have been present can become an autobiographical 
memory associated with the specific music, whether positive or negative. For example, if 
someone who has been in a car accident while a particular song was playing on the car radio, he 
or she may become anxious when hearing the song at a later time because of the recalled 
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memory of the accident. This is one reason why it is important to individualize the music utilized 
in music therapy, which would typically include familiar music, but probably not include songs 
that may be associated with traumatic events.  
 The use of familiar pieces of music in music therapy is hypothesized to facilitate the 
recall of autobiographical memories, and consequently to help regulate emotions. Music is 
known to facilitate memory recall, especially of episodic and autobiographical memories (Foster 
& Valentine, 1998; Irish, 2006; Clark, Lipe & Bilbrey, 1998). When autobiographical memories 
are brought to mind, the emotions associated with those memories are also thought to be re-
experienced (Juslin & Vastfjall, 2008; Pereira et al., 2011). It is posited that this may be due to 
the physiological reactions to the original experiences being stored in memory along with any 
other additional information making up the memories (Lang, 1979, cited in Juslin & Vastfjall, 
2008). These reactions are then later recalled with the memories as well. While studies have 
demonstrated biophysiological reactions to recalling autobiographical memories, it is important 
to point out that some researchers believe that these biophysiological responses are not emotions 
themselves, and that they are not even necessary for people to feel or experience emotion 
subjectively (Johnsen et al., 2009).  Nevertheless, many people report using music to remind 
them of pleasant events in their past in order to re-experience the associated emotions and 
improve mood (Juslin & Vastfjall, 2008; Pereira et al., 2011). This can be especially valuable in 
people with AD who may otherwise not be able to recall these events. 
 The loss of one’s autobiographical memories that occurs with AD and other related 
dementias is essentially the loss of one’s self-identity (Caddell & Clare, 2011; Kasl-Godley & 
Gatz, 2000). Therefore any interventions facilitating the recall of one’s past experiences, such as 
reminiscence therapy, may help one maintain a sense of self while facing the disabling effects of 
77 
 
diseases such as AD. Autobiographical recall has specifically been shown to be improved in 
people with dementia while listening to music than without listening to music (Foster & 
Valentine, 1998; Irish, 2006; Clark et al., 1998; Sacks, 2008). Clark and colleagues (1998), 
Sacks (2008), and many others have witnessed older people with AD and other related dementias 
who are ordinarily nearly completely withdrawn become highly sociable, sharing lengthy, 
detailed stories, after listening to their favorite music from their youth. This recall of distant-past 
life events is thought to facilitate emotional responses that are commonly experienced to familiar 
pieces of music in people with AD and other dementias (Koelsch, 2001; Clark et al., 1998; 
Sacks, 2008).  
 This possible connection of music and autobiographical memory demonstrates the utility 
of music in therapeutic settings for people with AD. For example, Foster and Valentine (1998) 
suggest playing music in the background when interviewing people with AD about their lives in 
order to improve the flow and accuracy of the information received. Another potential 
therapeutic use of music aiding the recall of pleasant, past memories is to help people with AD 
adjust to living in a nursing home or other long-term care facility (Koelsch, 2001). For instance, 
helping new residents of a nursing home to recall their pleasant life events can help to reduce the 
anxiety of adjusting to the new situation. Music is also often utilized in reminiscence therapy in 
order to aid in the recall of pleasant experiences along with the positive emotions associated with 
them (Caddell & Clare, 2011; Kasl-Godley & Gatz, 2000). However, even when music is used as 
a solitary mode of therapy, without the intentional recall of autobiographical memories, it can 





Music and Stress Threshold in Alzheimer’s Disease 
One of the most prominent features of the use of music for treating the symptoms of AD 
and other dementias has been its efficacy in reducing agitation and related anxious feelings and 
behaviors (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & Chang, 2005; Witzke, et al., 
2008 ). While many studies have found the effect of reduced agitation, few have examined the 
underlying mechanisms or postulated theories for the phenomenon (Gerdner, 1997; Spiro, 2010). 
However, an extensive search of the literature regarding the use of music as an intervention for 
dementia revealed one underlying theory posited by Gerdner (1997), who posits a mid-range 
theory on music’s effects on stress and agitation in people with dementia or other cognitive 
impairment. The cognitive impairment found in dementia and other similar conditions is 
hypothesized to lower one’s stress threshold for environmental stimuli, creating greater stress 
levels and making one more prone to agitation when presented with multiple, concurrent stimuli. 
Having and continuing to develop a lower stress threshold when cognitively impaired means that 
people with dementia are more easily stressed under less of a load of stimuli in their 
environments than those who are not cognitively impaired (Hall & Buckwalter, 1987; Gerdner, 
1997).  
Since cognition continues to decline with the advancement of AD, Hall and Buckwalter 
(1987) have identified the resultant increasing stress reaction to environmental stimuli in people 
with AD as the Progressively Lowered Stress Threshold (PLST). This theory, based on aging and 
stress research in animal models, posits that as the brain ages, it becomes less resilient to stress, 
which may further accelerate cognitive decline since stress is known to cause degenerative 
changes within the brain (U.S. Department of Health and Human Services, 2011). The PLST 
theory (Hall & Buckwalter, 1987) suggests that people with AD are more prone to the effects of 
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stress, and studies on persons with AD have found high levels of some hormones, especially 
stress hormones (e.g., cortisol) in participants (U.S. Department of Health and Human Services, 
2011). Aging itself seems to reduce the brain’s ability to stop the production of stress hormones 
since levels typically increase with age, with or without the presence of AD (Richter & Richter, 
2004). Stress hormones are known to increase inflammation in the body and brain, and high 
levels of inflammation are also associated with having AD (Alzheimer’s Association, 2012; U.S. 
Department of Health and Human Services, 2011). In her model based on the PLST, Gerdner 
(1997) proposes that familiar music acts as a central focal point for people with dementia to 
attend to in their environment, and consequently reduce the stress of trying to comprehend other 
concurrent multiple sources of stimuli. Consequently, the lowered stress leads to less agitation 
and fewer disruptive behaviors. While many prior studies have demonstrated music’s ability to 
reduce agitation in people with AD, few have explicitly attempted to test this model in an 
empirical approach.   
Conclusion 
  Several theoretical mechanisms that help explain music’s effects on us, based on both 
biophysiological and psychosocial reactions to music, were discussed. Emphasis was given to the 
emotional responses of music in people with AD, since this is the author’s intended area and 
population of study. Spiro (2010), searching for the underlying mechanisms for music’s effect on 
the regulation of emotion and autobiographical memories in people with AD, identified some 
possible roles of music therapy when utilized with this population. The music therapy roles he 
identified included: 1) as a leisure activity which contributes to wellbeing; 2) as an intervention 
showing positive effects on memory and communication; and 3) as an intervention affecting 
one’s state of mind and behavior (e.g., agitation, anxiety and stress, disruptive behaviors; Spiro, 
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2010). Theoretically, the aforementioned increased recall of pleasant autobiographical memories 
contributes to all three of these roles of music in people with AD. However, other underlying 
mechanisms, as also previously discussed, are probably also partially responsible for music’s 
effects on people with AD. The identification of these roles of music therapy, however, does help 
elucidate possible theoretical approaches applicable to the uses of music with people with AD 




















CHAPTER 4: REVIEW OF MUSIC THERAPY LITERATURE 
The purpose of this literature review is to examine relevant research on music 
interventions and their effect of decreasing agitation found in people with AD or other similar 
dementias. Agitation and the resultant behaviors in people with dementia are frequently reported 
by caregivers to be the most challenging aspect of their duties (Sung & Chang, 2005; Witzke et 
al., 2008). If left uncontrolled, agitated behavior in dementia sufferers can put one at risk of harm 
to themselves, their caregivers, or others, since these behaviors can often lead to aggressiveness 
and destructive acts (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sung & Chang, 2005; 
Witzke et al., 2008). Reducing the agitation and related behaviors associated with dementia 
improves the quality of life of both the persons with dementia and those around them, and music 
therapy and other music interventions can help facilitate this process.  
This chapter explores research related to the use of music therapy and music 
interventions as a potential treatment for symptoms of AD. First, this chapter conceptualizes 
music therapy by exploring various definitions and types, including the methods and techniques 
that are commonly used in treatment. The use of music for treating symptoms of autism spectrum 
disorders, for pain management, and in neuro-rehabilitation are also briefly discussed in order to 
give the reader a broader sense of how music can be used therapeutically. A discussion of 
relevant literature specific to the use of music for treating symptoms of AD then follows. Finally, 
this chapter discusses prior studies on the use of music as an intervention specific for agitation in 
people with AD and the limitations of this body of knowledge.  
Conceptualization of Music Therapy 
Music therapy can be thought of as any use of music by a qualified music therapist that 
provides a therapeutic benefit to a client or group (Bruscia, 1998; Darnley-Smith & Patey, 2003; 
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Peters, 2000). While this simple, yet broad definition encompasses what music therapy is, many 
other more specific definitions have been posited, which identify distinct types and certain 
techniques in which music can be used for therapeutic purposes.  However, all forms of music 
therapy aim to create a secure, stimulating environment, meet social and emotional needs, 
increase attention and quality of life, and regulate the arousal level of clients receiving it 
(Bruscia, 1998; Darnley-Smith & Patey, 2003; Peters, 2000). Music therapy has been shown to 
improve both the mental and physical health of participants in prior studies (Koelsch, 2009). The 
underlying mechanisms that are thought to contribute to music therapy’s effects, while not fully 
understood, are believed to modulate emotion, attention, cognition, behavior, and 
communication (Koelsch, 2009). Additionally, involvement with music throughout life is 
believed to contribute to increased brain plasticity, even when music is not learned until late in 
life (Bruhn, 2002; Wan & Schlaug, 2010). Two broad categories of music therapy are active, in 
which recipients actively participate in the creation of music during sessions, and passive, where 
recipients simply listen to prerecorded music (Darnley-Smith & Patey, 2003; Peters, 2000). Both 
broad categories of music therapy, along with related treatment models, are discussed further 
below.  
Active Music Therapy 
 Active forms of music therapy involve the music therapist and the recipient engaging in 
the creation of music during sessions (Darnley-Smith & Patey, 2003; Peters, 2000). For example, 
the music therapist may play familiar songs and encourages recipients to sing along or clap. 
Simple instruments may also be used, such as shakers and hand drums. Recipients with musical 
skill may utilize more complex instruments to create music in active music therapy sessions. In 
these sessions of music creation, the use of music acts as “a means of interaction and self-
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expression within a therapeutic relationship” (Darnley-Smith & Patey, 2003, p. 8).  The majority 
of music therapists acknowledge utilizing active forms of music therapy in their practices, 
although a variety of methods are used to accomplish this (Darnley-Smith & Patey, 2003; Peters, 
2000). Many factors can affect how music therapy is carried out in sessions, including the 
number of clients, the setting of the session, the aims of the session, and the theoretical 
orientation of the therapist (Bruscia, 1998). Music therapists will often choose the most suitable 
method based on the clients’ current circumstances and needs. For example, if the client is 
unable to actively participate in music therapy, passive modes may need to be used.  
 One common mode of active music intervention is the community music therapy model 
(Darnley-Smith & Patey, 2003; Peters, 2000), which provides treatment within a community in 
which clients live. Darnley-Smith and Patey (2003) describe the community model of music 
therapy as “the work undertaken by music therapists outside the boundaries of one-on-one or 
small group therapy sessions…applied to situations where the therapist is responding flexibly to 
the social and cultural context of the setting” (p. 10). Community music therapy could be group 
music therapy done at a nursing home or other institutional settings, such as day habilitation 
centers for people with disabilities or inpatient mental health or substance abuse treatment 
centers, where the issues and needs of each distinct community are taken into consideration.  
 Another mode of active music therapy is improvisational music therapy (Darnley-Smith 
& Patey, 2003; Peters, 2000). In this model, the music therapist and the client improvise music 
together to facilitate communication and foster a helping relationship between them. The 
improvisation is usually done using simple instruments such as hand drums and/or singing, 
unless the client has other specific music skills. This practice of music therapy is the most 
common in Britain, and therefore much of the music therapy research done within this region has 
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been done on this particular mode of music therapy (Darnley-Smith & Patey, 2003). Many sub-
models of improvisational music therapy have been posited and are based on different treatment 
theories; however, they all contain the element of creating improvised music during sessions.  
Improvised music denotes creating original pieces of music during therapy sessions, whereas 
music therapists are likely to choose familiar, prewritten pieces for use in community settings or 
passive music therapy interventions (Bruscia, 1998; Darnley-Smith & Patey, 2003; Peters, 2000). 
Passive Music Therapy 
 Passive modes of music therapy utilize music listening for its innate restorative and 
healing qualities (Darnley-Smith & Patey, 2003; Peters, 2000). No active creation of music is 
done by the client during a passive music therapy session; however, the music therapist may sing 
or play an instrument while the client listens.  Passive methods can be used to evoke emotional 
responses and promote greater self-expression in the client. In passive models of music therapy, 
the role of the relationship between the therapist and the client is secondary to the application of 
music as a treatment intervention (Bruscia, 1998; Darnley-Smith & Patey, 2003). Passive music 
therapy also has several distinct modes of treatment that may also include guided-imagery and 
in-depth analysis. For optimum efficacy, music therapists will often include music that is 
meaningful to their clients, individualizing their selections for each client (Gerdner, 1997, 2001).  
 Vibroacoustic therapy is one form of passive music therapy in which the music therapist 
uses the vibrations of sounds, or sometimes single tones, for treating pain and/or other physical 
disabilities (Darnley-Smith & Patey, 2003). This particular method is also known as the “music 
bath”, since clients are “bathed” in sound vibrations chosen and played by the therapist (Darnley-
Smith & Patey, 2003, p. 8). Vibroacoustic therapy is sometimes utilized first in order to 
encourage clients to later become involved in more active methods of music therapy. Some 
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conditions that have responded to this treatment are cerebral palsy, asthma, abdominal pain, 
insomnia, and sports injuries (Darnley-Smith & Patey, 2003).  
 Another passive method where music is listened and attended to is the Guided Imagery 
and Music (GIM) model. This method involves “listening to carefully selected… music in a 
relaxed state [to evoke] powerful feelings and symbolic images…leading to significant insights 
into therapeutic issues” (Darnley-Smith & Patey, 2003, p. 11). In this model, the music therapist 
chooses pieces of music based on the client’s history and current mood. There are four phases of 
treatment in GIM: 1) preliminary conversation, which serves as a guideline to the selection of 
music; 2) the induction, which invokes relaxation and focus within the client; 3) the music 
listening phase, where the client actually listens to the selected music; and 4) the post-session 
integration, where the client is encouraged to share perceptions of the experience and draw 
insights from it (Darnley-Smith & Patey, 2003). 
 Lastly, in passive forms of music therapy is the use of recorded music as a supplement in 
curing illness model (Darnley-Smith & Patey, 2003; Peters, 2000). This is the use of prerecorded 
music for the relief or reduction of pain, anxiety, or stress, where the music listening experience 
is not the primary treatment. This method involves listening to prerecorded music in order to 
supplement a primary treatment for a specific illness. The use of this method, along with primary 
treatment, can often result in pain-management clients needing fewer drugs for treating their pain 
(Kneafsy, 1997; Peters, 2000). Like most applications of passive music therapy, the music that is 
listened to for treatment in this model is music that is familiar to, and preferred by the client.   
Individualized Music   
Music therapy models and other interventions that incorporate familiar music will 
normally utilize the type and specific works of music that are preferred by the client for 
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individualized treatment whenever possible (Gerdner, 1997, 2001). While it may not be possible 
to individualize treatment for each person in a group setting, incorporating mixed modes and 
forms of music therapy in individual treatment regimens can get closer to this goal. For instance, 
in group settings, music therapists may assess preferences and include a variety of songs familiar 
to and preferred by several of the clients in the group. Clients may also each have individualized 
listening regimens when they are not in group settings; however, it is important to note that 
music preferences may change based on clients’ current circumstances.  
While different types of music may be preferred by individual clients, prior research has 
demonstrated that strength of music preference is based on the fulfillment of current needs of 
listeners (Schäfer & Sedlmeier, 2009). For example, if a listener is in need of relaxation, a 
preference for slow, soothing, and consonant (i.e., pleasing harmonies, not dissonant) music is 
likely over a preference for music featuring hard, fast rhythms and dissonant harmonies (e.g., 
heavy metal). Schäfer and Sedlmeier (2009) demonstrated that music’s function of expressing 
self-identity and representing values of listeners was associated with strength of preference for 
different types of music, but that internal emotional states also influence music preference and 
allowed for variations. For instance, listening to loud rock music, while not inherently relaxing, 
may provide a cathartic experience for the release of stress in listeners that prefer this type of 
music, while others may prefer soft, slow music to help them relax during stressful situations. 
While many people report using soft, slow music in order to help them relax, research suggests 
that one of the primary functions of all types of music in any situation is the regulation of 
emotions, mood, and arousal (Hargreaves & North, 1999; Schäfer & Sedlmeier, 2009). The 
ability of music to influence these internal states serves as the foundation for music’s use in 
therapeutic situations, and specifically, for regulating emotions and behaviors in people with AD. 
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Applications of Music Therapy 
 Autism Spectrum Disorders. Research literature regarding autism spectrum disorders 
(ASD) reports that most individuals with this type of disorder respond positively to music, often 
showing heightened interest and responses (Wigram & Gold, 2006; Whipple, 2004). Music 
therapists treating people with ASD utilize music as an educational tool in order to promote 
learning and skill acquisition (Whipple, 2004). Research supports connections between speech 
and singing, rhythm and motor behavior, memory for song and memory for academic material, 
and overall ability of preferred music to enhance mood, attention, and behavior to optimize 
students’ abilities to learn and interact (Wigram & Gold, 2006; Whipple, 2004). Studies have 
shown that the use of music therapy has been beneficial to individuals with ASD predominantly 
in terms of improved social and behavioral skills and interpersonal relationships (Whipple, 
2004). Additionally, music therapy research has revealed improved communication and language 
skills in people with ASD as a result of music therapy treatment (Wigram & Gold, 2006; 
Whipple, 2004). 
 Pain Management. Music therapy for pain management uses music as a means of 
altering the perception of pain (Kneafsy, 1997; Schorr, 1993). This can be used for people 
suffering from chronic pain due to ailments such as arthritis and cancer, or to help mange pain 
due to injury. Results from a study by Schorr (1993) on the perception of pain in women with 
arthritis showed that pain thresholds increased when participants listened to preferred music. 
Other studies on the perception of pain which utilized music therapy as an intervention have 
found similar results in post-operative participants and participants with cancer (Kneafsy, 1997).  
Findings from these studies suggest that music can reduce the perception of pain in a variety of 
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situations, leading to less adverse reactions to pain and lower use of medications to treat the pain 
in individuals receiving music therapy as a part of their treatment regimen.  
 Neurorehabilitation. Neurorehabilitation is an interdisciplinary treatment for people 
with acquired brain abnormalities, and currently, music therapy has often become a part of it 
(Baker & Tamplin, 2006). Music therapy is recognized as being able to facilitate the 
redevelopment of functional skills in people with brain abnormalities. However, the emotions of 
clients receiving treatment are also taken into consideration, and clients with emotional problems 
seem to be helped the most by music therapy in neurorehabilitation (Baker & Tamplin, 2006). 
Brain damage in patients receiving neurorehabilitation can be acquired through stroke, traumatic 
injury, or other causes, and while prognoses are usually uncertain, music therapy can help 
facilitate the recovery process.  
 One of the benefits of music therapy in neurorehabilitation is enhanced coping during the 
recovery period (Lee & Baker, 1997). This can be achieved through improving the self-
expression of patients by either performing music or through songwriting. Improved moods and 
enhanced hope has also been found in cancer patients recovering from chemotherapy who were 
recipients of GIM therapy (Bonde, 2007). Singing songs was also found to help patients with 
impairments in speech, improving its rate, articulation, and intonation (Baker & Tamplin, 2006).  
The use of music in physical rehabilitation can additionally serve as a guide that is effective for 
facilitating gait training, providing a rhythm for the patients to follow (Baker & Tamplin, 2006). 
In addition, song lyrics used in neurorehabilitation may sometimes include instructions for daily 
activities which assist in their completion by improving memory for the steps involved (Sacks, 




Music Interventions for Alzheimer’s Disease   
Music therapy and other music interventions may be as easy as playing recorded music to 
agitated AD sufferers (i.e., a passive music intervention) (e.g., Sung & Chang, 2005; Witzke, et 
al., 2008). This would usually involve playing familiar songs that the person with AD is known 
to enjoy in order to have the intended effect of improving mood and reducing agitation.  
Although prior studies have demonstrated that passive music interventions can be effective for 
reducing agitation in AD, active interventions involving singing and/or playing simple 
instruments in a group and/or individual setting with a music therapist or musician have also 
been shown to be effective (e.g., Gardiner & Furois, 2000; Ledger & Baker, 2007). Playing 
prerecorded music for people suffering with AD is an inexpensive and noninvasive intervention 
that can be easily incorporated by caregivers into daily routines in order to reduce the feelings of 
agitation and possible disruptive and aggressive behaviors. However, some consider active 
participation in music therapy (e.g., singing or playing an instrument) to be the superior form of 
treatment for agitated AD sufferers (Gardiner & Furois, 2000; Gotell et al., 2009; Ledger & 
Baker, 2007).  
 While active music therapy interventions may be harder to implement for AD sufferers, it 
is posited that active interventions provide greater cognitive stimulation than the mere passive 
listening of music can provide (Gardiner & Furois, 2000; Ledger & Baker, 2007; Sacks, 2008). 
While some training may be necessary, anyone with some music ability, including informal AD 
caregivers, should be able to learn to implement an active music intervention with people who 
have an AD diagnosis. This could be as simple as caregivers singing familiar and preferred songs 
and encouraging their care recipients to sing along with them.  
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In addition to affecting agitation in people with AD, music therapy and other music 
interventions have demonstrated noteworthy memory retention, sustained attention, increased 
arousal, and positive emotional effects in people with various forms of dementia in many prior 
studies (Carruth, 1997; Foster & Valentine, 1998; Lee & Baker, 1997; Spiro, 2010). The 
recognition of these effects of music interventions helps to elucidate possible approaches for the 
use of music with people with AD and related dementias.  Furthermore, music’s encouraging 
effects on stimulating autobiographical memory, improving cognitive functioning, and positively 
affecting behavior (e.g., reducing agitation and disruptive behaviors), suggest its utility beyond 
that of a leisure activity and advocate for its inclusion in AD treatment regimens.  
Cognitive Stimulation. Although many treatment options are available for AD sufferers, 
a multi-disciplinary approach including cognitive stimulation- such that music therapy provides- 
is considered best to maximize treatment regimen efficacy (Chapman, Weiner, Rackley, Hynan, 
& Zientz, 2004; Kasl-Godeley, & Gatz, 2000; Richter & Richter, 2004; Sacks, 2008). In one 
study of people with AD (Chapman et al., 2004), the effects of drug treatment alone with drug 
treatment plus a cognitive stimulation intervention were compared. Results found that the drug-
treatment-alone participants showed a significant decline from baseline measures of cognitive 
functioning one year later, while the drug treatment plus cognitive stimulation participants nearly 
maintained the same level of performance after one year. Since the disease would normally 
progress during this time, maintaining cognitive performance through the use of cognitive 
stimulation demonstrates the intervention’s efficacy of slowing the decline in cognitive 
performance (Chapman et al., 2004). That is, cognitive decline over the year-long study was 
expected in all participants since they had AD, though the participants receiving the cognitive 
stimulation intervention demonstrated significantly slower decline than the control group after a 
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year. Participants in the control group were offered the cognitive stimulation intervention at the 
conclusion of the study since results revealed its efficacy.   
The intervention used in the aforementioned study included participants creating a life 
story involving significant events, and engagement with hobbies and other activities throughout 
their lives, and discussing and presenting them to others in the group. While the cognitive 
stimulation intervention used in this study did not utilize music directly, other research suggests 
that music is an excellent source for cognitive stimulation (Carruth, 1997; Foster & Valentine, 
1998; Lee & Baker, 1997; Sacks, 2008). Additionally, the life story intervention, while providing 
cognitive stimulation, also provided social interaction, since, like many psychosocial 
interventions for AD including most music therapy, it was done in a group setting, which may 
have influenced the results (Chapman et al., 2004). Nonetheless, this study does provide some 
empirical evidence for cognitive stimulation’s effect on AD beyond that of observational studies 
relying on self-report since a battery of cognitive tests, including the Mini Mental State Exam 
(MMSE) and the Cognitive subscale of the Alzheimer’s Disease Assessment Scale (ADAS-Cog) 
were used. Being the most popular treatment for AD, one would assume that drug therapies are 
the most efficacious for treating the disease; however, the results from the aforementioned study 
point out the limitations of drug therapy for AD and advocate a multidisciplinary approach to its 
treatment, possibly including some form of cognitive stimulation like music therapy. 
 Other studies have also found music to directly have cognitive-enhancing effects, 
including improved memory, in people with AD (e.g., Foster & Valentine, 1998; Lee & Baker, 
1997).  Foster and Valentine (1998) found that simply playing background music during memory 
tasks for people with AD consistently enhanced their retrieval of autobiographical memories. 
Improved recall of autobiographical memories in people with AD through the use of music is 
92 
 
thought to be due to the associations connecting certain pieces of music to people’s past 
experiences (Foster & Valentine, 1998; Sacks, 2008). As previously mentioned, these recalled 
experiences can facilitate the regulation of emotion by inducing emotions associated with the 
lived experiences.  
 In addition to autobiographical memory, Carruth (1997) reported an improvement in 
naming abilities in people with AD when music was used to form songs with lyrics pairing 
names with faces. For comparison, the researcher used the same text in a non-music situation in 
which the lyrics were simply spoken and not sung to a melody. A significant advantage was 
found for those in the music situation, with the percentage of correct face-name recognition 
responses being higher than the comparison group, and the majority of the music-situation 
participants were also able to recall names even more than one day later (Carruth, 1997). This 
demonstrates not only that music can have a positive effect on memory, but that music may help 
facilitate the formation of memories throughout life. The use of music as a autobiographical, 
mnemonic device for people with AD has been postulated by Sacks (2008), stating that music 
has the power to elicit emotions and past associations, giving people with AD greater access to 
forgotten memories, moods, and thoughts. This regulation of autobiographical memories and 
emotions is also hypothesized to be another underlying reason for music’s effect of reducing 
agitation in people with AD (Gerdner, 1997, 2001; Koelsch, 2010; Spiro, 2010).  
Research Utilizing Music Interventions for Agitation in Alzheimer’s Disease 
 A comprehensive search of scholarly literature for music-related activities done with 
people with AD and other dementias revealed numerous studies conducted with varying 
methodologies over the past 20 years. Most of these studies have focused on reducing the 
agitated symptoms associated with dementia. The following review provides an overview of 
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what was done and the findings of the majority of the studies that examined the effects of music 
on agitation in people with AD and other dementias that were done over the past 20 years (1993 
– 2012). The studies included were selected in order to give the reader an objective view of the 
findings of this area of research by including all research designs and organizing the studies by 
the strength of the design. It is important to note that true experimental designs were not done in 
this area until recently and therefore weaker methodologies, such as quasi-experimental designs, 
make up the predominance of studies reviewed here.  
Case Studies. A broad literature search using the keywords “music” and “dementia” 
revealed a small number of case studies examining the effects of recorded music on older people 
suffering with dementia. These case studies examined the effects of participants’ preferred music 
on agitated and disruptive behaviors associated with dementia (Gerdner, 1997; Gerdner & 
Swanson, 1993; Ragneskog, Asplund, Kihlgren & Norberg, 2001). Gerdner and Swanson’s 
(1993) early study used a multiple case study design that included five participants who were 
played their preferred music each day for five days. A standardized scale, the Cohen-Mansfield 
Agitation Inventory ([CMAI], Cohen-Mansfield, 1997), was used to measure agitation; however, 
flexible, observational techniques were also done in order to capture emotions and behaviors that 
the scale may have missed. In this multiple case study, decreases in agitation were found both 
during and one hour after the music intervention for four of the five participants in this study, 
though no inferential statistics were used in the analysis (Gerdner & Swanson, 1993). 
Another case study by Gerdner (1997) also examined the effects of preferred music in a 
single-subject design using flexible, observational methods. Music was played twice per week 
for eight weeks (e.g., with a total of 15 sessions) in order to study its effects on the participant 
with AD’s agitated behaviors. Observational methods were utilized to record the participant’s 
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behavior in a purely qualitative fashion, with the author simply noting any changes or 
distinctions during the sessions. Gerdner’s (1997) intention was to try to understand and explain 
the underlying mechanisms for why music may have an effect on agitation in AD, and she 
proposed a theory based on the Progressively Lowered Stress Threshold (PLST) theory of AD 
(Hall & Buckwalter, 1987). The PLST theory (Hall & Buckwalter, 1987) suggests that people 
with AD are more prone to the effects of stress because the cognitive impairment found in 
dementia is hypothesized to lower one’s threshold for comprehending multiple, simultaneous 
environmental stimuli, creating greater stress levels and making one more prone to agitation. In 
her model based on the PLST, Gerdner (1997) proposes that familiar music acts as a central focal 
point for people with dementia to attend to in their environment, and consequently reduces the 
stress of trying to comprehend other concurrent multiple sources of stimuli. Consequently, the 
lowered stress leads to less agitation and fewer disruptive behaviors.  
Gerdner’s (1997) single-subject case study found a decrease in agitated behavior, 
especially with the participant’s wandering tendencies (i.e., wanting to leave). The author stated 
that the participant indicated no desire to quit or leave the music sessions, and that the participant 
actually stated that the music sessions were enjoyable. Behavioral observations recorded 
included the participant smiling and even dancing during the sessions (Gerdner, 1997). 
A multiple case study of music’s effects on agitation was done in one study of four 
participants with dementia (Ragneskog et al., 2001). This study used an interrupted-time series 
design where the music intervention was given during one period and was compared with 
another period without music. Each participant served as his/her own control, making this a 
multiple case study. Video recording was done to record observations for later coding. 
Observations were made before, during, and after the music and non-music sessions for 
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comparison purposes. Ragneskog and colleagues’ (2001) multiple case study also found 
reductions in agitated behaviors, including screaming, in two of the four cases. 
Another case study by Gardiner and Furois (2000) compared the effects of music therapy 
to reading in two participants, one with AD, and one with a cerebrovascular accident (CVA). The 
music therapy included both active singing and playing instruments, and passive listening to both 
live and recorded music. The reading intervention included discussion of the books. 
Interventions were alternated between the two participants along with periods without treatment 
using an ACABA design for the CVA participant, and an ABACA design for the participant with 
AD. Measurement was done using a disruptive behavior rating scale through observation over 
nine weeks, with five observations done per week. Times of the observation were varied 
throughout the mornings and afternoons in order to get representative means of behaviors.  
 Gardiner and Furois (2000) found that the reading intervention significantly reduced 
disruptive behaviors, including agitated behaviors, for the participant with CVA, although during 
the music intervention, the participant had the highest level of disruptive behaviors measured 
throughout the study. Disruptive behaviors were again reduced after repeating the reading 
intervention with the participant with CVA, although not significantly. The participant with AD, 
however, demonstrated significantly lower disruptive behaviors both during and after the music 
therapy. The reading intervention again lowered the participant’s disruptive behaviors, 
demonstrating the efficacy of both the music and reading interventions for the participant with 
AD (Gardiner & Furois, 2000). This study is important since it points out that music therapy may 
not be effective, and may even have negative consequences in some instances, such as with the 
participant with CVA. However, in this and the aforementioned case studies, the sample sizes 
were too small to generalize these findings.  
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Observational Content Analysis. An observational study by Gotell, Brown, and Ekman 
(2009) utilized content analysis in order to examine the effects of both background music and 
caregivers’ singing during the regular morning care sessions of nine people with dementia. While 
explicit research questions were not stated in the article, the authors’ aim was to examine the 
effects of the music and caregivers’ singing on dementia patients’ emotions and behavior. 
Drawing from prior research, the authors expected positive effects of both background music and 
singing. This was done using previously videotaped sessions of caregivers in their morning 
routines with the patients, making it a purposive convenience sample. The flexible, qualitative 
analysis used labeled emotions and moods without a priori codes so that new categories could 
emerge at any given time during the analysis without being bound to the physical distinctions of 
a predefined list. This means that the labels could be a single word or a phrase which the authors 
felt represented a specific emotion. The authors state that a qualitative analysis of this type has 
never been done on music’s effects with caregivers and people with dementia, with similar 
previous studies utilizing a priori checklists of emotions and behaviors (Gotell, Brown, & 
Ekman, 2009). 
Results from the content analysis indicated that positive effects of both music and 
caregiver singing were found with regards to the behavior and emotions of people with dementia 
(Gotell, et al., 2009). The authors also stated that caregiver moods were also enhanced due to 
their caregiving duties being easier since their patients were better-behaved and in improved 
moods. The music helped patients better express themselves, improving the communication 
between the caregiver and the recipient. Results also demonstrated a reduction in aggressive 
behaviors of the patients with dementia when in the music or singing situations, which is 
consistent with other music therapy literature involving people with dementia. This study, 
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however, did not have the people with AD actively participate in music making since the 
caregivers were doing the singing. This suggests the effectiveness of passive music interventions 
for people with dementia, although a stronger research design would strengthen this evidence. 
 Quasi-Experimental Designs. A pre-post-test quasi-experimental study by Brotons and 
Pickett-Cooper (1996) examined live music’s effect on agitation in 20 people with AD from four 
different nursing homes. The music therapy was given twice a week for five total sessions by 
certified music therapists who provided live music and encouraged singing and playing 
instruments in participants who were able to do so. An observational checklist of seven agitated 
behaviors with five levels of severity was used as the primary measure. The ratings were done by 
caregivers and staff within the nursing homes before, during and 20 minutes after the music 
sessions. Musical background of participants was also obtained by surveying family members in 
order to assess its impact on the efficacy of the music therapy sessions. 
 Results indicated significantly less agitated behaviors both during and after the music 
therapy sessions than before the sessions (Brotons & Pickett-Cooper, 1996). Inter-rater reliability 
between different observers was reported to be r = .99, demonstrating meticulousness in 
observations in this study.  Musical background of participants was not found to be significant 
with respect to agitation. Weaknesses of this study include the measurement instrument, for 
which no psychometric properties are given, the small sample size, and the short assessment 
period (i.e., only 5 sessions). However, this study is notable since it suggests that people with 
AD do not need a musical background in order to benefit from music therapy.  
 Another pre-post test design to assess music therapy’s effect on agitation in people with 
AD was conducted by Brotons and Marti (2003). This study is important because participants 
were people diagnosed with probable AD and their spouses who were their primary caregivers 
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and lived at home with them. Most prior studies of this type have included only nursing home 
residents with AD. Although participants in this study did not live in a nursing home, they stayed 
in a rural house together for the 12 days of the study, and not in their home environments. A total 
of 14 couples were assessed using a pre-test and two post-tests, one given two days before the 
end of the music sessions and another two months after music therapy sessions had ended. The 
Cohen-Mansfield Agitation Inventory (CMAI), a widely used agitation scale with strong 
psychometric properties was used to assess agitation in the people with AD. Cognitive 
functioning of the participants with AD was also assessed directly with the Neuropsychiatry 
Inventory and Dementia Scale. Caregivers were assessed for burden, depression and anxiety, and 
were also asked to assess emotional and behavioral changes in their care recipients.  
 Brotons and Marti (2003) found that the participants with AD had significantly lower 
agitation and other behavior problems reported by caregivers on both the post-tests, including 
two months after treatment. Cognitive functioning in participants with AD, however, did not 
improve. The caregivers reported significantly lower anxiety on both post-tests, although burden 
and depression did not improve.  Limitations in this study include the small sample size and the 
short treatment period. Additionally, testing effects from repeated testing and being placed in a 
new environment during the study may have influenced the results. The follow-up post-test 
showing persistent effects two months later also does not demonstrate a causal effect of the 
music therapy since many other influences on agitation and behavior may have occurred during 
that time (Brotons & Marti, 2003). However, this study remains important because it included 
both the people with AD and their caregivers in both the treatment and assessment.  
A crossover-design was utilized in one study on music’s effects on agitation and related 
behaviors in people with dementia, with each participant serving as their own control for 
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comparison purposes (Gerdner, 2001). Gerdner (2001) used repeated measures to compare the 
effects of individualized music in some sessions with sessions that utilized classical relaxation 
music in 39 participants using the Cohen-Mansfield Agitation Inventory (CMAI), a standardized 
measurement scale for agitation modified to assess agitation over 10 minute intervals over a half 
hour total. Baseline agitation levels were assessed over three weeks, followed by six weeks of 
individualized music, a two week “washout” period containing no music, and finally, six weeks 
of classical music. Music sessions were given twice a week during the treatment periods, for a 
total of 12 sessions each of individualized and classical music.  
Results from this study revealed significant decreases in agitation and related behaviors 
in the participants with dementia from the individualized music sessions (Gerdner, 2001). Lower 
agitation was found both during the sessions using preferred music and a half hour afterward. 
While a half hour does not seem like much, the participants had moderate to severe levels of 
dementia and may not have even remembered that music was played, although the relaxing 
effects of the music still seemed to persist since lower agitation was still found (Gerdner, 2001). 
The individualized treatment also demonstrated a significantly greater effect on agitation than the 
classical music treatment. The lack of a true control group and therefore true experimental 
design, was due to the convenience sample used and the nonrandom assignment, however, this is 
commonplace with this type of research. Due to the vulnerability of elderly people with 
dementia, true experimental designs are usually not feasible or ethical since this would involve 
withholding treatment. Since each participant was in both the treatment period and non-treatment 
period in this study, everyone received music therapy at some point. The use of a crossover 
design such as this presents the strongest evidence yet known for music therapy’s efficacy in 
treating agitation in AD.  
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Another quasi-experimental design was used in one study where participants with AD 
were played relaxing music during their evening meals (Hicks-Moore, 2005). This study also 
involved repeated measures to compare the music’s effects with that of no music present. Thirty 
participants were tested on agitation and associated behaviors before and after their meals each 
week for four weeks. Weeks two and four contained relaxing music during mealtimes, with the 
other two weeks not containing any music. The CMAI, a standardized observation scale was the 
sole measure of behaviors in this study.  
The study by Hicks-Moore (2005) found significant decreases in agitated behaviors 
during mealtimes when relaxing music was played as compared to when no music was played. It 
is important to note that this study used a simple passive music intervention (i.e., listening to 
recorded music) that did not involve individualized or preferred music, but was still found to be 
effective in reducing agitation. Playing recorded music is an inexpensive and noninvasive 
intervention that can be easily incorporated by caregivers into the daily routines of those with 
AD in order to help reduce agitation, and may even be as simple as turning on a favorite radio 
station.  
A Taiwanese study on music’s effects on agitation by Sung, Chang, and Abbey (2006) 
was conducted using a quasi-experimental design that included 32 elderly participants with 
dementia. This study used participants’ preferred music in sessions conducted twice a week for 
six weeks and measured agitation levels in the participants using a standardized observational 
measurement scale. Observers who did the ratings were trained and inter-rater reliability was 
also measured.  
Sung et al. (2006) also found decreases in agitation and related behaviors in persons with 
dementia using music as an intervention. Specific findings indicated significant reductions in 
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physical, nonaggressive behaviors (e.g, repetitive motions) and overall agitation levels in the 
participants during the music sessions. This study is notable since it included Taiwanese 
participants, demonstrating that music’s effects are also valid in this population and further 
advocating applicability across cultures.  
Another quasi-experimental design was done by Clark, Lipe, and Bilbrey (1998) testing 
music’s effects on agitation and aggressive behaviors in people with dementia. This study used a 
single group repeated measures crossover design where participants received a music 
intervention, had a “washout” period, and then received the music intervention again. The 
repeated measures design seems to be the most common in this type of research since it is 
usually not feasible to include a separate comparable control group. Including a one week 
washout period in this study as a safety measure may have helped to lessen any carry over effects 
that may have occurred in the first music intervention period, however, most music therapy 
research with persons with dementia reveal no long-term effects.   
Clark et al. (1998) found significant reductions in agitation and aggressive behavior in the 
abovementioned quasi-experimental design. Fifteen participants were included in this study, and 
12 demonstrated significant reductions in aggressive behaviors, including hitting behaviors. Two 
aspects of this study make it stand out from the others examined here. One is that this study used 
qualified music therapists, whereas many other studies have used volunteers or musicians to 
provide the intervention. Another distinction of this study is the use of a washout period to 
ensure no carryover effects were involved in the second music intervention period, and that the 
intervention was given and assessed twice to lessen the influence of confounding factors.  
Another quasi-experimental research design using a small sample (n=5) used each 
participant as their own control to examine the effects of music on relaxation, agitation and 
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aggressive behaviors (Snyder & Olson, 1996). This study is distinctive because it compared the 
effects of music therapy to hand massage on aggressive behaviors in people with dementia. 
Though an a priori checklist of agitated and aggressive behaviors was used as a measurement 
tool in this study, no mention of its name or its psychometric properties was given. Frequencies 
were simply counted for each behavior during the observation periods. Relaxation was also 
assessed with the Luiselli checklist, although the validity of this scale is also unknown. Since 
both hand massage and music could be relaxing and affect aggressive behavior, a lack of 
difference between groups during intervention periods would not indicate a lack of efficacy of 
music. Results are reported individually for each of the five participants, with paired t tests also 
being done on data gathered before and after interventions. Relaxation was found to be 
significantly enhanced (p = .05) with music, however, agitated and aggressive behaviors were 
not significantly reduced (Snyder & Olson, 1996). Hand massage did not have a significant 
effect on either relaxation or agitated and aggressive behaviors. 
The Snyder and Olson study (1996) did not find reductions in agitation and aggressive 
behavior in participants with dementia when using a music intervention; however, music was 
only played for 10 minutes each day for 10 days. This could simply mean that the hand massage 
intervention used for comparison was equally effective in reducing agitation since there was no 
true control group. This study did, however, find significantly improved levels of subjective 
relaxation with music in the participants when compared with hand massage and no music. 
Limitations of this study include the small sample size (n = 5), the short length of the sessions, 
and the use of a checklist for measurement with unknown psychometric properties.  
 Finally, a recent crossover study by Cooke, Moyle, Shum, Harrison, and Murfield (2011) 
investigated the effects of active participation in a music group by people with dementia (N = 
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47), and utilized a reading group as a control. The music group’s activities included both singing 
and listening (i.e., both active and passive interventions), however, the effects of each were not 
differentiated. This study used randomization to place participants in either the music or the 
reading groups for 8 weeks, and then participants were switched to the alternate intervention 
group for another 8 weeks. The short-form of the Cohen Mansfield Agitation Inventory (CMAI-
sf) was the instrument utilized to measure agitation at three different times: two weeks before the 
interventions, after the first intervention, measuring the previous two weeks of receiving the 
interventions, and after the second intervention, also measuring the previous two weeks. Anxiety 
was also assessed during these times. This study did not find a significant difference in agitation 
or anxiety between the participants when given the music or reading intervention; however, 
measures were significantly lower during both interventions (Cooke et al., 2011). The authors 
conclude that participation in a music group may not have any more benefit on agitation and 
anxiety than that of a reading group, which included discussions (Cooke et al., 2011). This could 
mean that participation in any group activity that involves socialization may be beneficial to 
those with AD or other dementias. 
 There were many strengths of this study that addressed some of the issues of past studies, 
including the length, use of randomization, use of standardized scales, and the crossover design. 
However, the assessment of agitation using the CMAI-sf was done over two-week periods as the 
instrument suggests. This means that the measures were done after the two-week intervention 
periods were completed. Past studies of music’s effect on agitation in people with dementia have 
shown that reductions usually do not last long after the intervention (e.g., 30 minutes to an hour). 
Looking for reductions in agitation over a two-week period after receiving a music intervention 
was probably not precise enough to demonstrate reductions during and immediately after the 40 
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minute sessions that were done 3 times a week. That is, even if agitation was reduced during 
these times, the assessment over a two week period would likely not demonstrate a significant 
difference. Additionally, there was not a true control group since both groups received both 
interventions over the course of the study, and as previously mentioned, the social activity of the 
reading group may have been just as beneficial. 
 Experimental Designs. Few true experimental designs have been done utilizing music 
interventions for dementia. Additionally, no experimental designs have been done thus far that 
have compared the effects of active interventions to passive listening. However, one study 
utilizing a randomized experimental design examined the effects of passive music listening on 38 
people with dementia who lived in an assisted-living facility (Janata, 2012). In this study, 
participants were randomly assigned to either have individualized music piped into their rooms 
several hours a day (e.g., around 3 hours/day), or not, for 12 weeks. An initial two-week baseline 
measurement was done before implementing the intervention, making the study last for a total of 
14 weeks. The participants were assessed on a weekly basis for agitation and depression using 
standardized scales, including the CMAI for agitation (Janata, 2012).  
 Results from this study showed that both agitation and depression were consistently 
reduced for both the treatment and the control groups (Janata, 2012). Janata (2012) attributed this 
to diffusion of treatment. That is, because the music was played for several hours a day in the 
rooms of participants in the experimental group, participants in the control group were likely also 
exposed to music at some times during the course of the study. For example, the researcher states 
that participants would often enter into other participants’ rooms if they liked the music (Janata, 
2012). Therefore, there was not a true control group in this study, but rather an “indirect 
treatment group” (p. 14, Janata, 2012). That is, participants who were only indirectly exposed to 
105 
 
the music intervention demonstrated similar reductions in agitation and depression as the 
participants who received the individualized music interventions in their rooms. It is important to 
note that the music was not individualized for participants only indirectly receiving the 
intervention, yet it still may have been effective. Overall, the evidence from this study indicates 
that exposure to music, either individualized and direct, or not individualized and indirect, may 
help lessen agitation and depression in people with dementia (Janata, 2012). 
Mixed Methods. With the immediate effects of music therapy on agitation in people with 
AD already demonstrated in prior studies (e.g., Gardiner & Furois, 2000; Sung & Chang, 2005; 
Witzke, et al., 2008), one study (Ledger & Baker, 2007) sought to examine the long-term effects 
of music therapy on agitation in this population. Utilizing a longitudinal quasi-experimental 
design along with observational note-taking by the therapists, participants were non-randomly 
chosen and assigned based on their place of residence (i.e., participants were from two different 
nursing homes where one nursing home used music therapy and the other did not) to either 
receive or not receive weekly group music therapy sessions for one year. Mean agitation scores 
obtained from the CMAI were calculated for each group at three month intervals for comparison. 
This longitudinal design used analysis of variance on agitation scores, which revealed significant 
differences in agitation within group participants over time but not between the two groups, 
however, there were large fluctuations in agitation across time for both groups (Ledger & Baker, 
2007). The authors concluded that findings from this study may indicate that music therapy’s 
effects are not long lasting after sessions since differences between the treatment and control 
groups were not found at the three-month intervals. However, consistent with prior research, 
observations made by the therapists in this study suggest initial reduced agitation both during and 
immediately after the music therapy sessions (Ledger & Baker, 2007).  
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 Another study by Gerdner (2005) utilized mixed-methodology with a design 
incorporating both quantitative and qualitative methods. This was a small pilot study (n= 8) that 
used repeated measures in the participants with dementia to test for reductions in agitation levels. 
While this study used a standardized measurement tool (i.e., the CMAI) for assessing agitation in 
the participants, it also utilized flexible, qualitative methods such as open-ended interviews to 
more fully capture the effects of the music intervention. Additionally, this study is distinctive 
because the intervention was utilized on an as-needed basis, meaning that preferred music was 
played for the participants as they displayed agitated behaviors. Interviews were conducted 
afterward to ask about the effects of the music.  
The study conducted by Gerdner (2005) demonstrated reduced agitation levels in the 
nursing home residents during the full eight week period of the study. However, this effect was 
only present during daytime hours. Nightshift observers reported reduced agitation in only two of 
the eight weeks during the nighttime. This may have been due to increased agitation in the 
participants during nighttime hours in general though. This study is notable since the efficacy of 
providing the intervention only as-needed demonstrates that preferred music can be played 
during times of elevated agitation to calm persons with dementia (Gerdner, 2005). Other studies 
have used music interventions only at set intervals (e.g., twice a week, always occurring at the 
same time). Because of the small sample size in this study, the effect of music given on an as-
needed basis for agitation in AD would need to be further examined in order to generalize these 
findings.  
Limitations of Prior Research 
 Theoretical Base. The studies included in this review have mostly found reduced 
agitation when using music for treating dementia. Few studies, however, have examined or 
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specifically tested underlying theories for the phenomenon (Gerdner, 1997, 2001; Spiro, 2010). 
For example, Gerdner’s (1997) mid-range theory of music’s effects on agitation in people with 
AD, which is based on the espoused PLST theory but is specific to music’s effects, has not been 
tested extensively using empirical methods. To the authors’ knowledge, no other theories 
specific to music’s effects on agitation in people with dementia have been posited. Having a 
theoretical base in research of this type can not only help demonstrate that music interventions 
are effective for treating agitation in people with AD and other related dementias, but also how 
and why music may have this effect. 
 Experimental Designs. The lack of true experimental designs in prior studies of music 
therapy with people with AD is commonplace because of feasibility issues.  True experimental 
designs are usually difficult to implement in vulnerable populations. For example, in studies 
examining people with degenerative diseases such as AD, true experimental designs may not be 
feasible or ethical since this would involve withholding treatment or manipulating daily routines, 
which may have negative consequences. Due to the vulnerability of elderly people with 
dementia, weaker research methods are frequently used, such as case studies relying purely on 
observation and not involving any inferential statistics (e.g., Gerdner & Swanson, 1993). 
Furthermore, even the quasi-experimental studies reviewed here did not have comparable control 
groups. The lack of comparable control groups in most of the studies reviewed diminishes both 
internal and external validity.  
 Without a control group, the effects seen in participants in these studies cannot 
necessarily be attributed to the intervention. There is no way to tell if something else happened 
that may have influenced agitation levels in the participants during the time of the study (i.e., 
history effects), and selection biases may also have occurred since there was no random 
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assignment in most of the designs. This would be probable in the case studies done on music’s 
effects on AD (e.g., Gerdner, 1997) since participants were likely chosen to participate for 
specific reasons such as having known enjoyment of music. Other studies of music therapy with 
people with AD have utilized either subjects acting as their own controls in crossover designs or 
compared the music treatment group to groups receiving other treatments (e.g., hand massage, 
reading) without random assignment. Only one study included in this review attempted to 
include a true control group using random assignment (e.g., Janata, 2012), however, the 
participants in the control group in this study were also indirectly exposed to the music 
intervention (i.e., diffusion of treatment). Diffusion of treatment may have also contaminated the 
results found in other studies utilizing more than one group, since participants are likely to share 
their experiences with others, especially when studies were done in facilities where participants 
all live together (e.g., a single nursing home).  
While other studies of music therapy with people with AD have used a control group for 
comparison purposes, the groups used may not have been truly comparable, and some were even 
residents of a completely separate nursing home where music therapy was not done (e.g., Ledger 
& Baker, 2007). The two groups probably vary in many ways, including daily routines, other 
activities and treatments, or even criteria for living in different nursing homes, making the 
groups not only dissimilar in many ways, but receiving other various treatments in different 
situations and environments, and likely affecting the outcomes of the studies.  This lack of 
empirically-based rigor in research on music interventions for people with AD has destructive 
effects on internal validity and is a major limitation in this field of study.   
Measurement Issues. Most music therapy research with persons with dementia revealed 
no long-term effects, with effects shown only 30 minutes to an hour afterward (e.g., Gerdner, 
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2001).  If the effects of music therapy are limited to immediate and short-term effects, studies 
should restrict measurements to these times. For example, many studies have utilized the CMAI 
since it has demonstrated strong psychometric properties; however, it was originally intended to 
measure agitation over a two-week period (Cooke et al., 2011; Ledger & Baker, 2007). While 
both Cooke and colleagues (2011) and Ledger and Baker (2007) utilized the CMAI for its 
original assessment period of two weeks and showed no effects of music on agitation, other 
studies have modified the scale to measure agitation for as short a period as a half hour and have 
shown effects (e.g., Gerdner, 1997, 2001). This modification of the scale may influence its 
validity, and therefore affect the validity of these studies.  
 Some studies of music therapy with people with AD have used other scales with 
unknown psychometric properties or have relied on observation alone for assessing agitation in 
AD and related dementias (e.g., Gerdner & Swanson, 1993; Snyder & Olson, 1996). 
Additionally, the short assessment and treatment periods in many of the prior studies (e.g., only 5 
sessions of music therapy) could be too short or not enough measurements done to best capture 
music’s effects on agitation. For example, even though long-term effects of music therapy were 
generally not found, participants first starting this treatment may not get the most out of it during 
the sessions until they are acclimated to the new situation and environment. Participants may 
also want to “do well” in the study and appear that they are being helped by the intervention, and 
thus portray themselves as better off than they really are. For example, elderly participants in 
music therapy may want to seem like they are being helped by the intervention in order to please 
the therapist, and thus attempt to hide their agitation. However, this same effect could threaten 
internal validity in any research design relying on self-report or overt observation. All of the 
aforementioned measurement issues may affect the validity of this field of research, since, if the 
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measurements are not accurate, it would be impossible to attribute the effects of changes in 
agitation to music.   
Intervention Issues. No prior research has compared the efficacy of a music intervention 
given consistently at set intervals with one given on an as-needed basis to this author’s 
knowledge. If music therapy only works during the sessions and for a short while afterward, 
using it as-needed at peak agitation times could be the most effective method of delivery. Only 
the aforementioned small pilot study provided evidence of the efficacy of an as-needed music 
intervention to reduce agitation (e.g., Gerdner, 2005), therefore further research in this area is 
warranted.    
Previous studies of music therapy with people with AD have also utilized either music 
used passively where participants simply listened to music (Sung & Chang, 2005; Witzke, et al., 
2008) or active sessions where participants engaged in the music-making process through 
singing (Ledger & Baker, 2007), but none have compared passive to active music interventions. 
While both forms have demonstrated efficacy either separately or combined (e.g., Cooke, 2012), 
comparison of the two would provide further knowledge of what form to implement and in what 
situations. Furthermore, including both types of interventions, without distinguishing between 
the two, in not only research studies, but also in scholarly literature reviews and meta-analyses 
could affect the validity of the results.   
Additionally, most research on music’s effects on AD has not employed professionally 
trained music therapists, but often utilized the researchers themselves for providing passive 
interventions, or volunteer musicians for providing active interventions, such as sing-along 
groups. This lack of intervention fidelity can seriously affect the validity of research findings.  
Consistency in the method and delivery of music interventions utilized for AD and related 
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dementias across studies would help solidify the efficacy of these interventions and strengthen 
the internal validity of these studies. 
Sampling Issues.  Most of the studies reviewed here have used convenience sampling 
methods in addition to small sample sizes, therefore weakening the external validity of the 
findings. Results from these studies may not generalize beyond the sample and setting utilized in 
each study since random selection was not used. And, although random selection may be ideal, it 
is not feasible for the AD population and therefore studies of this kind usually rely on 
convenience samples.  Since studies of music therapy in people with AD commonly use 
convenience samples (e.g., residents of a single nursing home), results cannot be expected to 
generalize beyond the population in the setting for each study, even when utilizing random 
assignment to different groups as in the classic experimental design. Nonetheless, the classic 
design allows some generalizability to other similar populations in similar settings, whereas 
other designs do not allow this to nearly as high a degree.   
 The similarity between samples and settings is key to the generalizability in any type of 
research. For example, the sample of people with AD in one nursing home may not be 
representative of the broader population of people with AD. The setting of one particular nursing 
home may also not be representative of other nursing homes in different areas in which daily 
routines and other treatments are probably varied. This and the previously mentioned factors can 
strongly affect the external validity of studies of music therapy in people with AD. Therefore, it 
would be wise to assess as many attributes of as many nursing homes and their residents with 
AD as possible prior to conducting any study to determine whether or not the sample and setting 
are truly representative of the broader population of nursing home residents with AD. However, 
the feasibility of such an undertaking prevents most researchers from examining this. Even if 
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they did, results still may not generalize beyond AD residents of nursing homes because many 
people with AD live at home and are cared for by family members. Indeed only one small pilot 
study (i.e., Brotons & Marti, 2003) investigated the effects of music intervention on AD suffers 
normally cared for at home.  
Some studies of music therapy in people with AD included participants with other forms 
of dementia besides AD, and those participants may respond differently to music. This limits the 
generalizability of this research by ignoring the differences in AD and other types of dementia.  
Researchers may have to make exceptions to sampling and assignment to treatment because of 
both practical and ethical reasons. For example, it may not be ethical to withhold treatment in a 
control group, or be realistic to randomly sample an entire population. No studies of music’s 
effects on agitation in people with AD and related dementias have been conducted using a true 
experimental design and incorporating a matched control group and random assignment to 
treatment while also using a large random sample. This is likely due to feasibility issues of such 
a study.  
Finally, attrition may have also affected the internal and external validity of some of the 
studies reviewed in this paper. Since participants were elderly and had AD or related dementias 
which are progressive, degenerative diseases, the loss of participants over the course of the study 
could have been an uncontrollable factor that may have posed a threat to the internal and external 
validity of each study. Some studies did mention attrition rates (e.g., 4 participants did not finish 
the study), though none discuss how this may have influenced the results found. Future research 






 This chapter reviewed conceptual models of music therapy and musical activities, and 
their utility in treating several symptoms of a variety of disorders, with a focus on treating 
agitation related to Alzheimer’s disease (AD) and other dementias. Both active and passive 
forms of music therapy and their modes were discussed along with the distinctions of each mode. 
Music’s beneficial effects on cognition and behavior were also examined in people with 
dementia. The efficacy of music therapy to reduce agitation and disruptive behaviors associated 
with AD and other dementias was given extra emphasis since this is the author’s primary area of 
interest for future study. A thorough review of the literature regarding the treatment of agitation 
with music in people with AD, and the limitations of this research, including internal and 















CHAPTER 5: METHODOLOGY 
Previous studies on music’s effects on agitation in elderly people with AD and related 
dementias have utilized either prerecorded familiar music or have used sing-along sessions with 
a music therapist or musicians, but no previous studies have attempted to evaluate both active 
and passive music interventions. The current research study focused on comparing the effects of 
both active and passive music interventions in order to determine which has greater effects on 
agitation levels in people with AD. Additionally, participants’ engagement in both types of 
music therapy was examined in order to determine if efficacy is influenced by participation and 
differences when the intervention employs live music played by a musician (i.e., an active 
intervention) or prerecorded music (i.e., a passive intervention). Both verbal (e.g., singing) and 
kinesthetic (e.g., clapping) participation were examined to further distinguish the effects of 
participants’ engagement with the interventions. Discovering exactly what type of music 
intervention and how to maximally engage participants in music interventions can demonstrate 
which is the most effective for reducing agitation in people with AD and will allow caregivers 
and others who treat the symptoms of the disease to utilize best practices.  
This study utilized a unique sample consisting of people with moderate to severe 
dementia who live at home and are cared for by an informal caregiver—a population that has 
largely not been studied  for music’s effects on agitation previously— in order to help further the 
generalizability of the utility of music interventions to this new population. The participants were 
obtained from the clients of a local daytime respite center where clients already received both 
active and passive music interventions on a daily basis. This chapter will cover the 
characteristics of the respite center and its clients, the measurements that were utilized in this 
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study, the basic research design and procedures, the plan for data analysis, and any potential 
internal and external validity issues with this study and how they were controlled. 
Characteristics of the Respite Center 
 Participants in this study included a convenience sample of clients at a daytime respite 
center for people who have been diagnosed with AD or related dementias. The respite center is 
run by an independent, non-profit organization providing numerous dementia-related supportive 
services to a ten-parish area centered around Baton Rouge, Louisiana. The respite program is 
designed to enable caregivers time to run errands, go to the doctor, or take care of other needed 
responsibilities, such as regular home care, since constant caregiving duties may normally 
prevent these activities. The respite service is provided to caregivers for 5 hours a day, one to 
three times a week for each client. The organization limits each client’s attendance to one to 
three days a week in order to serve more of the community, since the facility is only equipped to 
provide care to up to 15 people per day. These conditions allow the facility to maintain a 1:3 
ratio of staff to clientele, so that each client can receive more individual attention from staff.  
While the respite program provides temporary relief from caregivers’ duties during the day, it 
also provides direct care to the clients with AD and other dementias, mostly in the form of 
psychosocial interventions.  
 Several cognitively-stimulating activities and social interventions are offered to the 
clients who attend the daytime respite program. Among these are arts and crafts, gardening, light 
physical exercise, storytelling, cooking classes, game playing, and music and pet therapy. Most 
of the structured activities, such as the music therapy sessions, are provided on a daily basis since 
clients typically only attend once or twice per week. However, some activities and services such 
as pet therapy and cooking classes are usually provided only once or a couple of times a week 
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based on the availability of session facilitators.  When facilitators are not available, substitute 
activities are scheduled. For music therapy this means on some days the clients have a set time to 
simply relax and listen to prerecorded music instead of singing along with a live musician 
playing an instrument for accompaniment, since the volunteer musicians that lead the music 
sing-along sessions are not available every day of the week. In the case of pet therapy and other 
activities such as arts and crafts, when a facilitator is unavailable, a different activity may be 
scheduled in its place, such as the game Bingo. The schedule of activities is also shuffled around 
in this manner so that clients who usually attend the same day each week will be exposed to a 
variety of socially-interactive and cognitively-stimulating activities. This ensures that not only 
are the caregivers appreciative of the respite provided by the program, but that the clients are 
also benefitted through the stimulation and interaction they receive, and usually also enjoy 
themselves while they are there.   
 Clients are provided with cognitive stimulation and social interaction in some form the 
entire time they are in attendance at the day respite program. Simple observation of these 
activities elucidates their underlying positive meaning to the clients. Seeing the clients smile and 
laugh during game play or watching clients sing along and even dance to music during music 
therapy sessions makes one aware that not only are the clients enjoying themselves, but that they 
are also receiving the beneficial effects of the cognitive stimulation and social interaction, such 
as enhancing moods and reducing agitation, anxiety, and stress.  This study intended to 
demonstrate through empirical means, the benefits of the use of music interventions, and of 





Characteristics of Clientele 
 The daytime respite center program is designed to accommodate individuals with 
moderate to beginning severe (i.e., middle stage to early-late stage) AD and other dementias. 
One requirement of entrance to the program is that clients are able to function physically on their 
own. Since physical functioning is usually not affected until the middle or late stage of AD, most 
clients have been diagnosed with middle-stage AD or other similar dementias. Some clients are 
in late-stage dementia, but have thus far retained enough of their physical functioning ability to 
not require additional care. Additionally, a thorough assessment is done on potential clients 
before granting entrance into the program. Part of this is assessing cognitive functioning using 
the Mini Mental State Exam (MMSE), a common screening measurement tool for cognitive 
impairment (Folstein, Folstein, & McHugh, 1975). This is done to ensure that clientele are 
receiving the most benefit from the services provided by the program, and treatment can be 
individualized to some extent. For example, certain days of the week may cater to lower or 
higher functioning groups. This ensures that clients are able to actively participate in at least 
some of the many activities offered and that clients are offered the most appropriate psychosocial 
interventions for their current level of functioning.  While cutoff scores on the MMSE for 
suspected dementia are not definitive, Lourenco and Veras (2006) suggested varying the cutoff 
score based on the recipient’s level of education and literacy.  Lourenco and Veras (2006) 
propose cutoff scores for further testing for dementia in people who are illiterate and have scored 
18-19 or below, and scores of 24-25 and below in people who are literate. While a score below 
24-25 on the MMSE would normally indicate noticeable cognitive impairment, people who are 
illiterate but not necessarily cognitively impaired may easily fall below this score because they 
did not fully understand the questions (see Cognitive Impairment and Stage of Alzheimer’s 
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Disease in the Measurements section of this chapter for more information on MMSE scores and 
symptomology).  
 The respite center has had more than 130 clients attend the program since its inception in 
2007. Twenty-two of those were active clients who attended the program on a weekly or bi or tri-
weekly basis during the course of the study. This client base served as the sample for the current 
study (see Participants in the Study below). While the majority of the clientele have reported 
their race as white (n = 114), there have been several clients who have reported being of minority 
races (n = 15). The majority of clients have also been female (n = 81), and report their 
relationship to their primary caregivers as being their daughter (n = 53) or spouse (n = 52). The 
average length of stay in the program for current clients (n = 22) is 14 months, an increase from 
the average length for the former, now discharged clients, at 9 months. This means that the 
current clients are staying in the program longer than previous clients. Clients may be discharged 
because their disease progresses to the point where the program cannot provide the support they 
need (e.g., loss of physical functioning), or the program can no longer benefit them due to greater 
cognitive impairment, or for other reasons such as uncontrollable disruptive behaviors (e.g., 
aggression towards others) or death.   
Participants in the Study  
 All current clients of the respite center during the course of the study were eligible to 
participate; however, participation was voluntary, and clients may have withdrawn from the 
study at any time. The participants in this study had MMSE scores below 24, except for one who 
did not take it, but all have had an official medical diagnosis of dementia. Therefore, the 
participants all had at least some symptoms of early-stage dementia, and usually also some 
symptoms of middle-to-late-stage dementia (see Symptoms of Alzheimer’s Disease in Chapter 2 
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and Cognitive Impairment in the Measurements section of this chapter for more information). 
The sample was not randomly selected from the population of people with AD or the respite 
center’s clientele, since sample size was limited to what was available, and a larger sample size 
was of greater benefit to the study. The sample size was 22 participants (N = 22), the number of 
currently active clients at the respite center during the course of the study. No participants, or 
their caregivers when necessary, chose not to give their consent, and therefore all the active 
clients participated in the study. Only one previous study utilized a sample of people with 
dementia that did not live in assisted-living homes (e.g., Gerdner, 2005), but had the participants 
stay in a residential facility along with their caregivers during the course of the study. Therefore, 
the current study was the first to examine the effects of music on a sample of people with AD 
who live at home and are cared for by informal caregivers during the course of treatment to this 
researcher’s knowledge.  
Measurements 
Demographics 
  Demographic variables of age and gender of clients was assessed at the beginning of the 
study, shortly after participants or their caregivers gave their informed consent to participate. 
Demographic information was collected from the clients’ charts at the respite center and was 
checked for currency and accuracy. Age of participants was collected as real numbers, but was 
also parsed according to the following categories: below 65, 65-69, 70-74, 75-79, 80-84, 85-89, 
and 90 and above for descriptive data analysis. This allowed for describing frequencies and 
percentages of other characteristics (e.g., stage of AD) in each age group. Gender of participants 
was recorded as either male or female and was also used as a descriptive variable (e.g., 
frequencies and percentages). Race was recorded as Caucasian and Other since the majority of 
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prior clients have been Caucasian. Relationship to Caregiver was collected as a categorical 
variable with the attributes of Son, Daughter, Spouse, Sibling, and Other. Refer to Chapter 6 for 
results from the aforementioned descriptive statistics.  
Cognitive Impairment and Stage of Alzheimer’s Disease  
 This study examined stage of AD as a variable at three ordinal levels. Increased levels of 
agitation were expected in participants in the later stages of AD, and in those who show greater 
cognitive impairment, a recognized phenomenon as dementia progresses (Gardiner & Furois, 
2000; Ledger & Baker, 2007; Richter & Richter, 2004; Sung & Chang, 2005). Consequently, it 
was expected that the effects of music therapy will be the most prominent in participants with 
greater cognitive impairment and baseline agitation levels. Stage of AD was operationalized as 
early, middle and late, and will be based on functionality and impairment of each participant 
according to their official dementia diagnosis. This was determined by consulting clients’ charts 
at the respite center and referring to their diagnoses of AD. The point in time of the last update to 
each participant’s stage of AD was also taken into consideration. If participants did not have an 
up-to-date assessment made within the past 90 days, an effort was made to obtain more recent 
information regarding their dementia status. Due to the respite center’s criteria of physical 
functionality for admittance to the program, it was deemed unlikely that any clients were in late-
stage dementia, however 6 (27.3%) of the 22 participants were found to have a late-stage 
dementia diagnosis, while none were found to be in the early-stage. This consequently altered 
Stage of AD into a dichotomous variable with only middle and late attributes.   
Cognitive impairment, which should correlate with stage of AD and therefore also 
agitation, was also assessed by scores on the Mini Mental State Exam (MMSE; Folstein et al., 
1975). The MMSE is one of the most commonly used measurement instruments for assessing 
121 
 
cognitive functioning and screening for dementia worldwide (Lourenco & Veras, 2006). One 
reason for this is its simplicity in execution, with no special skills required by the assessor. 
Because of its basic nature, however, when dementia is suspected more comprehensive cognitive 
testing is normally done before arriving at a diagnosis (see diagnosis of Alzheimer’s disease 
section in Chapter 2). However, the MMSE is considered a valid and reliable indicator for 
screening cognitive functioning in the elderly (Lourenco & Veras, 2006). Psychometric 
properties of the MMSE have proven its worth as a screening tool for dementia and its ability to 
reflect the level of cognitive impairment whether dementia is present or not (Lourenco & Veras, 
2006).  MMSE scores were obtained from clients’ charts at the respite center in order to 
determine their association with agitation and possibly participation in music sessions. This 
measure may provide greater precision than the Stage of AD, since there are only 3 stages of AD 
(and effectively only 2 stages in the current study), while the MMSE provides a 30 point scale.   
 Since the MMSE is scored globally, people who score below 25—an indication of 
cognitive impairment—may not have identical domain-specific impairments, but will be 
impaired in some of the following domains assessed by the test: person, time & space 
orientation, attention and recall, language, and calculation (Folstein et al., 1975). For example, 
someone who scores 17-25 may know who and where they are, the time, and be able to read 
somewhat, but may not be able to recall words or perform simple calculations at all. 
Psychometric evaluation of the MMSE has demonstrated that cutoff scores of 23-24 for 
suspecting dementia are highly sufficient in most instances (Lourenco & Veras, 2006), and the 
scores for the participants in  this study ranged from 1 - 23.  
 Most participants in this study had a diagnosis of middle-stage dementia, with AD being 
the most common form of dementia. Cognitive deficits are the most prominent characteristics of 
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early-to-middle-stage AD (Alzheimer’s Association, 2012). These may include difficulties with 
short-term memory and orientation, often with respect to time. Problem-solving skills also may 
begin to deteriorate. MMSE scores in people with early-stage AD would typically range from 21 
to 28 (Alzheimer’s Association, 2012). The cognitive deficits present may also interfere with 
complex functional activities that require memory, such as shopping, driving, and managing 
money. However, basic ADLs usually remain intact. Behavioral problems also may start to 
emerge during this stage. The most frequent behaviors in early-stage AD are agitation, apathy, 
disinhibition, and irritability. Social withdrawal, anxiety, and depression may also be present, but 
they are generally subtle at this stage. 
 Participants in this study mostly had a diagnosis of middle-stage AD (n = 16, 72.7%). 
MMSE scores generally range between 10 and 20 for people in this stage (Alzheimer’s 
Association, 2012). As AD progresses to the middle stage, recent memory and cognition become 
more obviously impaired (Alzheimer’s Association, 2012). Patients frequently become 
disoriented with respect to both time and location. This cognitive decline parallels a loss of 
abilities to perform complex tasks such as traveling alone or using home appliances. Although 
basic functions such as dressing and grooming are usually preserved at this stage, patients may 
require assistance or prompting. Behavioral symptoms such as agitation, apathy, and irritability 
often also increase as the disease progresses to the middle stage. In addition, anxiety and 
dysphoria often become evident. At this stage, wandering, delusions, and hallucinations may also 
begin to increase in frequency. The participants in this study who have MMSE scores of 1-23 
varied greatly, with some at the upper end of cognitive functioning, but diagnosed as in the 
middle-stage of dementia (i.e., with scores above 20), and therefore did not have all the 




 Agitation in participants with AD, the primary dependent variable in this study, was 
measured by two distinct scales, including the Cohen-Mansfield Agitation Inventory (CMAI; 
Cohen-Mansfield, 1997), a commonly used measure of 29 observable agitated behaviors (Cohen-
Mansfield, 1997; Ledger & Baker, 2007; Sung & Chang, 2005). This scale splits agitated 
behaviors by being either verbal or physical, and being either aggressive or non-aggressive 
(Cohen-Mansfield, 1997; Ledger & Baker, 2007). Consequently, four subscales are generated: 
verbal non-aggressive, verbal aggressive, physical non-aggressive and physical aggressive 
(examples of each type of behavior can be found in Chapter 2 under Agitation). However, the 
verbal aggressive and verbal non-aggressive subscales are often combined, which was done for 
this study in order to minimize the number of variables due to the small sample size. Therefore, 
only three subscales were used: physical non-aggressive, physical aggressive, and verbal. The 
CMAI measures these types of behaviors, and was found in prior research to have high reliability 
in several aspects, including internal consistency reliability (r > 0.82), inter-rater reliability (r = 
0.8), and test-retest reliability (r =0.97) (Ledger & Baker, 2007). It was also found to correlate 
significantly with other measures of agitation, demonstrating that it is a valid observational rating 
scale of agitation (Ledger & Baker, 2007; Sung & Chang, 2005). The CMAI is typically utilized 
to assess agitation through observation for periods of two weeks and has been normed using this 
method in populations of people with dementia.  
The CMAI includes 29 specific behaviors with each belonging to one of its four 
subscales (e.g., verbal non-aggressive, verbal aggressive, physical non-aggressive and physical 
aggressive). Each of the specific behaviors is rated on a 7-point scale for frequency, with ratings 
ranging from never (1) to several times an hour (Cohen-Mansfield, 1997).  The ratings for the 29 
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included behaviors are intended to measure the frequency of each behavior for the past two 
weeks. The CMAI manual states that “since it is impossible to include all possible 
examples…each line is intended to capture a group of closely related behaviors” (p. 2, Cohen-
Mansfield, 1997). For example, making strange noises can include any verbalizations that cannot 
be understood as words; however, a loud, sustained sound may be classified as screaming or 
shouting. Detailed descriptions of each behavior are found in the CMAI instruction manual. For 
example, kicking is defined as “striking forcefully with feet at people or objects” (p. 12, Cohen-
Mansfield, 1997). Instructions for the CMAI also recommend fitting any unlisted behaviors that 
may occur into the most similar one that is listed. The CMAI was created for use in nursing 
homes by staff, although it has also been utilized elsewhere by others including family caregivers 
and social workers (Cohen-Mansfield, 1997). A total score can be obtained simply by summing 
the ratings for each behavior, resulting in a range of scores from 29-203, with higher scores 
indicating greater levels of agitation; however it is recommended against using an overall score 
since the scores on the four subscales can be much more revealing.  
The four subscales of the CMAI were identified through factor analysis, however the 
instruction manual suggests conducting a factor analysis whenever the scale is used since 
“factors may depend on the population studied” (p.5; Cohen-Mansfield, 1997). This is because 
some previous studies have identified different subscales or categorizations of behaviors through 
factor analysis. For example, Whall et al. (1999) identified only three subscales: aggressive 
behavior, physically nonaggressive behavior, and verbally agitated behavior.  Since this study 
mostly included participants with middle-stage dementia where agitation is less prevalent than 
late-stage dementia, participants were anticipated to demonstrate more verbal (both aggressive 
and nonaggressive) and nonaggressive physical behaviors (e.g., wandering, repetitive motions) 
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than physically aggressive behaviors. The use of subscales may help identify not only that music 
may have an overall effect on agitation, but possibly what specific types of agitated behaviors are 
most affected.  
 Another commonly used scale to measure agitation in the elderly is the Richmond 
Agitation–Sedation Scale (RASS; Sessler, et al., 2002). This will be utilized in this study in 
addition to the CMAI in order to obtain richer data and strengthen findings by comparing the 
results from each scale. The RASS measures agitation on a continuum with sedation as the 
opposite pole, therefore, a neutral score (i.e., a score of 0) is indicative of being alert and calm 
(i.e., neither sedated nor agitated) (Sessler, et al., 2002). Scores range from -5 indicating that the 
patient is unarousable, to +4, indicating combativeness. There are specific guidelines to 
determining a person’s score, such as +1 indicating restlessness, or anxious, but not aggressive. 
A specific example for the criteria for this score on the RASS is “anxious or apprehensive, but 
movements not aggressive” for a score of +1, restless (Sessler, et al., 2002, p. 1339). A score of 
+2 indicates agitation, judged by “frequent non-purposeful movement,” while a score of +3 is 
indicative of being very agitated, judged by aggressive behavior in the person (Sessler, et al., 
2002, p. 1339). Scores below 0 indicate increasing levels of sedation and decreasing levels of 
response to either verbal or physical stimulation (Sessler, et al., 2002). Although the RASS is 
based on the judgment of the person administering the test, it was found to be a clinically useful 
tool for assessing level of consciousness and agitated behavior (Sessler, et al., 2002). Inter-rater 
reliability was found to be very high (r = .96), along with its construct validity, which was 
determined through correlations with other scales of agitation and sedation (Sessler, et al., 2002). 
Moderately high correlations with the Sedation-Agitation Scale (SAS; r = .78) confirmed its 
concurrent, convergent validity, along with correlations with the Ramsay Sedation Scale (RSS; r 
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= -.78), and the Visual Analog Scale (VAS; r = .93) (Sessler, et al., 2002). Because of its ease of 
administration and valid and reliable psychometric properties, the RASS was incorporated into 
this study in order to assess agitation and sedation in addition to the CMAI.  
 The procedure for administering the RASS is simply to observe the person one time and 
assign a score based on the single observation (Sessler, et al., 2002).  Positive scores indicate 
agitation, and therefore alertness, so no further procedure is necessary. The level of agitation is 
based on the aforementioned parameters defined for each score. A score of 0 indicates the 
absence of both agitation and sedation, and also only requires a single observation and no further 
procedure. Negative scores indicate sedation and require further procedure to identify the level of 
sedation. The procedure if not alert indicates to say the person’s name and observe whether the 
person opens their eyes or responds in some other way (Sessler, et al., 2002). The level of 
sedation is determined by this response. For example, if the person awakens the first time their 
name is called with sustained eye contact, a score of -1 would be assigned. Increasingly negative 
scores indicate less response of the person being observed and prompted, down to a score of -5, 
indicating no response from any stimulation. The addition of a sedation measurement in this 
study may not only indicate the absence of agitation in participants, but also a level of 
stimulation from the music intervention. For example, if a participant seems sedated during the 
baseline measurement period, but not during the music intervention, this may indicate that the 
participant is cognitively stimulated by the music. This arousal may then lead to the person 
becoming more engaged with the intervention, and therefore participate at a greater level. As 
mentioned in the hypotheses section of Chapter 1, greater participation in the music intervention 
should theoretically lead to greater reductions in agitation and increased arousal in sedated 
clients.   
127 
 
 Both the CMAI and the RASS were useful in assessing agitation and sedation in this 
study involving people with AD. Advantages of the RASS are that it is easy to administer and 
does not take much time to do so; however, the CMAI may be more accurate in capturing an 
overall average level of agitation since it assesses more specific behaviors over a longer period 
of time. The RASS is based on a single observation and a lone judgment call of current behaviors 
in the small amount of time it takes to administer the test (i.e., 30-90 seconds; Sessler, et al., 
2002). The utilization of both the CMAI and the RASS in the current study was beneficial since 
it provides richer data to assess agitation and also provides a source for triangulation in order to 
strengthen findings. However, since the assessment period for the CMAI will be shortened to 
assess agitation for an hour rather than its intended 2 week period in this study, the assessment 
period will also be altered for the RASS to also assess agitation for an hour as well. While the 
CMAI specifies and classifies 29 distinct behaviors associated with agitation and generates four 
subscales (Cohen-Mansfield, 1997), the RASS produces a single score, and therefore will be 
compared to each subscale score separately for the CMAI. The administration protocols of both 
scales in this study will be altered by basing assessments of agitation on one-hour periods instead 
of their intended periods (i.e., 2 weeks for the CMAI and 30-90 seconds for the RASS), during 
both types of music interventions and during baseline measures (see Research Design and 
Procedure section for more information on how scales will be utilized).  
Many prior studies of music therapy in people with dementia have altered the assessment 
time of the CMAI to the time period of the music sessions, sometimes even being as short as 30 
minutes (e.g., Gerdner, 1997, 2001). This has generally been done in previous studies because 
music has not shown any long-term benefits to people with dementia, and a two-week 
assessment period would not demonstrate any immediate effects (see Measurement Issues in 
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Chapter 4 for more information). For example, if a music intervention is done for one hour on a 
daily basis, that is still only fourteen hours out of the two-week period of assessment and will 
likely not have an effect large enough to demonstrate reduced agitation during the 1 hour 
intervention periods.  That is, if the effect of reduced agitation does not last far beyond the time 
of the one-hour intervention, it would not be necessary or valid to measure agitation over a two-
week period. Assessment over a two-week period would not indicate whether levels of agitation 
were actually reduced during the time of the intervention since much more assessment time is 
dedicated to non-intervention periods. Only separate measurements done both during and not 
during the intervention can demonstrate immediate effects. This study utilized this method by 
comparing baseline measurements to measurements done during the music interventions, both 
for 1-hour lengths.  
Participation in Music Therapy  
The primary independent variable in this study was participation in music therapy. This 
was assessed through observation of the music sessions, recording if participants sang along, or 
danced or clapped to the music for each song. Singing was characterized as verbal participation, 
and was hypothesized to have the greatest influence on agitation since it theoretically would 
provide the highest level of cognitive stimulation for participants (see Chapter 1 for all 
hypotheses and Chapter 3 for discussion of music and cognitive processing for rationale). 
Physical movements, such as dancing, clapping, and foot tapping were classified as kinesthetic 
participation, which was hypothesized to have less of an effect on agitation than verbal 
participation. Since the participation variables were measuring the level of each type of 
participation, if clients did nothing but sat and listened but did not participate, they received zero 
scores on both verbal and kinesthetic participation measures. Since active and passive music 
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interventions were used, this was also recorded as a variable affecting agitation. While the 
passive music intervention type utilized only prerecorded music played to participants with the 
intention of passive listening only, some participants still actively participated through singing 
along or through movement to the music played, and therefore participation was evaluated in 
both passive and active sessions. Additionally, since clients at the site of the study were exposed 
to both types of intervention, participation was assessed by type of intervention and type of 
participation separately in order to compare one type to the other. Since long-term effects of the 
music interventions were not expected (Gerdner, 1997, 2001), no crossover effects from 
participants receiving both types of intervention were anticipated.  
Research Design and Procedure 
Institutional Review Board Review and Approval 
This study applied for expedited approval from Louisiana State University’s Institutional 
Review Board (IRB) once the design and procedure were finalized. Expedited approval, and not 
the full review process, was all that was required since participants were simply being observed 
in their natural environments without manipulation by the researcher. That is, the participants 
were already receiving music therapy interventions at the respite center individually on a weekly, 
bi-weekly, or tri-weekly basis, and the researcher and an additional observer simply sat in the 
music sessions with the participants and at other times for baseline measurements to observe and 
fill out the scales and ratings being utilized (e.g., CMAI, RASS, verbal and kinesthetic 
participation). There was minimal risk to participants engaged in the music sessions or baseline 
observations, and staff was available for assistance to clients at any time when needed, since the 




Participant Informed Consent 
Participants who volunteered to be included in this study were first asked to sign an 
informed consent form, which explained the purpose and procedures utilized in the study. The 
informal caregivers were asked to sign the consent form when the participant was unable to give 
their own consent due to their severity of cognitive impairment. The researcher attempted to gain 
permission from both the primary caregivers and the clients; however, in some instances clients 
were not able to give their own consent such as when dementia affected reading comprehension 
or language ability. When clients were unable to give consent, the primary caregiver gave 
consent in order for the client to participate. The signed consent forms are kept on file at the 
respite center. Demographic variables of age, gender, and stage of disease, and MMSE scores 
were obtained from the participants’ files at the respite center after obtaining permission from 
either the client or the primary caregiver for the requisite information. The participants in this 
study were also assigned a subject number after giving their informed consent to participate in 
order to protect their anonymity and confidentiality during the course of the study.  
Research Design and Procedure  
 The study followed a one group, pre-post test design with several statistical and 
methodological procedures implemented to strengthen validity. The one group, pre-post test 
design was utilized out of necessity since the study examined a preexisting music program at a 
respite center where the researcher did not have control over the intervention implementation 
procedures or assignment of participants who were exposed to both active and passive music 




 First, to strengthen the design, was the use of multiple baseline measurements for 
comparison to the intervention periods. Baseline measurements were done by observing 
participants during time periods at the respite center other than when clients were receiving 
either a passive or active music intervention, for one hour per week per one hour music session. 
Because the respite center has scheduled activities throughout the day, baseline measurement 
periods were randomized so that the possible effects of other activities on agitation may be 
minimized. All activities during the baseline measurements did not have music on in the 
background. The multiple baseline observations over the 10 week course of the study were 
intermittent observations done at varying times of the day to aid in the accuracy of baseline 
agitation measurements. Since agitation may be influenced by other activities at scheduled times 
during the day (e.g., lunch, arts & crafts time), baseline observation times were varied each week 
in order to find an average level of agitation throughout the day. This time-sampling technique 
was done in order to factor out varying agitation levels due to either time of day or the effect of 
other activities done at the respite center. For example, if baseline measures were done at the 
same time each week, it would likely have been during a particular activity (e.g., clients do arts 
and crafts at 2 p.m. on Wednesdays), which may have had a particular influence on agitation 
levels. This, along with agitation levels generally increasing in people with dementia as the day 
unfolds (i.e., a phenomena known as sundowning; Alzheimer’s Association, 2012), means that in 
order to obtain more accurate baseline measurements, data were collected at various times 
throughout the day. If baseline measurements were always done at a specific time, it would 
likely have been during one particular activity for most participants. Since this researcher is not 
interested in comparing music interventions with another activity, but to an average of other time 
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periods, baseline measurements were done during a different time of day each day that 
measurements were done.  
 Another strength in the current study’s design was the use of multiple pre and post tests 
over a relatively long time period, rather than a single measurement. Clients received music 
interventions for one hour each day, with active sessions usually on Mondays and Tuesdays, and 
passive sessions on Wednesdays, Thursday, and Fridays. The study assessed agitation during 10 
sessions each of both active and passive interventions over a 10 week period (i.e., 20 total 
intervention periods), and compared that to 20 observations done without music where agitation 
was also assessed on the same days as the music interventions in order to establish a baseline for 
agitation.  Since some clients attend the respite program twice or three times a week, some 
participants were included in both active and passive groups on different days; therefore 
measurements were made and compared for each day individually in order to ensure that the 
same participants were being compared during baseline and music intervention periods. 
Additionally, since active sessions were not always provided on both Mondays and Tuesdays, 
only one active and one passive session were observed each week. Both the music sessions and 
baseline measurement periods lasted for one hour each time. This resulted in 40 total hours of 
observation per participant over a 10 week period, which provided a more accurate assessment of 
agitation than a single measurement done during a single session. For example, in each week of 
assessment, one hour was assessed during an active music intervention, one hour during a 
passive music intervention, and one hour during a randomized time other than the music 
intervention on each day of observation in order to establish baseline agitation levels.  
 Music sessions, whether involving a live musician and the clients singing familiar songs 
(i.e., active), or simply clients listening to prerecorded music (i.e., passive), were observed each 
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week for coding of agitated behaviors, sedation, and participation. Passive sessions included 
listening to prerecorded music while either having coffee or a snack, watching a slide show with 
music, or simply sitting and listening to music. One, 1 hour active session and one, 1 hour 
passive session, along with 1 hour without music on each of the two days observing music 
sessions were observed each week of the study for each participant. Levels of agitation were 
assessed using the Cohen-Mansfield Agitation Inventory (CMAI; Cohen-Mansfield, 1997), a 
standardized scale for measuring agitation, and the Richmond Agitation – Sedation Scale 
(RASS; see Measures section in this chapter for further information on the scales that were 
used).  
Observer Training and Reliability 
 Two coders were trained through the use of the scales’ manuals and preliminary 
observations of agitated behaviors at the respite center, and were utilized for the assessment of 
agitation using the CMAI and the RASS on observations of both the music sessions and during 
other time periods in order to establish baseline measurements. The coders explained to the 
clients before the sessions that research was being conducted on music therapy and that they will 
be observed for the next hour, and also were asked to act naturally as if the observers were not 
there. This minimized the clients attempting to engage with the coders during observation 
periods. Additionally, during the music sessions coders also assessed levels of participation in 
the clients. Inter-rater reliability was established for both scales and level of participation 
measurements prior to collecting data for analysis to ensure the quality of all the ratings. Cohen’s 
Kappa was used to measure inter-rater reliability and was set at a threshold of 0.61 or higher, a 
level considered substantial (Landis & Koch, 1977), before proceeding to collect the data for 
analysis. The two observers then each assessed half of the participants in each session to increase 
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the accuracy of the ratings, since accuracy would have probably suffered if both observers 
attempted to assess every client during every session. This resulted in each observer assessing 
only 2-5 clients per session.  
Data Analysis 
 The data obtained from the scales used in this study were initially analyzed for quality 
using visual methods, including creating scatterplots and histograms for each variable, to ensure 
assumptions of linearity and normality were met. Because of the small sample size (N = 22), 
however, considerable variability in variables was found but was acceptable for a study of this 
size. For descriptive statistics, frequencies and percentages were obtained for non-parametric 
variables and central tendency measures were calculated for parametric variables. Inferential 
analyses were done utilizing agitation as the dependent variable and music intervention type as 
the independent variable. Correlations were also utilized to reveal potential associations between 
the type of music intervention, participation in the sessions, demographic variables, and agitation 
levels. Averages of variables over the 10 week course of the study were also analyzed in a 
similar manner to assess the reliability and consistency of findings using meta-analysis 
techniques, treating each day of observation as a separate study. All statistical analyses were 
done by means of SPSS (Statistical Package for Social Sciences) and CMA (Comprehensive 
Meta-Analysis) software.  
Power Analysis 
 A priori power analysis was conducted to ensure that the anticipated sample size was 
sufficient to detect a small to medium effect size. It is accepted as a general rule in social science 
research that 10 subjects per predictor are necessary (Cohen, 1988). This study followed this 
guideline by including two potential predictors of agitation (e.g., type of music intervention and 
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participation) with a sample size of N = 22. A priori power analysis utilizing the coefficient of 
determination (R² = .25), reveals that a sample size of N = 31 is necessary with alpha level set at 
.05 and power level at .80 and would be acceptable for detecting an estimated effect size of .31, a 
relatively small effect (Cohen, 1988), when utilizing three predictors. However, since this sample 
size is smaller, ex post facto power analysis was also conducted on the data collected to ensure 
the sample size obtained was large enough to show statistical significance without a high 
probability of error. Ex post facto power analysis also ensured results could be interpreted with 
confidence and minimized Type II error, using a .80 power level as a standard for adequacy 
(Cohen, 1988), and an alpha level (i.e., Type I error) standard of .05. Because of the small 
sample size in this study, some later adjustments to ex post facto power analysis were necessary, 
but will be addressed when discussing the limitations.  
Descriptive Statistics 
 Demographic variables of age and gender will be reported with frequencies and 
percentages for the aforementioned categories, with age additionally having mean and standard 
deviation as a continuous variable. Stage of AD will be treated as another variable, with 
frequencies and percentages in each stage, and age and gender reported within each stage. Mean 
agitation levels obtained from scores on the CMAI and RASS both before and after 
implementing the music interventions will also be given for each week of the study along with 
corresponding standard deviations. Grand means and standard deviations for all continuous 
variables over the 10 week course of the study will also be given.  
Inferential Statistics 
 Data will be further analyzed utilizing inferential statistical methods, first by using simple 
t-tests to compare intervention periods to baseline measurements due to the small sample size. 
136 
 
Repeated measures were used to assess differences in agitation levels between baseline and 
intervention periods, before and after implementing the music interventions. In order to assess 
how the two types of music interventions differ from one another in affecting agitation levels, 
each day of observation, which included 1 hour of observation of either an active or a passive 
music intervention and 1 hour of a baseline observation, was treated as a separate study and 
included in a meta-analysis. This was necessary due to some overlapping participants in both the 
active and passive groups. That is, since some clients were at the respite center more than one 
day per week, they participated in both active and passive music sessions.   
Agitation levels for each day of observation were expected to be reduced while receiving 
the music interventions and immediately after in all participants; however, the greatest reduction 
was predicted to be seen in those with agitation that was higher at baseline levels. Additionally, 
agitation was predicted to be decreased more from baseline levels for participants in active music 
interventions than those in passive interventions. Levels of agitation were also predicted to 
continue increasing as the study progressed through its 10-week course since participants’ stage 
of AD may worsen during this time (see Internal and External Validity Issues below). It was not 
posited that the music intervention’s effects would continue for long after each individual session 
was completed, and therefore decreasing overall agitation over the 10 week period of the study 
was not anticipated.  
Since the effects of music on people with AD and related dementias who live at home 
during the course of the study have not been examined previously, the current research may 
expand the generalizability of the knowledge base of the effects of active and passive music 
interventions for people with dementia. This study hopes to illustrate the efficacy of music’s 
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power to reduce agitation to a broader population of people with AD who live at home while 
























CHAPTER 6: RESULTS 
 Results of the current study were obtained by inputting the raw data from the measures 
used into IBM Corp. SPSS (Statistical Package for Social Sciences) software for the initial 
analysis of each day of observation. This included one baseline measurement and one 
intervention session (either passive or active) per day. Further analysis was done utilizing 
Biostat, Inc. Comprehensive Meta-Analysis software in order to combine and compare the days 
of observation and the passive and active music interventions. Additionally, demographic 
information about the participants was calculated using Microsoft Excel software in order to 
obtain frequencies and percentages.   
Demographic and Descriptive Data 
The present, active clientele at the respite center during the time of the study (N = 22) 
was made up of 45.5% females (n = 10) and 54.5% males (n = 12). With respect to race, 86.4% 
(n = 19) reported their race as white, while 9.1% (n = 2) reported being African-American and 
4.5% (n = 1) stated Hispanic. No other races were recorded among the current clientele. Twelve 
(54.5%) of the clients reported their primary caregiver as their spouse, with seven (31.8%) 
reporting their daughter, two (9.1%) reporting their son, and one (4.5%) reporting their sister as 
their primary caregiver. The age range for the participating clients was 66 to 93 years of age with 
a mean age of 80.7 (SD = 7.52). While this sample may not reflect the broader general 
population of those diagnosed with AD, it is important to note that the clients live at home with 
their families caring for them, except when at the respite center during daytime hours, either one 
(n = 11), two (n = 8), or three (n =3) days per week. 
Mini-Mental State Exam (MMSE) scores for the participants in this study ranged from 1 - 
23. Participants in this study mostly had a diagnosis of middle-stage AD (n = 16, 72.7%). 
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Additionally, 6 (27.3%) of the 22 participants were found to have a late-stage dementia 
diagnosis, while none were found to be in the early-stage. Demographic information on the 




 Male             12   54.5    
 Female                        10   45.5 
Age 
 65-69      2    9.1     
 70-74      3   13.6 
 75-79      4   18.2 
 80-84      5   22.7 
 85-89      6   27.3 
 90+      2     9.1 
Race 
 White     19   86.4 
Other      3   13.6 
Stage of Dementia 
 Moderate (2)    16   72.7 
 Severe (3)     6   27.3 
Relationship to Caregiver 
 Spouse     12   54.5 
 Daughter     7   31.8 
 Son      2    9.1 
 Sister      1    4.5 
Days/Wk. at Respite Center 
 1     11   50.0 
 2      8   36.4 
 3      3   13.6 
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The means, standard deviations, and ranges for the parametric variables of age, MMSE 
scores, and attendance and number of each type of session appear below in Table 2.   
Table 2_______________________________________________________________________ 
Means, Standard Deviations, and Ranges of Age, MMSE, and Attendance and Number of each 
Type of Session____________ x__________SD_________Range________________________ 
Age    80.7   7.5  66 - 93 
MMSE   13.9  6.7  1 – 23 
Active Attendance (n)  7.3  1.2  5 - 9 
Passive Attendance (n)  7.1  1.7  5 - 10 
Baseline Attendance (n)  6.9  1.3  5 – 9  
Active Sessions (n = 10)  3.1  2.5  0 – 8 
Passive Sessions (n = 10)  3.4  2.4  0 – 8 
Baseline Sessions (n = 20)  6.1  4.2  1 – 15 
 
Table 3_______________________________________________________________________ 
Mean Percentages and Standard Deviations (in Parentheses) of Verbal and Kinesthetic 
Participation in Total Number of Songs in Active Sessions 
     Participation 
Active Session  _Verbal___________Kinesthetic  _______________________ 
Week 1   36.5 (30.2)  23.0 (22.0) 
Week 2   43.8 (35.5)  40.2 (35.4) 
Week 3   48.8 (45.3)  36.9 (34.0) 
Week 4   63.3 (32.1)  20.0 (31.5) 
Week 5   26.1 (33.5)  30.7 (37.0) 
Week 6   37.5 (37.3)  23.5 (28.6) 
Week 7   32.3 (31.2)  26.3 (43.6) 
Week 8   19.3 (29.4)  20.0 (37.5) 
Week 9     5.9 (9.1)  37.3 (40.2) 




 Table 3 above displays the mean percentages and standard deviations of the verbal and 
kinesthetic participation in the active music sessions for each week of the study. The percentages 
reflect the number of songs in which participants either sang, hummed, or whistled songs (i.e., 
verbal participation), or moved rhythmically to the music in some way (i.e., kinesthetic 
participation). Both types of participation were measured per song and counted with participation 
of any part of each song. Percentages were used because the number of songs performed varied 
for each session. Additionally, there were 4 separate performers who led the active music 
sessions, which also varied each week, and may have influenced participation.  
Figures 1 through 8 below display line graphs for the means of each agitation measure 
(RASS, Physical Aggression [CMAI], Physical Non-Aggressive [CMAI], and Verbal [CMAI] 
agitation), per week separately for the passive and active music sessions with their respective 
baseline measurements.  
______________________________________________________________________________ 
  
























Figure 5: Mean CMAI Scores for Physical Non-Aggressive Behaviors during Active and 






Figure 6: Mean CMAI Scores for Physical Non-Aggressive Behaviors during Passive and 
















 Overall participation was obtained by calculating a grand mean for verbal and kinesthetic 
participation percentages for the entire 10 weeks of the study. Grand means were also obtained 
for the measures of the RASS, Physical Aggression (CMAI), Physical Non-Aggressive agitated 
behaviors (CMAI), and Verbal agitation (CMAI); however, scores on these scales were first 
standardized into z-scores due to the non-independence of the weekly sessions. That is, most 
participants were involved in more than one week of the study, but the number of observations 
varied for each person (see Table 2 for means for attendance of each type of session). 
Additionally, several participants were involved in both active and passive sessions due to 
attendance at the respite center multiple days per week.   
Table 4 on the next page presents the correlations between overall participation and the 
agitation measures in the active sessions for all 10 weeks of the study. Verbal participation was 
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found to significantly correlate to lower Physical Non-Aggressive behaviors on the CMAI (r = -
.71, p < .05, two-tailed). Additionally, Physical Aggression and Verbal agitation were 
significantly correlated (r = .67, p < .05, two-tailed). No other significant correlations were 
found.    
Table 4_______________________________________________________________________ 
Correlations between Overall Participation in Active Sessions and Agitation Measures________ 
Measure______________________________1_____2_____3_____4_____5_____6_________ 
1. Verbal Participation     - 
2. Kinesthetic Participation   -.55   - 
3. RASS     -.11 .25   - 
4. Physical Aggression (CMAI)  -.42 .48 .47   - 
5. Physical Non-Aggressive (CMAI) -.71* .54 .01 .43   - 
6. Verbal (CMAI)    -.14 .25 .40 .67* .28   - 
*p < .05 (two-tailed) 
 
Matched-pair t-tests were done for each day of observation in order to test for significant 
differences between the music sessions and the baseline observations each week. Table 5 on the 
next page displays the means and t-scores for each agitation measure for each week by the type 
of observation session. Only two results either significant or approaching significance were 
found in these initial analyses of the differences between the baseline and active and passive 
intervention sessions. One was a significant increase from baseline in the RASS during the 
active session in week one. Second was a decrease in Verbal agitation on the CMAI during the 




Means and t-Scores for Agitation Measures per Session 
    Active     Passive 
Week Measure Baseline Intervention t Baseline Intervention     t 
1 RASS  0.00   0.78          -2.80* 0.40  0.20   1.00 
PA (CMAI) 11.00  11.00  - 11.00  11.00       - 
PN (CMAI) 10.11  11.11          -1.00 10.00  10.00       - 
V (CMAI)  8.00  8.00  - 9.20  8.60   1.00  
2 RASS  0.50  0.50  - 0.20  -0.20   0.59 
PA (CMAI) 11.00  11.00  - 11.00  11.00       - 
PN (CMAI) 10.63  11.00          -1.00 10.40  11.80  -2.06 
V (CMAI)  8.63  8.25           1.16 8.40  8.40       -      
3 RASS  0.17  0.67          -2.24 0.17  0.33  -1.00 
PA (CMAI) 11.00  11.00  - 11.00  11.00       - 
PN (CMAI) 10.50  11.50          -1.07 11.00  11.17  -0.54 
V (CMAI)    8.17  8.17  - 9.17  8.83   0.50     
4 RASS  0.60  0.40           0.54 0.67  0.17   1.17 
PA (CMAI) 11.00  11.00  - 11.33  11.00   1.58 
PN (CMAI) 11.60  11.60  - 11.33  11.50  -0.08 
V (CMAI)  8.60  8.40           0.34 8.83  8.67   1.00       
5 RASS  0.14  0.29          -1.00 0.44  0.33   0.32 
PA (CMAI) 11.00  11.00  - 11.00  11.11  -1.00 
PN (CMAI) 11.00  11.29          -0.34 12.22  10.67   1.62 
V (CMAI)  8.00  8.14          -1.00 8.44  8.56  -0.26       
6 RASS  0.63  0.38           0.61 0.38  0.13   0.80 
PA (CMAI) 11.13  11.00           1.00 11.00  11.00       - 
PN (CMAI) 11.38  11.63          -0.21 10.75  10.13   1.26 
V (CMAI)  8.13  8.00           1.00 9.00  8.50   0.61       
7 RASS  0.71  0.29           1.44 0.71  0.43   0.80 
PA (CMAI) 11.00  11.00  - 11.00  11.00       - 
PN (CMAI) 11.57  11.43           0.16 11.71  10.86   0.71 
V (CMAI)   9.71  8.00           2.20+ 9.43  8.71   1.37      
8 RASS  0.43  0.14           0.55 0.83  0.17   1.58 
PA (CMAI) 11.14  11.00           1.00 11.33  11.00   1.58 
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PN (CMAI) 10.71  12.14          -1.13 12.00  11.00   0.87  
V (CMAI)  8.71  8.00           1.26 8.33  8.00   1.58       
9 RASS  0.17  0.50          -1.00 0.40  -0.20   1.00 
PA (CMAI) 11.00  11.00  - 11.40  11.00   1.00 
PN (CMAI) 12.00  13.00          -0.97 11.00  10.00   1.00 
V (CMAI) 11.17  8.17           1.58 10.80  8.00   1.10        
10 RASS  0.38  0.75          -0.70 0.14  0.43  -1.55 
PA (CMAI) 11.00  11.38          -1.43 11.00  11.14  -1.00 
PN (CMAI) 11.13  12.50          -1.01 10.43  10.43       - 
V (CMAI) 8.75  8.50           0.37 8.43  8.86  -1.00        
_____________________________________________________________________________________________ 
*p < .05 (two-tailed), +p < .07 (two-tailed), PA = Physical Aggression, PN = Physical Non-Aggressive, V = Verbal 
 
Meta-Analysis 
 Meta-analysis was conducted on the data obtained from each day of observation in order 
to accommodate the overlap in participants in both active and passive sessions and for each 
week. Additionally, meta-analysis takes the small sample size into consideration, weighting each 
day accordingly, which increases the power available and allows for a clearer representation of 
the overall effects of each agitation measure. Forrest plots for each of the agitation measures 
(RASS, Physical Aggression [CMAI], Physical Non-Aggressive [CMAI], and Verbal [CMAI]) 
appear on the pages below for passive and active sessions separately. Additional plots for each 
measure display meta-analyses comparing the active and passive sessions using the intervention 
sessions only, and also comparing the active and passive interventions using mean differences 
between intervention and baseline measurements.  
First, results from the meta-analysis indicate an effect approaching significance favoring 
the passive over the active intervention for the RASS (Figure 11) (z = -1.78, p = .076). However, 
this effect is strengthened and becomes statistically significant at the standard p < .05 level when 
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also taking the baseline measurements into account using the mean differences (see Figure 12) (z 
= -2.30, p = .021). Next, Figure 17 reveals that for Physical Non-Aggressive behaviors on the 
CMAI, baseline sessions are favored over the active music sessions (z = -2.06, p = .04), but not 
for the passive sessions. Consequently, passive music interventions are favored over active 
interventions, as seen in Figure 19 (z = -2.50, p = .01). This effect is strengthened as well by 
using the mean differences in intervention and baseline measurements (see Figure 20) (z = -3.39, 
p = .001).  Lastly, Verbal behaviors on the CMAI were found to be significantly reduced during 
the active music interventions over the baseline measurements (see Figure 21) (z = 2.01, p = .04), 
but not for the passive sessions. Accordingly, active sessions are favored over passive sessions 
for Verbal behaviors, approaching significance (z = 1.80, p = .07). This effect also became 
statistically significant at the p < .05 level, as seen in the final analysis, when the differences in 
baseline and intervention measurements are taken into account (see Figure 24) (z = 2.50, p = 
.01). No other statistically significant or approaching significant effects were found. Figures 9 
through 24 follow on the next 16 pages. 
The aforementioned results from the inferential analyses and the meta-analyses will be 
discussed thoroughly regarding their interpretation and possible implications in the next chapter, 
along with the limitations of the current study and potential recommendations for future research 






































Figure 11: RASS Meta-Analysis Comparing Passive and Active Sessions. Negative Values favor Passive Intervention, Positive Values 













Figure 12: RASS Meta-Analysis Comparing Baseline-Passive and Baseline-Active Mean Differences. Negative Values favor Passive 














Figure 13: CMAI Physical Aggression Meta-Analysis for Active and Baseline Sessions. Negative Values favor Baseline, Positive 














Figure 14: CMAI Physical Aggression Meta-Analysis for Passive and Baseline Sessions. Negative Values favor Baseline, Positive 















Figure 15: CMAI Physical Aggression Meta-Analysis Comparing Passive and Active Sessions. Negative Values favor Passive 














Figure 16: CMAI Physical Aggression Meta-Analysis Comparing Baseline-Passive and Baseline-Active Mean Differences. Negative 














Figure 17: CMAI Physical Non-Aggressive Behaviors Meta-Analysis for Active and Baseline Sessions. Negative Values favor 














Figure 18: CMAI Physical Non-Aggressive Behaviors Meta-Analysis for Passive and Baseline Sessions. Negative Values favor 














Figure 19: CMAI Physical Non-Aggressive Behaviors Meta-Analysis Comparing Passive and Active Sessions. Negative Values favor 















Figure 20: CMAI Physical Non-Aggressive Behaviors Meta-Analysis Comparing Baseline-Passive and Baseline-Active Mean 














Figure 21: CMAI Verbal Behaviors Meta-Analysis for Active and Baseline Sessions. Negative Values favor Baseline, Positive Values 














Figure 22: CMAI Verbal Behaviors Meta-Analysis for Passive and Baseline Sessions. Negative Values favor Baseline, Positive Values 
















Figure 23: CMAI Verbal Behaviors Meta-Analysis Comparing Passive and Active Sessions. Negative Values favor Passive 















Figure 24: CMAI Verbal Behaviors Meta-Analysis Comparing Baseline-Passive and Baseline-Active Mean Differences. Negative 




CHAPTER 7: DISCUSSION 
 The current study aimed to examine the effects of participation in active and passive 
music interventions on agitated symptoms of AD and related dementias. Agitation in both active 
and passive music sessions was compared with baseline sessions without music using standard 
statistical methods, and to each other using meta-analysis techniques due to the non-
independence of the groups (see Methodology in Chapter 5 for more information). Participation 
was measured during active music sessions and was tested for correlations with the agitation 
measures during these sessions. While participation was originally intended to be measured in 
the passive music interventions as well, virtually no participation was found during these 
sessions, and therefore correlations could not be made. This study relied on naturalistic 
observations of the effects of participation in music activities, and did not manipulate 
participants’ daily routines in any way. The research design was quasi-experimental and used a 
convenience sample of people with AD who live at home and are cared for by an informal 
caregiver, and were already attending a daytime respite program 1 – 3 times per week that 
included the music interventions. The current research attempted to increase the generalizability 
of the effects of music interventions for people with dementia to a broader population, and also 
to examine the effects of participation and the type of intervention on agitation in order to 
illuminate best practices for caregivers, social workers, and others who regularly work with 
people with AD and related dementias as part of their treatment.    
Results of Hypotheses 
This study assessed the following hypotheses: 1) the level of music intervention (e.g., 
passive and active) will influence agitation differently in people with AD; 2) agitation is 
expected to be reduced during the interventions when compared to baseline measurements; 3) 
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greater participation (e.g., if participants sing or clap rather than simply listen) will result in 
greater reductions of agitation whether the intervention is active or passive; and 4) the active 
form of music intervention in which participation is encouraged will result in greater reductions 
in agitation than the passive form due to greater focus on the music and cognitive stimulation. 
How the results from this study either supported or did not support these four hypotheses is 
discussed below.  
Hypothesis 1  
Hypothesis 1 focused on the comparison of active and passive forms of music 
interventions and their ability to affect agitated symptoms in people with dementia differently. 
This is also directly connected to Hypothesis 4, which stated that the active form would have a 
greater effect on agitation than the passive form. The line graphs (Figures 1 - 8) in the previous 
chapter reveal that the passive interventions (see Figures 2, 4, 6, and 8) are consistently lower in 
agitation  than are the active interventions versus their respective baselines (see Figures 1, 3, 5, 
and 7). While this result was not as expected, it is based purely on visual analysis of the graphs, 
and was not supported by further inferential analysis. Individual t-tests for each day of 
observation only revealed one result approaching significance of the active intervention for 
verbal agitation during week 7. This is likely due to the low power of the analyses due to treating 
each day as a separate experiment, and therefore having a very small sample size per day (n = 5 – 
10).  
Additional investigation of the data was done using meta-analysis in order to combine 
each day of observation and each type of intervention for comparison of the active and passive 
forms. This technique was utilized because of the non-independence of the groups receiving each 
intervention and to add additional power to each analysis by combining all 10 weeks of each 
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form in order to reveal an overall effect. These analyses revealed that the passive intervention 
was more effective in reducing agitation according to scores on the RASS, which measured 
overall agitation on a continuum with sedation as the opposite pole (i.e., negative scores). 
Although sedation may not have been the goal of the intervention, this analysis did not take this 
into consideration, and greater differences may have been found due to participants falling asleep 
during the passive intervention (see Figure 2). Additionally, for Physical Non-Aggressive 
behaviors on the CMAI, the passive music intervention was more effective than the active form 
(see Figures 19 and 20). While this is a strong effect in favor of the passive music intervention, it 
is important to note that the passive music intervention did not show a significant effect over 
baseline measurements (see Figure 18).  This was also true of the previous effect on the RASS 
(see Figure 10). While both analyses supported the efficacy of the passive intervention over the 
baseline measurements, neither was statistically significant. The passive intervention may have 
been associated with lower agitation than the active form, but overall it was not effective 
according to these measures.  
Consequently, Hypothesis 1 is supported by the abovementioned differences in active and 
passive forms of the intervention. The results of passive being favored for scores on the RASS 
and Physical Non-aggressive behaviors on the CMAI, and additionally, the active intervention 
being favored over passive and baseline measurements for Verbal agitated behaviors on the 
CMAI, clearly demonstrate the differences in the effects of passive and active music 
interventions on agitation in individuals with AD and related dementias.   
Hypothesis 2 
The one effect found that revealed the efficacy of the music interventions is that Verbal 
agitated behaviors on the CMAI were significantly lower than baseline measurements during the 
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active intervention (see Figure 21). This directly supports Hypothesis 2 that the music 
interventions will reduce agitation more so when compared to baseline measurements. However, 
this only supports the active form of the intervention, since significant differences were not 
found for the passive form over baseline measurements. Additionally, this only supports the 
active form for the Verbal agitated behaviors on the CMAI, since the baseline measurements 
were significantly lower than the active intervention for Physical Non-Aggressive behaviors (see 
Figure 17),  and not significantly different for the  Physical Aggression subscale (see Figure 13). 
Physical Non-Aggressive behaviors may have been higher during the active music sessions due 
to the general stimulating effect lively popular music can sometimes have on individuals, such as 
raising arousal levels, respiration, and heartbeat (Juslin & Vastfjall, 2008; Levitin &Tirovolas, 
2009). That is, the intervention may not have only stimulated movements directly related to the 
music (e.g., clapping, tapping foot), but also may have stimulated movements interpreted as 
Physically Non-Aggressive agitated behaviors (i.e., repetitive motions not clearly connected to 
the rhythm, fidgeting, restlessness). Whether or not participants were engaged and actually 
singing along during the active sessions may also have contributed to this finding (see discussion 
of Hypothesis 3 below). While the active music intervention was not effective at reducing 
physical agitated symptoms overall, it was effective at reducing Verbal agitated behaviors, and 
thus partially supports Hypothesis 2. 
Hypothesis 3 
 Hypothesis 3 stated that participation in the music interventions would affect agitation, 
with greater participation showing greater reductions in symptoms. Examining participant 
engagement could provide insight into the best methods of engaging clients in music 
interventions for caregivers, social workers, and others who care for people with dementia, and 
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therefore help them get the most out of the sessions. This hypothesis was supported by the 
significant negative correlation between overall verbal participation and the Physical Non-
Aggressive behaviors subscale on the CMAI (see Table 4). While verbal participation may help 
regulate Physical Non-Aggressive behaviors, recall that overall the active sessions were not 
significantly different over baseline for these behaviors. What this means is that the people 
verbally participating (e.g., singing, humming, whistling) in the active intervention had lower 
Physical Non-Aggressive behaviors, but the others who were not participating had more of these 
behaviors, which apparently was enough to not only nullify any differences between the overall 
active and baseline measurements, but actually create the opposite effect of the baseline 
measurements being favored for these behaviors. Nonetheless, the strong negative correlation 
between verbal participation and Physical Non-Aggressive behaviors still partially supports 
Hypothesis 3, and also supports the necessity for engaging clients fully in the intervention in 
order for it to be effective.   
 It was also anticipated that participants who were singing during the active sessions 
would be less verbally aggressive, although the correlative analyses did not support this. The 
very weak, non-significant negative correlation between overall verbal participation and the 
Verbal agitation measure on the CMAI during the active sessions demonstrates that there was 
little effect. Additionally, examining correlations between verbal participation and Verbal 
agitation on a weekly basis further discredits this notion. Week 7 was the only weekly analysis 
that was even approaching significance, and it did not have the highest verbal participation (see 
Tables 3 and 5). Furthermore, Week 9, which had the lowest verbal participation, also had a 
reduction in Verbal agitation, although not significant (see Figure 7). Since Verbal agitated 
behaviors on the CMAI were found to be significantly reduced during the active music 
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interventions over the baseline measurements (see Figure 21), this means that participation 
probably did not greatly influence this measure. This effect is likely due to the greater focus on 
the music during the active intervention over the passive intervention, even when not 
participating. However, the strong correlation for verbal participation reducing Physical Non-
Aggressive behaviors clearly demonstrates the importance of fully engaging clients when 
implementing active music interventions. 
Hypothesis 4 
The effect of the active music intervention reducing Verbal agitated behaviors on the 
CMAI also supports Hypothesis 4, stating that the active form will be more effective than the 
passive form at reducing agitation. Meta-analysis on the Verbal agitated behaviors subscale of 
the CMAI revealed that the active sessions showed a strong effect for significantly reduced 
agitation over the passive sessions, especially when using mean differences between intervention 
and baseline measurements (see Figure 23 and 24). This effect was anticipated since participants 
who were singing during the active sessions were assumed to not also be able to simultaneously 
be verbally aggressive, and furthermore, any verbal comments made during the active sessions 
may not have been able to be heard above the music and others’ singing. However, the verbal 
participation during the active sessions each week did not necessarily support this idea (see 
discussion of Hypothesis 3 above). The greater cognitive stimulation and focus on the music 
during the active intervention versus the passive intervention, rather than participation, may be 
what cultivated this effect. The lower Verbal agitation during the active sessions as compared to 
the passive sessions does partially support Hypothesis 4, and also lends support to Gerdner’s 
(1997) theory of music’s ability of reducing stress by being the focal point during the 




 Examining the participation in the active music intervention each week (see Table 3) 
revealed that the type of music, the protocol of implementation, and the setting may all affect 
verbal participation. For instance, week 9, which had the lowest verbal participation, consisted of 
only religious hymns, while the other weeks contained mostly popular music from the 1920’s to 
the 1960’s. Additionally, week 10’s low verbal participation may have been due to the setting 
since it was the only session that was implemented outdoors. Looking at Figures 1, 3, and 5, 
reveal that overall agitation according to the RASS, and physical agitation on the CMAI, both 
aggressive and not aggressive, were higher during the active intervention than during baseline on 
week 10. Although this was not significant, mostly due to the low sample size, the marked 
increase could be explained by the outdoor setting since the performer had played before week 
10, but indoors, and this effect was not seen. Additionally, baseline sessions were significantly 
favored over active sessions for overall Physical Non-Aggressive behaviors, with week 10 
contributing to this effect. This demonstrates that an active music intervention implemented in an 
outdoor setting may increase physical agitated behaviors, possibly due to less focus on the music 
and an outdoor environment being more stimulating, as observed through participants’ greater 
movements and activity, and music’s known effect for being both cognitively and physically 
stimulating in general (Juslin & Vastfjall, 2008; Levitin &Tirovolas, 2009). However, in this 
case the abundance of stimuli other than the music in the outdoor setting may have created 
greater stress for the participants with AD, as Hall and Buckwalter’s (1987) theory of the 
Progressively Lowered Stress Threshold in individuals with cognitive impairment posits.  
Lastly, the performer and their varying methods of implementing the active music 
intervention may have also influenced participation. Variables such as performers talking to 
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participants and asking them questions between songs, whether the performer was facing the 
participants (e.g., when sitting and playing guitar) or facing the wall (e.g., when playing a piano 
against the wall), what songs were played, and the number and what participants were there each 
day all may have affected participation and the outcome of the music interventions. While 
participation was measured in the current study, these other abovementioned variables, while 
observed and noted, were not included in the analysis since they were not empirically measured.   
Strengths and Limitations  
The current study utilized strong research methodology which helped control for some 
possible confounds, and therefore contributed original knowledge to the field. The study focused 
on music therapy and musical activities and their utility in treating agitation associated with 
Alzheimer’s disease (AD) and related dementias, and was methodologically unique from prior 
studies. Both active and passive forms of music therapy were utilized and compared, and 
participation and engagement with the interventions were also measured. The study also included 
a unique population of people with dementia who remained living at home during the course of 
the study.  
Few studies of music’s effects on agitation in people with dementia have been conducted 
using a true experimental design while incorporating a matched control group and random 
assignment with a large random sample to this author’s knowledge. This is likely due to 
feasibility issues of such a study. One researcher (Janata, 2012) that attempted a true 
experimental design using random assignment of music exposure encountered diffusion of the 
treatment due to its being at a single location and, consequently, the control group had indirect 
exposure to the music (see Experimental Designs in Chapter 4 for more information). Feasibility 
issues such as this make it difficult to implement the “gold standard” of true experimental 
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designs when studying the effects of music on dementia in real-world situations. Therefore, like 
research in almost any field using human participants, prior research and the current study on 
music’s effects on people with AD and related dementias suffers from multiple threats to both 
internal and external validity, including many confounding variables that may also influence 
agitation.  
Internal and External Validity  
 While the one group, pre-post test design is relatively weak in controlling for validity 
issues when compared to true experimental designs, the enhanced methodology of the current 
study lent support for some of these concerns. First, the multiple observations for both the pre- 
and post tests (i.e., 40 total for baseline, passive, and active music sessions) over a ten-week 
period made this essentially an interrupted time series design, and potentially controlled for 
maturation, history, testing, regression, selection, and some additive and interactive effects of 
threats to internal validity (Shadish, Cook, & Campbell, 2002). The multiple baseline 
measurements were also a means of controlling for threats of history.  Using multiple baseline 
measurements, any effect due to an historical event would be expected to reveal itself at around 
the same time in each participant. Therefore, it is easier to determine that a change seen in the 
participants’ behavior may be due to an historical incident rather than to the intervention (Rubin 
& Babbie, 2008).  Additionally, the multiple baseline and intervention measurements should 
have also helped control for maturation effects. If agitation increased due to the progression of 
AD in participants over the 10-week course of the study, this would appear during both the 
baseline measurement periods as well as the intervention measurement periods. If agitation only 
increased in the baseline measurements over time, it would reveal that the music interventions 
are more effective for participants with greater agitation levels. That is, if agitation continued to 
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increase over time during the course of the study in baseline measurements, but not in 
intervention measurements for the same participants, this would indicate that the intervention 
was having a greater effect reducing agitation when it is higher before the intervention is given. 
Utilizing multiple baseline measurements helped facilitate in giving a clear indication of what 
level of effect the music interventions were having on the participants.  
The characteristic common to all baseline sessions in the current study was that they did 
not include music in the background. The baseline sessions did, however, involve a variety of 
group activities, including recreational games, some of which involved movement (e.g., balloon 
volleyball, bowling), and some of which involved relatively still activities, seated at tables (e.g., 
Bingo, Family Feud). This difference in movement during the baseline activities may have 
affected agitation in the participants. Those involving greater movement were likely more 
physically stimulating, and may have provoked more physical agitation, compared to activities 
done while sitting still. Additionally, the competitive recreational activities during some baseline 
sessions may have influenced physical aggression between participants. 
The variability of activities during the baseline measurement periods presented the 
problem of obtaining a true baseline measurement of agitation in the participants in the current 
study since the other activities may have also influenced agitation. Some previous studies that 
have specifically compared the effects of music on agitation to other activities have found that 
the other activities can be just as effective as music at reducing agitated symptoms of dementia 
(e.g., Cooke et al., 2011, Gardiner & Furois, 2000, Snyder & Olson, 1996). Reading groups 
including discussion of the books (Cooke et al., 2011; Gardiner & Furois, 2000), and hand 
massage (Snyder & Olson, 1996) have both demonstrated effects of relaxation and reduced 
agitation in  participants with dementia in prior studies. Additionally, Kasl-Godley and Gatz 
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(2000) theorize that the actual activity done is less important than the social interaction and 
cognitive stimulation provided by psychosocial interventions done in groups. This means that not 
finding a significant difference between music interventions and other activities does not 
necessarily mean that music is not effective; it may simply mean that the other activities are 
effective as well. The baseline measurements in the current study included a variety of other 
activities done in groups, and thus may have contributed to some of the non-significant results. 
While utilizing multiple baseline measurements may have helped control for some of the 
variability in the current study, and also historical and maturation threats to internal validity, the 
issue of instrumentation was also a concern.  Instrumentation issues with internal validity can be 
dealt with by utilizing multiple observers and demonstrating high inter-rater reliability in well-
designed research studies (Rubin & Babbie, 2008).  According to Ruben and Babbie (2008), an 
adequate level of agreement between multiple observers is one way to increase the accuracy of 
the data gathered by the observers, and therefore would decrease any instrumentation error.  The 
current study utilized two observers and trained each in assessing both agitation and participation 
to ensure substantial inter-rater reliability (Cohen’s Kappa = 0.61; Landis & Koch, 1977), before 
actually collecting the data used for the analyses. Additionally, the primary measures (e.g., 
RASS, CMAI) utilized for this study were standardized and had strong psychometric properties 
(see Measures in Chapter 5 for specifics).   
 Passive music sessions in the current study also varied in their activity level and their 
focus on the music, which may have affected their outcome. While some sessions had 
participants focused on the music (i.e., along with a slide show), others had participants engaging 
in conversation or other activities with music on in the background (e.g., drinking coffee, eating 
a snack, sitting in a circle to facilitate conversation). Prior studies on passive music’s effects on 
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dementia have also varied their focus on the music, from simply having music playing in the 
background while dining (e.g., Hicks-Moore, 2005) to utilizing familiar, preferred music played 
in headphones placed on participants (e.g., Gerdner, 2005). These differences in the focus on the 
music during passive music interventions may influence agitation in the participants in both 
previous research and the current study. If the passive music interventions were kept consistent 
and included only sessions where participants paid full attention to the music, an overall effect of 
the passive music intervention over the baseline measurements may have been found in the 
current study. Unfortunately the researcher did not have control over this aspect of the 
intervention.  
Another important limitation in this research on music interventions utilized for AD and 
related dementias is the sampling method. Like most of the prior studies of this type, this study 
used a convenience sample, in addition to a small sample size (N = 22), therefore weakening the 
external validity of the findings. Results from this study may not generalize beyond the sample 
and setting utilized since random selection was not used. Since studies of music therapy and 
music interventions in people with AD and related dementias commonly use convenience 
sampling methods (e.g., clients of a single respite center in this instance), results cannot be 
expected to generalize beyond the population in the setting for each study, even when utilizing 
random assignment to different groups as in the classic experimental design. 
 While generalizability is best with the utilization of random sampling, it is not always 
feasible. The current study used a convenience sample, and only had a single group, since 
participants were already exposed to both active and passive forms of music interventions at the 
respite center where the study was conducted. Additionally, the current research may have 
suffered from low representativeness of the broader population of people with AD since the 
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sample was drawn only from this one location. Since the researcher did not have control over 
these factors, external validity may have suffered. However, the participants with AD included in 
this study lived at home and were cared for by a family member, and not in assisted-living 
facilities or nursing homes, during the course of the study. This population has not been studied 
for the effects of music on their agitated symptoms of AD and related dementias except in one 
small, pilot study (i.e., Brotons & Marti, 2003) where participants stayed away from home in a 
rural setting with their primary caregiver (i.e., their spouse) during the study. While this study 
did show the effects of reduced agitation and anxiety from music in both caregivers and their 
recipients, being on vacation in a rural setting may have also contributed to the results. Since the 
effects of music on people with AD and related dementias who live at home during the course of 
the study have not been studied previously to this author’s understanding, the current research 
expands the knowledge base of the effects of music interventions for people with dementia to a 
broader population of people with AD and related dementias who live at home while receiving 
respite services that include multiple psychosocial interventions including music.    
Implications 
Future Research 
 While prior research and the current study have found some reduced agitation symptoms 
when using music interventions for treating people with dementia, more research is still needed. 
Further research in the area should concentrate on the strength of the research design and the 
protocol of implementing the interventions. While true experimental designs are not always 
feasible, especially with vulnerable populations such as those with AD and related dementias, 
future research designs testing music interventions in this population should continue to strive 
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for this. Most prior research in the area, including the current study, lacked a true control group, 
which diminishes the validity of the study.  
Additionally, the small sample sizes of most studies of this kind mean low power to find 
a moderate effect of music interventions in people with AD and related dementias. Most prior 
studies, including the current study, have also used convenience sampling methods in addition to 
small sample sizes, further weakening the validity of the findings. Future research in the area 
should aim for larger sample sizes and also random assignment and even random selection 
whenever possible.  
Consistency in the implementation protocols of interventions is also likely to help with 
research fidelity in this area. This could include more control for the type of music and setting, 
and using prerecorded or even live music performers as-needed for agitation rather than at set 
times. Additionally, future research may want to compare active sessions with passive sessions 
in which participants are actually focused on the music rather than merely having music on in the 
background for a passive intervention. Consistency in the method and delivery of music 
interventions utilized for AD and related dementias across studies would help solidify the 
efficacy of these interventions and would also strengthen the validity of future studies.  
Results from this study also lend support to the theoretical base in research on music 
interventions’ effectiveness with reducing agitated dementia symptoms. Gerdner’s (1997) mid-
range theory of music’s effects on agitation in people with AD is based on the increased effects 
of stress due to age-associated cognitive decline, which has been specifically applied to AD by 
Hall and Buckwalter (1987), who created the Progressively Lowered Stress Threshold (PLST; 
see Chapter 3 for further explanation). Gerdner’s theory is based on the PLST theory but is 
specific to music’s effects on AD. This study demonstrated that greater participation, and 
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therefore greater focus on the music, provided relief from some agitated symptoms of dementia, 
a result that directly supports this theory.  Having a theoretical base in research of this type can 
not only help future researchers demonstrate that music interventions are effective for treating 
agitation in people with AD and other related dementias, but also build upon it and help explain 
how and why music may have this effect. 
Practice Implications 
The widespread use of music interventions by caregivers, social workers, and other 
practitioners working with people with AD and related dementias is partly explained because 
research has demonstrated music’s efficacy in reducing some forms of agitation, and 
consequently disruptive behaviors, in this population. Results from this and previous studies on 
music’s effects on dementia suggest that music interventions and activities involving music may 
provide both professional and informal caregivers a potential method of reducing agitation and 
disruptive behaviors in their care recipients that they could implement at home, and additionally 
for social workers and other practitioners to implement in respite and residential settings. 
Implementing music interventions can be as easy as playing recorded music to people suffering 
from dementia (i.e., a passive music intervention), although singing and/or playing simple 
instruments in a group and/or individual setting (i.e., an active music intervention), while more 
difficult to implement, may be more effective for the management of some symptoms. This 
could be as simple as caregivers singing familiar songs and encouraging their care recipients to 
sing along. Reducing the agitation and related behaviors associated with dementia improves the 
quality of life of both the persons with dementia and those around them, and music therapy and 
other music interventions can help facilitate this process.  
181 
 
This study demonstrated that the particulars of the music intervention, including the type 
of music, the setting, and the performer and their method of implementation, may make a 
difference in participation and therefore the effectiveness for reducing agitation. It is important 
for social workers and practitioners who utilize music and other psychosocial interventions to 
know how to maximally engage participants in the intervention. For instance, this study showed 
that sessions with popular music had much greater participation rates than a session with only 
hymns. Participants also showed more agitation in an outdoor setting rather than indoors, even 
with popular music. Additionally, the passive music intervention, which merely included having 
music on in the background, showed more consistently lower levels of agitation than the baseline 
measurements (see Figures 2, 4, 6, and 8 in Chapter 6), meaning caregivers and practitioners 
may simply need to play prerecorded preferred music  for their recipients in order to reduce 
agitation. These results demonstrate the music intervention protocol is likely to be important in 
reducing agitation in people with AD and related dementias, and will allow caregivers, social 
workers, and others who treat the symptoms of the disease to utilize best practices when 
implementing this type of intervention.  
There are many methods, including psychosocial interventions such as music therapy and 
other interventions involving music, which may help to temporarily prevent some symptoms 
once AD or other dementias have taken hold.  Individualized, multidisciplinary treatment 
regimens, including psychosocial interventions that provide cognitive stimulation and social 
support such as group music interventions provide seem to be one of the finest treatments 
available for AD and other dementias at this time. Additionally, since music and other 
psychosocial interventions are effective at reducing agitated and aggressive behaviors in 
individuals with AD and other related dementias, they should be preferred over the common use 
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of sedative and antipsychotic medications and physical restraints. While medications or restraints 
may sometimes be necessary in extreme cases, treatment regimens for AD and related dementias 
can be maximized for efficacy by including psychosocial interventions, such as those including 
music. Furthermore, music therapists and other musicians are becoming increasingly more 
available to work with respite centers, residents of nursing homes or assisted-living facilities, and 
other settings and locations with older adults, including those suffering with AD and other 
dementias, in order to enhance and complement their current treatment regimens through the 
utilization of music interventions.   
Policy Implications 
Recent interest in non-pharmacological interventions by social workers and others who 
treat behavioral symptoms of AD and related dementias has grown vastly, widely due to the 
limitations of current medical treatment regimens, the side effects of medications, and the 
efficacy and relative ease of implementation of some psychosocial interventions (see treatment 
of Alzheimer’s Disease in Chapter 2). Non-pharmacological treatments for dementia that are 
evidence-based, such as the use of music, should be included in treatment regimens since a 
multidisciplinary approach is required to effectively manage the cognitive and physical 
symptoms of the disease. The use of music through both passive listening and music groups 
involving active singing and playing have been implemented recently at many nursing homes, 
respite centers, and other care facilities for older adults around the world. For example, the 
Music and Memory program, which was created by Dan Cohen in 2010, has now grown to be 
implemented at over 3000 care facilities throughout the U.S. (Music and Memory, 2016). This 
program provides iPods to seniors filled with their preferred music (i.e., on a playlist if iPods are 
shared) so that they can enjoy listening to music through headphones at any time without 
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disturbing others. A recent study, yet unpublished, compared care facilities that have 
implemented the Music and Memory program with those that have not, and results showed 
improvements in behavioral symptoms and lowered antipsychotic medication use in residents at 
the facilities with the program (Music and Memory, 2016). This, the current study, and prior 
research on music’s efficacy for treating behavioral symptoms of AD and related dementias 
points out music’s usefulness as a part of multidisciplinary treatment regimens. Policy-makers 
need to be aware of interventions such as this in order to embrace them into local, state, and 
federal policies.      
 At the local level, organizations should stay focused on policies that implement 
evidence-based interventions such as the use of music for treating the agitated and other 
behavioral symptoms of dementia. Awareness of music’s ability to reduce some symptoms of 
AD and related dementias is a prerequisite for the implementation of music programs, such as 
the Music and Memory program, at an organizational level. Research, such as the current study, 
raises the awareness of music’s effectiveness for treating certain symptoms of dementia in 
individuals in care facilities. For instance, the director at the research site of the current study 
looked into and implemented the Music and Memory program as a direct result of the outcome 
of this study. However, music programs are usually only implemented when sufficient funding is 
available to organizations, and even after the programs are implemented, they often go unused or 
underutilized, or are implemented incorrectly. This is why organizational policies are needed 
regarding the types of music, and the settings and protocol for implementation of music 
interventions. This study and prior research point out that factors, such as individualizing the 
music, the setting of the intervention, and the consistency of which it is implemented, matter for 
maximizing the efficacy of music interventions for treating the behavioral symptoms of 
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dementia.  Furthermore, the protocol of the implementation of music interventions for dementia 
may also vary by individuals. For example, someone who is currently agitated may not enjoy 
having headphones being placed on them, so their individualized, preferred music being played 
through speakers may be more effective and appropriate. Additionally, encouraging active 
participation such as singing or playing along on simple instruments may be more beneficial with 
certain types of agitation. Organizational policies regarding the exact use of music interventions 
and training for implementation of such programs are necessary to ensure that not only are music 
programs available to individuals with AD and related dementias, but that they are properly 
utilized.    
On a broader scale, federal and state policies are necessary to fund music programs at 
care facilities such as nursing homes and respite centers throughout the U.S. Once more, 
awareness of music programs and their efficacy for treating symptoms of dementia is necessary 
in order for policy-makers to include them in policies regarding dementia treatment. Policies 
such as Medicare and Medicaid could cover the costs of music programs at care facilities for 
older adults through reimbursements to the organizations that implement music programs such as 
Music and Memory. Because both Medicare and Medicaid are joint programs between the 
federal government and each individual state, state policies along with federal policies must also 
address the issue of dementia treatment to include non-pharmacological interventions along with 
medical treatment. Research on music’s effects on dementia, such as the current study, raises the 
awareness of evidence-based psychosocial interventions for dementia. For example, after the 
Music and Memory program was implemented at the research site, knowledge of the program 
grew to a state level with the Department of Health choosing to implement the program at 78 
nursing homes and care facilities throughout the state. State and federal policies regarding the 
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treatment of AD and related dementias can determine whether individuals with the disease are 
able to receive necessary treatment, whether the treatment is in a community setting or in a 
nursing home, and exactly what treatments are made accessible. This has a direct influence on 
the availability of psychosocial interventions such as music programs for people with dementia, 
and policy–makers should include music and other evidence-based non-pharmacological 
interventions in funding treatment regimens for AD and related dementias. Unquestionably, the 
need for effective programs such as the Music and Memory program and other music-related 
programs to be included in treatment regimens for AD and related dementias will continue to 
grow as the population continues to age, and local, state, and federal policy-makers need to 
become more aware of music’s importance, especially with its effects concerning dementia.            
Conclusion 
This study sought to examine the effects of both passive and active music interventions 
on the agitated behavioral symptoms associated with AD and related dementias. The analysis 
focused on the comparison of both types of music intervention and the effect of participation on 
agitation. Reduced agitation in the active intervention over the passive intervention, and in both 
interventions over the baseline measurements was anticipated. Results show that verbal 
participation was associated with reduced Physical Non-aggressive behaviors during the active 
intervention as expected. Additionally, Verbal agitated behaviors were also reduced during the 
active intervention over baseline measurements. Unanticipated results include the passive 
intervention being favored over the active; however, the passive intervention did not demonstrate 
a significant effect over the baseline measurements.  Also unexpectedly, baseline measurements 
illustrated greater reductions in Physical Non-aggressive behaviors over the active intervention 
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despite the strong correlation between verbal participation and Physical Non-aggressive 
behaviors.  
Findings suggest that verbal participation (e.g., singing, humming, whistling) in an active 
music intervention does help regulate Physical Non-aggressive agitated behaviors in individuals 
with AD and related dementias. However, people not verbally participating had greater Physical 
Non-aggressive behaviors, creating the effect of favoring the baseline measurements over the 
active intervention. This clearly demonstrates that it is important to fully engage participants and 
encourage verbal participation in active music interventions for maximum efficacy. Additionally, 
the reduced Verbal agitation during the active intervention illustrates the greater efficacy of 
active music interventions over passive. The greater focus on the music and the additional 
cognitive stimulation participation in an active intervention provides over a passive one probably 
produced this effect. However, results also indicate reduced Verbal agitation for people who 
were not necessarily verbally participating in the active intervention as well. This is likely due to 
being more focused on the music during the active intervention versus the passive intervention, 
which mostly only included music playing in the background during other activities. Since the 
baseline measurements also included other activities, but did not have music on in the 
background, no effect of the passive music intervention was found. Had the passive intervention 
included greater focus on the music, an effect may have been found.  
The current study also adds to the field of knowledge about music’s effects on AD and 
related dementias, especially regarding the implementation of music interventions and the effects 
on specific types of agitation. While only certain types of agitated symptoms were reduced, this 
study demonstrated that active verbal participation is important to the intervention’s efficacy. It 
also demonstrated that the setting and the type of music may make a difference when 
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implementing music interventions in a group, and that interventions should be kept consistent 
with the primary focus on the music whenever possible. Additionally, this study strengthens the 
theoretical base in research on music interventions’ efficacy of reducing agitated behavioral 
symptoms in individuals with AD and related dementias by demonstrating the effects of active 
music interventions and backing up the theory of the effect of music as the focal point and thus 
reducing the stress of trying to comprehend other environmental stimuli concurrently (Gerdner, 
1997; Hall & Buckwalter, 1987). A robust theoretical base in research regarding music’s effects 
on dementia can help strengthen the existing theories and help advance further, more complex 
models and explanations of how and why music has an effect. 
 Lastly, the use of music interventions to treat agitated behavioral symptoms of dementia 
has become widely implemented at many care facilities for older adults both nationwide and 
around the globe. Policy-makers should include any non-pharmacological treatments for 
dementia that are evidence-based since a multidisciplinary approach is required to effectively 
manage the symptoms of the disease. This includes the use of music by means of both passive 
listening, with programs such as Music and Memory, and music groups involving active singing 
and playing that have been implemented at many nursing homes, respite centers, and other care 
facilities for older adults. Frequently, music programs such as these are only implemented when 
sufficient funding is available to organizations, and even after programs are implemented 
through federal, state, or local policies, they often go unused or underutilized. While federal and 
state policies may be necessary to fund music programs at care facilities for older adults, 
organizational policies regarding the use and training for implementation of such programs at a 
local level are necessary to ensure that not only are music programs available to individuals with 
AD and related dementias, but that they are properly utilized.   
188 
 
The use of music interventions to reduce agitation and improve, especially in the short-
term, wellbeing among individuals with AD and other related dementias looks promising. 
However, additional research with improved internal and external controls - especially to reduce 
measurement errors, improve intervention/treatment fidelity, and improve external validity and 
generalizability - is needed.  Improved research designs and methodologies will assist scholars in 
their efforts to delineate such things as the effects associated with active versus passive music 
interventions, and the effects associated with individualized versus classical or other non-
individualized music interventions.  These methodological improvements may not only help 
scholars to elaborate on a theoretical basis for the beneficial influences of music therapy on AD 
individuals, but could very well improve multidisciplinary treatment regimens for AD suffers, 
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